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Glycans can be found in every living organism from plants to bacteria and viruses to 
human. It has been known that glycans are involved in many biological processes such as 
structural roles, specific recognition with glycan-binding proteins, and host-pathogen 
recognitions.  However, the understanding of glycan structure-function relationship is limited due 
to the structural complexity and heterogeneity. In this work, chemical approaches have been 
developed to facilitate the investigation of structures and functions of glycans. A tetrazine 
auxiliary was synthesized and its utility in a variety of glycomic applications including purification 
and fractionation of complex carbohydrates, compatibility in chemoenzymatic reaction with 
glycosyltransferases, and direct conjugation to chemical probes was demonstrated. A new 
chemoselective transformation of aldehydes to nitriles was discovered and found to be useful for 
a variety of substrates such as reducing sugars and simple aldehydes. Furthermore, the chemical 
tools were applied to the chemical investigation of poly(ADP-ribose) including the 
functionalization of ADP-ribose with the tetrazine auxiliary and the synthesis of a photoremovable 
b-NAD+ analogue.
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CHAPTER 1 
INTRODUCTION TO GLYCANS AND CHEMICAL TOOLS 
 
1.1. Introduction to Glycans and Their Biological Functions 
 Glycan is a generic term that refers to any type of carbohydrates from simple 
monosaccharides to complex oligo- and polysaccharides. Glycans can be found as 
glycoconjugates by connecting to different macromolecules such as proteins and lipids, 
and they are also found as free glycans.1 Glycoproteins are polyamides that contain 
saccharides covalently attached via N- or O-linkages to the peptide backbone. It was 
reported that more than half of all proteins are glycosylated, of which 90% are observed 
to have N-glycosylation and around 10% are O-glycosylation.2 Glycan in glycolipid is 
usually covalently linked to the terminal hydroxy group of the lipid moiety.1  
There are many monosaccharides available in nature; however, only 10 are 
commonly found in mammalian glycans including D-glucose, D-galactose, D-mannose, N-
acetyl-D-glucosamine (GlcNAc), N-acetyl-D-galactosamine (GalNAc), L-fucose, D-xylose, D-
sialic acid, D-glucuronic acid, and D-iduronic acid (Figure 1.1).3 To avoid the complication 
when drawing these glycan structures, the Consortium of Functional Glycomics (CFG) has 
agreed to use the glycan symbol system which uses shapes and colors to indicate 
monosaccharides.4 The symbols of 10 common monosaccharides are shown in Figure 1.2.  
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Mannose 
N-Acetylglucosamine 
N-Acetylgalactosamine 
Fucose 
Sialic acid 
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Figure 1.2: Glycan symbols. 
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Figure 1.1: Monosaccharides commonly found in mammalian glycans.  
D-Glucose D-Galactose D-Mannose 
N-Acetyl-D-glucosamine 
N-Acetyl-D-galactosamine 
L-Fucose D-Xylose D-Sialic acid 
D-Glucuronic acid L-Iduronic acid 
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Each monosaccharide can form a glycosidic linkage from its anomeric carbon to 
any hydroxyl group of another monosaccharide to create disaccharide. The configuration 
at the anomeric center can be either an a or b form (Figure 1.3). Each different 
configuration plays a unique role in biological functions. The structures of glycan become 
more complicated when the number of monosaccharides is higher because they can form 
linear or branched oligosaccharides. The study of mammalian oligosaccharides revealed 
that 25% of oligosaccharides are in linear form, and the rest of them contain at least one 
branch.3 Also, the average number of monosaccharides in mammalian oligosaccharides is 
about 8 units.3 
 
 
 
Glycans are involved in almost all biological processes. They are found in all living 
systems, including prokaryotic and eukaryotic cells. The roles of glycans can be divided 
into three major categories: (i) structural and modulatory roles, (ii) specific recognition 
with other biomolecules which can be divided into two subclasses including intrinsic 
O
O
O
OH
HO
OH
HO
HO
HO
OH
O
O
O
HO
HO
HO
OH
HO
HO
OH OH
OH
힫-(1→4)-Glycosidic bond
훂-(1→4)-Glycosidic bond
Figure 1.3: Illustration of glycosidic bonds; (a) b-glycosidic bond, (b) a-glycosidic bond. 
a b 
 4 
(intraspecies) recognition and extrinsic (interspecies) recognition, and (iii) molecular 
mimicry of host glycans.1,5 
The most obvious structural role that glycans serve is a plant cell wall which 
contains cellulose and hemicelluloses.6 The glycocalyx (glycoproteins and glycolipids) 
covers the surface of endothelial cells in bacteria and other cells are involved in many 
processes such as cell adhesion, maintaining and providing humidity in cell, and providing 
protection of cell from other substances such as antibiotic compounds.7 Inside the cell, 
glycans are known to participate in the folding of proteins synthesized in the endoplasmic 
reticulum (ER) and Golgi by covalent modifications such as O-mannosylation.5,8 
Furthermore, the glycosylated proteins can either prevent or induce the degradation of 
proteins from the proteasome.5,9 There are other roles of glycans related to physical 
properties such as increased water solubility of macromolecules, lubrication of mucins, 
protection from immune recognition, etc.5,9 
It is well known that glycans are involved in recognition and signaling processes. 
There are examples reported which signify the role of glycans in cellular trafficking such 
as the mannose-6-phosphate recognition in the ER-Golgi pathway.5 Figure 1.4 illustrates 
the interactions and recognitions of glycans with glycan-binding proteins (GBPs), bacteria, 
and viruses.10 The specific recognitions of glycans and GBPs (lectins, antibodies, and 
enzymes) mediate biological functions such as cell-cell adhesion, regulation of proteins 
and protein turnover, regulate phosphorylation.10 Furthermore, glycans can mediate the 
recognition between species such as host-pathogen recognition. For example, viruses 
recognize sialic acids on a host cell containing hemagglutinins.5 
 5 
  
 
Glycans are the most diverse biomacromolecules. The non-template formation 
and heterogeneity of glycan chains can participate in multiple ways in biological 
processes. Glycans are usually formed as mixtures, which made it difficult to predict their 
specific roles. Also, the different functions can be found from the same glycans depending 
on the cellular- and tissue-specific locations that glycans present.9 The study of glycan has 
advanced in the past decade; however, there are more glycans yet to be studied and 
discovered. Therefore, it is necessary to have robust and reliable methods to elucidate 
the structures and functions in glycobiology. 
Figure 1.4: General roles of glycans in cell. Reprinted from ref 10 with permission 
from Elsevier. 
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1.2. Methods to Elucidate Structures and Biological Functions of Glycans 
There are four major classes of macromolecules in living systems, including 
proteins, nucleic acids, lipids, and glycans. Despite the advances in the study of proteins 
and nucleic acids (DNA and RNA), the development of tools in glycan studies is deficient. 
One of the major reasons that impedes developments in glycobiology is the diversity of 
glycans in nature. While proteins and nucleic acids are formed in a template-directed 
manner, glycans can be linear or branched at a variety of available hydroxy positions. 
Furthermore, the glycosidic linkages that connect two monosaccharides can be either an 
a- or b-linkage, and they have distinct biologically recognition. Therefore, it is a challenge 
for scientists to elucidate the structures of glycans and their biological functions. 
 
1.2.1. Releasing of Glycans 
 In nature, glycans are in the form of glycoconjugates such as glycoproteins, 
glycolipids, glycosphingolipids, etc. There are two main strategies to release glycans: 
enzymatic release and chemical release. Peptide-N-glycosidase F (PNGase F) is an enzyme 
that cleaves all N-glycans that have a linkage between the core GlcNAc and asparagine 
residue.11 However, it cannot release glycans that contain fucose-linked GlcNAc attach to 
the protein.12 Other N-glycan releasing enzymes such as endoglycosidase H (endo H), 
which releases high-mannose glycans, endoglycosidase D (endo D) which cleaves all types 
of N-glycans, and endoglycosidase F3 (endo F3) which cleaves biantennary (two branches) 
and triantennary (three branches) glycans.11,13 Although there are many enzymes 
available for releasing N-glycans, the enzymatic release of O-glycans is challenging. 
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Currently, endo-a-N-acetylgalactosaminidase (O-glycanase) is the only enzyme available 
which cleaves O-glycans between GalNAc and serine or threonine residues.14 
 A chemical release is an option for releasing both N- and O-glycans from 
glycoconjugates. Reductive b-elimination under alkaline solution followed by sodium 
borohydride to reduce the terminal end of released glycans is commonly used for O-
glycans.11,15 Hydrazinolysis is another approach to release N- and O-glycans using 
hydrazine to functionalize the reducing end of glycan.16,17 Recently, the oxidative release 
of glycans from their natural sources using sodium hypochlorite (NaClO) was reported to 
be an alternative approach.18 Although the chemical release of glycans is useful and 
accessible, there are concerns about the degradation of glycans during the chemical 
treatments.  
 
1.2.2. Derivatization of Glycans 
 After releasing glycans from glycoconjugates, free glycans are usually derivatized 
with functional groups prior to further analysis. Due to the characteristics of native 
glycans which are very polar and lack a chromophore, derivatizing glycans with 
hydrophobic and fluorescent or UV active compounds would benefit the separation and 
detection of a glycan pool and would also enhance the ionization signal for mass 
spectrometry (MS). 
 Glycan is usually chemoselectively labeled at the reducing end because it contains 
an aldehyde group. A reductive amination is a popular approach for labeling glycans with 
chromophores or fluorophores. Details of the reactions on the reducing end of glycan will 
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be described in chapter 1, section 1.3. A variety of labeling compounds have been 
developed such as 2-aminobenzoic acid (2-AA), 2-aminobenzamide (2-AB), 2-
aminopyridine (2-AP), and 8-aminopyrene-1,3,6-trisulfonic acid (APTS) (Figure 1.5).19 
Permethylation is another approach to modify glycans by converting hydrogens 
on hydroxyl groups, amine groups, and carboxyl groups to a methyl group.15 This method 
is commonly used to derivatize glycans before analyzing with mass spectrometry (MS) 
because it enhances ion intensity and facilitates the spectral interpretation.20 
Furthermore, the labile bond between sialic acid and other saccharides can be stabilized 
by permethylation.  
 
 
 
1.2.3. Mass Spectrometry 
 The structural complexities and variation in the physical properties of glycans have 
challenged scientists to investigate their structures relating to biological functions. There 
O NH2
NH2
O OH
NH2 N NH2
2-Aminobenzamide 
(2-AB)
2-Aminobenzoic acid
(2-AA)
2-Aminopyridine 
(2-AP)
HO3S
HO3S
SO3H
NH2
8-Aminopyrene-1,3,6-trisulfonic acid
(APTS)
Figure 1.5. Structures of glycan labels. 
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are several approaches currently developed in an attempt to study and characterize the 
structures of glycans. At present, mass spectrometry (MS) is a powerful technique for 
obtaining structural information of glycans because it requires a small sample and 
provides high sensitivity.15 The limits of detection of MS techniques is in the range of 
femtomolar to attomolar.15,21 There are two general ionization techniques, electrospray 
ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). The benefit of 
using the ESI technique is that it can be coupled with liquid chromatography. In addition, 
both neutral and anionic glycans (such as sialylated compounds) can be analyzed in 
positive mode via an ESI. In contrast, MALDI detects neutral glycans in a positive mode 
and anionic glycans in a negative mode.15 However, MALDI ionization is still widely used 
for the analysis of glycans obtained from biological samples because it has higher 
sensitivity and tolerance to contaminants compared to ESI. Also, MS spectra obtained 
from MALDI ionization is simple to determine compared to spectra from ESI.22 
 The structural analysis of glycans can become more complicated when the sample 
contains mixtures of complex glycans. Therefore, the chromatographic separation of the 
mixtures prior to analysis by MS can be useful. Liquid chromatography is very common 
for the separation of complex glycans. There are several approaches for liquid 
chromatography depending on types of stationary phase. Reverse-phase liquid 
chromatography (RPLC) is the method that uses hydrophobic (C18 or C8) functionalized 
silica as the stationary phase. Hydrophilic interaction liquid chromatography (HILIC) is the 
technique that uses a highly polar stationary phase such as bare silica particles, amine-, 
amide-, or zwitterion-bonded silica.23 Glycans will interact with the stationary phase via 
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hydrogen bonding, dipole-dipole, or ion-dipole interactions.15 Porous graphitized carbon 
(PGC) is becoming more popular to use as a stationary phase. Although PGC is considered 
as a hydrophobic stationary phase, native glycans and reduced glycans tend to retain 
better than on a C18 column. Hydrophobic, polar, and ionic interactions between glycans 
and PGC column allow glycans to retain longer in the column.24 Figure 1.6 is an example 
demonstrating the separation and MS analysis of N-glycans released from 
immunoglobulin G (IgG).25 Figure 1.6a shows the ability to separate complex glycans 
through HILIC technique and Figure 1.6b shows MALDI-MS data obtained after 
permethylation of released glycans. 
 
for N-glycan release, enrichment, permethylation, and LLE.
Test methods written were run in simulation mode to minimize
errors and the automatically generated error messages were
rectified by making changes to the script. After running error
free simulation methods, all sample processing methods were
tested for wet chemistry runs, followed by processing of real
samples. The liquid handling robot deck consisted of a chemical
resistant vacuum manifold to harbor the cleanup plate. The
robot was not equipped with a built-in and integrated plate
shaker, incubator, or plate sealer. At these steps an on-screen
instruction was setup to prompt the user to manually perform
shaking, incubation or plate sealing, and press “OK” when
required action was performed. The most challenging method
to automate was the HT permethylation technique, especially
at the LLE steps, due to the volatility of the liquids such as MeI
and DCM involved. As a consequence, these liquid handling
steps involved prewetting the tips to overcome loss of volatile
liquids and the use of the liquid level detection to obtain good
sample recovery after four cycles of LLE steps. Automating the
workflow resulted in efficient sample handling with reduced
sample preparation times, lack of human errors that can arise
from manual pipetting, and it eliminated performing the
manually labor intensive LLE steps. We analyzed the following
samples glycoprotein standards (human IgG, fetuin O-glycans),
N-glycan standards, and biopharmaceutical samples (IgG1 mAb
standard, IgG4 mAbs, and rhEPO) using the automated HT
methods described.
Glycoprotein Standards. The methods for N-glycan
release, glycan purification and permethylation were validated
according to EMAs ICH Q2 (R1) analytical validation
guidelines.33 A few of these validation characteristics such as
accuracy, repeatability (intraday variation), and intermediate
precision (interday variation) are described in the following
section. See SI, section 1.3, for ICH Q2 (R1) validation for
details regarding linearity, working range, specificity, limit of
detection, and limit of quantitation. See SI, Figures S-1−S-4, for
the corresponding illustrations of these validation parameters.
Accuracy of Method. We analyzed human IgG N-glycans
using the automated HT permethylation method and compared
the data to those obtained from UHPLC analysis by
fluorescence detection, as shown in Figure 1A,B. Samples
were analyzed in triplicate and results were averaged. The peaks
from 13 major N-glycans were integrated and then normalized
to the sum of intensities. The averaged relative intensities (RIs),
standard deviations (SDs), and CVs were calculated from
triplicate sample analysis using UHPLC and MALDI-TOF-MS,
as shown in SI, Table S-1. For MALDI-TOF-MS signals with
RIs above 5%, the CVs were <12.3% compared to CVs of
<0.81% for the UHPLC data. The analysis confirmed that peaks
with higher RIs showed good correlation between the two
methods, while smaller peaks below 5% RI showed slight
variation particularly for the sialic acid containing glycan
species.
Repeatability (Intraday and Interday Variation).
Glycans from 6 independent human IgG glycoprotein standard
samples (50 μg) were released, enriched, permethylated and
analyzed by spotting these six samples only once on the
MALDI target. Glycan signals from these spectra were
integrated, normalized and the RIs, SDs and CVs were
calculated for the 13 major N-glycan peaks. The CVs for RIs
were <11.16% for the major N-glycans from IgG with a relative
area of ≥5%, as shown in SI, Table S-2. The same experimental
set up was applied to ten human IgG glycoprotein samples (50
μg) on two separate days to evaluate interday variability or
intermediate precision. The variation between average intensity
values for human IgG N-glycans prepared and analyzed on two
different day samples gave CVs < 11.4% for glycans with ≥5%
RI, with an exception of two N-glycans with m/z value of
2285.1 and 2605.3, which gave CVs of 42% and 25%,
respectively, as shown in SI, Figure S-5, section A. A linear
regression plot of the relative values from two different days
gave an R2 value of 0.98, indicating a high level of correlation
between the two data sets, as shown in SI, Figure S-5, section B.
Comparison with Manual In-Solution Permethylation.
The in-solution permethylation method was used as reference
standard for the development of the HT permethylation kit. SI,
Figure S-6 shows a comparison of the MALDI-TOF-MS
profiles from human IgG N-glycans permethylated using the
manual in-solution protocol (Figure S-6, section A) and
automated HT permethylation protocol (Figure S-6, section
B). The RIs of peaks were acquired from one sample for each
protocol and spotted on the MALDI target once. Both spectra
appear very similar with the advantage of identifying a few extra
glycan species with m/z values of 2401.0 (H4N4F1S1), 2431.2
Figure 1. Comparison of PNGase F released and purified human IgG N-glycans analyzed with orthogonal methods. N-glycans were analyzed by (A)
HILIC UHPLC after 2-AB labeling and (B) MALDI-TOF-MS after permethylation. Sample processing and preparation for both methods was
performed using the liquid handling robot. Permethylated N-glycans were registered as [M + Na]+.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.6b01639
Anal. Chem. 2016, 88, 8562−8569
8565
Figure 1.6: Glycans released from human IgG: (a) HILIC UHPLC chromatogram after 
2-AB labeling and (b) MALDI-TOF-MS after permethlyation. Reprinted with 
permission from ref 25. Copyright (2016) American Chemical Society. 
a 
b 
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1.2.4. Microarray 
  Inspired by the studies of DNAs and proteins through the array technologies, 
glycan microarrays were introduced to study the interaction of glycans with glycan-
binding proteins (GBPs). The process of this technique includes (i) the immobilization of 
glycans on the solid surface, (ii) the introduction of GBPs, and (iii) detection, as 
demonstrated in Figure 1.7.26  
The approach to the immobilization of glycans on the surface is important because 
it can affect the interaction of GBP. There are two major strategies including noncovalent 
and covalent immobilizations.27 The most convenient strategy is to use polysaccharide 
arrays because glycans can be noncovalently immobilized on the nitrocellulose surface 
without chemical modification.28 However, this technique is limited to glycans with high 
molecular weights. The most commonly and extensively used technique to immobilize 
glycans on the surface is by chemically modifying the reducing end of glycans with a linker, 
a NADPH oxidase inhibitor. The ndings suggest that carbo-
hydrate microarrays can be employed to simultaneously screen
glycans that elicit a cellular response by binding to the cell-
surface lectins.
Results and discussion
To date a number of immobilization methods of glycans on the
solid surface have been developed to prepare carbohydrate
microarrays.7b Most immobilization techniques include the
attachment of modied glycans on a properly derivatized
surface. However, the synthesis of modied glycans containing
functional group appendages, which are required for immobi-
lization, is time-consuming and sometimes difficult. To avoid
this task, we previously developed a facile immobilization
protocol which relied on the attachment of unmodied glycans
to a hydrazide-coated glass slide.13 In this method, mono-, di-,
oligo- and polysaccharides can be site-specically and cova-
lently attached to the solid surface. Thus, we used this method
to prepare the glycan microarrays employed in the present
study.
Carbohydrate microarrays were constructed by printing
thirty unmodied glycans (2.6 nL, mono (1–7), di (8–11), oligo
(12–15, 18) and polysaccha ides (16 and 17, 19–30)) and a high-
mannose glycan containing invertase (31) (Table 1 and Fig. S1†)
on a hydrazide-coated glass slide by using an automatic pin-type
microarrayer (spot size: ca. 200 mm in diameter).13 To initially
test the successful attachment of glycans on the surface, glycan
microarrays were probed with several Cy3-label d lectins,
including A. aurantia (AA), wheat germ agglutinin (WGA), R.
communis agglutinin I (RCA120) and Concanavalin A (ConA). The
results of the microarray data analysis show that the glycan
binding properties of lectins match those observed in previous
studies (Fig. S2†).13 This nding indicates that carbohydrate
probes become attached to the hydrazide-modied glass slide.
Studies were then conducted to determine if the glycans on
the microarrays are recognized by cells expressing the lectin. To
this end, DCEK cells expressing SIGN-R1 on the surface (DCEK-
SIGN-R1 cells, Fig. S3†) were grown under adherent culture
conditions16 and then detached from the culture dish by treat-
ment with a mixture of EDTA and trypsin. Aer centrifugation
and washing to remove the remaining EDTA and trypsin, cells
in culture media were applied to glycan microarrays washed
with 70% ethanol for sterilization. Microscopy image analysis of
microarrays incubated for 1 h at 37 !C reveals that the cells do
not adhere to glycans immobilized on the surface.
We assumed that this phenomenon might be a consequence
of cell-surface lectin damage caused by trypsin. Thus, in order
to avoid the use of trypsin during the cell harvesting process,
DCEK-SIGN-R1 cells were cultured in an uncoated plastic dish
under non-adherent conditions. The cell aggregates in the
suspension culture were then disassembled by cell shearing
with pipetting. Aer centrifugation, various densities of cells
(105 to 5 " 107 cells per mL) were applied to carbohydrate
microarrays washed with 70% ethanol, which were then incu-
bated for 1 h at 37 !C. Notably, cells cultured under the non-
adherent conditions recognize glycans on the microarrays in
a cell density-dependent manner (Fig. S4†). A cell density of 107
cells per mL was found to be appropriate for generating repro-
ducible and reliable microarray data. Specically, DCEK-SIGN-
R1 cells reproducibly adhere to a-mannose containing glycans
including 1, mannobiose (8, 9), a high-mannose conjugated
invertase (31), S. cerevisiaemannan (16) and C. albicansmannan
(17).14 Also, t ese cells bind to terminal fucose (5, 12–15)5 and
GlcNAc bearing glycans (4, 10).15 However, DCEK-SIGN-R1 cells
do not recognize b-mannose bearing glycans (18–21) and N-
acetylated (2) and 6-phosphorylated mannose (3), a phenom-
enon which is consistent with previous results.14 The invertase
containing a high-mannose glycan and C. albicans mannan
among glycans tested were found to reproducibly bind to DCEK-
SIGN-R1 cells with the strongest affinity.
To determine if the nonselective adhesion of DCEK-SIGN-R1
cells to glycans occurs, competition experiments using S. cer-
evisiae mannan, a tight binding ligand of SIGN-R1,16 were
Fig. 1 A carbohydratemicroarray based approach for the screening of functional glycans which stimulate ROS production by binding to the cell-
surface lectin. Unmodified glycans are immobilized on the hydrazide-coated glass slide to construct carbohydratemicroarrays. Lectin expressing
cells pretreated with a ROS probe are applied to the carbohydrate microarrays. The fluorescence intensity of each spot is measured by using
a microscopy and/or a microarray scanner.
This journal is © The Royal Society of Chemistry 2016 Chem. Sci., 2016, 7, 2084–2093 | 2085
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Figure 1.7: Illustration of process s in the stu y f glycan microarray. 
Reprinted with permission from ref 26. Copyright 2016 Royal Society of 
Chemistry. 
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then covalently attaching on the surface. This strategy will allow for site-specific 
attachment. Furthermore, linkers that contain a chromophore or fluorophore provide the 
ability to determine the concentration of glycans printed on the surface array. Therefore, 
it is important to select the appropriate linker and type of reaction to attach the glycans 
and construct the glycan arrays. It is known that the nature of the linker, length, and 
functional group can affect the binding-proteins. There are several ligation reactions 
reported, and examples are shown in Table 1.1.27 The maleimide-thio reaction (entry 1) 
is one of the earliest methods for the immobilization of a glycan array.29,30 In this 
approach, carbohydrates were functionalized with a thiol-terminated linker and 
immobilized on the maleimide-coated surface. However, the major drawback of this type 
of reaction is that the thiol functional group can be readily oxidized with air, which 
requires caution while constructing the array. The selective reaction between hydrazide 
and epoxide was introduced in 2005.31 A hydrazide-based linker was functionalized onto 
a carbohydrate then immobilized on the surface that was coated with epoxide (entry 2). 
This reaction is highly selective even though there are other nucleophiles such as thiols 
and amines present in the reaction. The inverse-electron-demand Diels-Alder (IEDDA) 
reaction was introduced in 201232 for the production of glycan arrays (entry 3). In this 
process, the electron-rich dienophile was attached to the carbohydrate, and the electron-
poor diene (tetrazine) was coated on the surface. This reaction is fast and highly selective 
without the need of a catalyst. Copper-catalyzed cycloaddition between alkynes and 
azides were also developed for glycan array applications. In this approach, an alkyne-
terminated linker was attached to a carbohydrate, then immobilized on the azide-coated 
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surface via a Cu(I)-catalyzed 1,3-dipolar cycloaddition. Similar to the IEDDA reaction, this 
reaction is highly chemoselective while there are other functional groups present. 
 
 
Table 1.1 Example of the immobilization reactions on the surface array. 
Entry Reaction Representative scheme 
 
1 
 
Maleimide-thiol reaction 
 
 
2 
 
Epoxide-hydrazide 
reaction 
Tetrazine-dienophile 
cycloaddition 
 
 
3 
 
Tetrazine-dienophile 
cycloaddition 
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Azide-alkyne 
cycloaddition 
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The interaction of glycans printed on the array and GBPs represents the 
interaction that happens in a cell (Figure 1.8a).33 Designing and constructing glycan arrays 
is important because the recognition of GBPs depends on the orientation of the glycans, 
the spacing between glycans, and the length of linker from the surface27,33,34 (Figure 1.8b). 
An array that contains a high density of glycans enables multivalent interaction between 
glycans and proteins, which is suitable for the study of GBPs that have weak interaction 
with glycans at the monovalent level. 
Figure 1.8: Comparing interaction between glycans and GBPs: (a) in a cell, 
(b) on the microarray. Reprinted from ref 33 with permission from 
Elsevier. 
T174). Therefore, there is a need to improve this tech-
nology and better understand how to interpret results.
This review will focus on recent advances and challenges
of glycan array technology.
Expanding structural diversity on glycan
arrays
The size and diversity of carbohydrates on a glycan array
contribute significantly to the information extracted from
Glycan array advances Oyelaran and Gildersleeve 407
Figure 1
Carbohydrate–macromolecule interactions. (a) Interaction of carbohydrate binding proteins and macromolecules with cell surface glycans presented
on glycoproteins and glycolipids. (b) Optimal spacing and orientation of carbohydrate ligands is critical to achieve high avidity multivalent binding.
www.sciencedirect.com Current Opinion in Chemical Biology 2009, 13 :406 –413
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There are many detection methods for the study of glycan microarrays (Figure 
1.9)27. The most commonly used is fluorescence detection because the reagents are 
commercially available and the instruments that measure fluorescence are common for 
many laboratories.27 The general approach is to attach fluorophores on either GBPs or 
secondary reagents that bind the GBPs. Then, the binding interaction can be analyzed 
based on the fluorescence intensity (Figure 1.9a). Other glycan array detection 
approaches including mass spectrometry detection35  which have been used to monitor 
enzymatic reaction (Figure 1.9b) and surface plasmon resonance (SPR) imaging36,37 which 
is used for real-time imaging of binding interactions (Figure 1.9c).  
 
 
 
4318 Chem. Soc. Rev., 2013, 42, 4310--4326 This journal is c The Royal Society of Chemistry 2013
There are many variations of this approach; some examples
include (1) direct fluorophore labeling of the GBP of interest, (2)
use of a fluorophore-labeled secondary reagent that binds the
GBP, and (3) use of a fluorophore-labeled secondary reagent
that binds a tag (e.g. biotin, His tag) on the GBP. The advantage
of this strategy is that there are many well-established systems
and commercially available reagents for this approach. For
example, biotinylated proteins can be readily monitored with
fluorophore-labeled streptavidin, and anti-glycan antibodies
can be readily detected with labeled secondary antibodies. In
addition, microarray scanners with fluorescence detection are
accessible in many laboratories due to their common use in DNA
microarray experiments.
While fluorescence detection is a versatile approach and has
been used in the majority of glycan microarray studies, there
are important limitations. First, modifications to GBPs, such as
fluorophore-labeling, biotinylation and insertion of a His tag,
can reduce activity or alter selectivity of binding.156 Second,
fluorophore-labeled secondary reagents are not available for
many proteins, especially newly discovered GBPs. Third, some
secondary reagents can have glycan-binding properties of their
own. For example, many polyclonal antibodies used to detect
proteins contain carbohydrate-binding antibodies within the
mixture. Therefore, one must ensure that proper controls are in
place to correctly interpret results. Finally, most fluorophores
are sensitive to light and prone to oxidative degradation. Therefore,
signal intensity will decrease over time and can vary with
experimental conditions. Due to these limitations, there has
been considerable interest in developing alternative detection
strategies, especially label-free methods.
One attractive alternative to fluorescence detection involves
analysis by MS (Fig. 11b). This approach has primarily been
used to monitor enzymatic reactions on slide surfaces that
result in a change in mass (see Section 4.4).157–162 Surface
plasmon resonance (SPR) imaging has also been used as a
label-free detection method for glycan microarrays (Fig. 11c).
SPR imaging offers real-time monitoring of binding events
with the capacity to measure kinetics and thermodynamics of
binding. A nice example comes from the work of de Boer
and colleagues using a ‘‘natural glycan array’’,130 an array
containing glycans isolated directly from a natural source.
The authors isolated N-linked glycans and glycolipids from
the pathogen S. mansoni, constructed microarrays immobilized
by these glycans, and then used an SPR imaging method to
profile binding of human serum antibodies and serum lectins
of infected and non-infected individuals. SPR imaging has
also been used to profile plant lectins and identify potential
inhibitors of the biological toxin ricin.163 While this approach
has a number of advantages, the technology is somewhat
limited in the total number of array components that can be
accommodated.
In addition to these methods, several methods have been
developed as alternative detection strategies. These include
detection of radioactivity,164,165 oblique-incidence reflectivity
difference (OI-RD) microscopy,166 electrochemoluminescence,167
complementary metal oxide semiconductor-based electric signal
readout,168 and cantilever-based detection.169
4. Applications
4.1. Rapid analysis of glycan–protein interactions
Since their advent in 2002,12–16 applications of glycan microarrays
to biological and biomedical research have been rapidly expanded.
Most extensive use of this technology has been in the high-
throughput analysis of the binding properties of proteins
(Fig. 12). Basically, all alleged GBPs can be assessed by using glycan
microarrays combined with any detection system, especially, a
fluorescence detection method. In general, supplementary assays
are required to obtain knowledge about key characteristic features
of the samples before and after screening to assure sample
activity and validation of the detected glycan binding.
4.1.1. LECTINS. Initially discovered in plants, lectins are
now identified in most microbes and animals.4 Through well-
defined carbohydrate-recognizing domains (CRD), lectins bind
to carbohydrate structures without effectuating changes in
glycan structures. Plant lectins are important tools for biological
research and diagnosis and their binding specificities have
long been extensively investigated by using conventional
solution-based methods, in particular, the hemagglutination
inhibition assay.170,171 Glycan microarrays probed with a wide
range of plant lectins have provided important information
about the detailed binding patterns and identified new glycan–
lectin interactions (see collections of lectin binding specificity
data obtained at website of CFG, www.functionalglycomics.
org).18,31,71,125
Fig. 11 Detection methods of glycan microarrays. (a) Binding events of
fluorophore-labeled proteins to glycans on microarrays can be monitored by
using a fluorescence scanner. (b) Enzymatic reactions on microarrays can be
detected using MS. (c) SPR imaging can be used as a label-free detection method
for glycan microarrays.
Fig. 12 Application of glycan microarrays for rapid analysis of glycan–protein
interactions.
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Figure 1.9: Detection methods for the study of glycan microarrays: (a) fluorescence 
detection, (b) mass spectrometry detection, and (c) surface plasmon resonance 
detection. Repri ted with permission from ref 27. Copyright 2013 Royal Society of 
Chemist y. 
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1.2.5. Imaging via Chemical Probes 
 For a complete understanding of the roles of glycans, it is necessary to be able to 
detect the changes of glycans and other events in biological systems. The development 
of imaging technology provides the ability to visualize and detect the changes of glycans 
in cellular processes by conjugating the chemical reporters onto glycans then visualizing 
by chemical probes that can specifically react with the reporters.38 This type of reaction 
is called bioorthogonal chemistry. Currently, there are many bioorthogonal reactions 
available depending on the types of applications. Examples of bioorthogonal reactions are 
presented in Table 1.2.38 Copper-catalyzed azide-alkyne cycloaddition39,40 (entry 1) is 
shown to be widely used for biomolecule labeling in vitro because the sizes of the 
functional groups are very small. However, it is not suitable for in vivo labeling because 
Cu(I) is cytotoxic.  
Strain-promoted azide-alkyne cycloaddition (SPAAC) was later introduced for the 
chemoselective cycloaddition without using a cytotoxic metal catalyst41 (entry 2). This 
reaction was designed to use a ring-strained cyclooctyne which promptly reacts with azide 
under ambient condition. SPAAC has been widely used for biomolecule labeling for 
imaging in vivo.42–44 Another popular cycloaddition for biomolecule labeling is the 
reaction between an azide and triaryl phosphine, which is called Staudinger ligation45,46 
(entry 3). This reaction is highly selective and suitable for a cellular environment. Although 
the rate of the Staudinger reaction is often slow, it is widely used for in vivo studies 
because this reaction is compatible with living cells.47,48 The IEDDA reaction between 
trans-cyclooctene and tetrazine (entry 4) is another popular choice for imaging in living 
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systems because the reaction rate is fast with a rate constant from 103 to 106 M-1s-1.49,50 
Furthermore, only small amounts of reagents are required for the reaction without using 
an excess of chemical probes which improves the signal-to-noise ratios.38 
 
 
 
Table 1.2 Example of bioorthogonal reactions.a  
Entry Reaction Reactant 1 Reactant 2 
 
1 
 
Copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) 
  
 
2 
 
Strain-promoted azide-alkyne 
cycloadditions (SPAAC) 
 
  
 
3 Staudinger ligation 1,3-Cycloaddition 
  
 
4 
Inverse electron-demand Diels-Alder 
reaction 
 
 
R N3
R
PPh2
OMe
O
R , Cu(I)
R N3
R N3
R
N
N N
N
R R’
R
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1.3. Chemoselective Reaction with Unprotected Carbohydrates 
As introduced in section 1.2.2, the current methods to investigate biological 
functions of glycans can be accomplished by conjugating glycans with noncarbohydrate 
molecules (ex, auxiliaries, linkers, fluorophores), then studying the glycoconjugates 
through various techniques such as attachment on the microarrays, labeling of glycans 
for bioimaging,20 etc. 
A number of chemoselective reactions have been developed over the past decade 
including O-, N-, S-, and C-linked glycoconjugates.51 In this thesis, only examples that are 
relevant to our projects will be described. The main idea of these reactions is to take 
advantage of the reducing end of carbohydrate as it contains an aldehyde in a ring-
opened form (Scheme 1.1). This unique property provides the ability to conjugate directly 
at this position without disturbing other functional groups. Therefore, carbohydrates can 
be directly functionalized without a need for protecting groups.  
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R’
O
R
OH
HO
N
Reductive aminat
ion
Ox
im
es
 a
nd
 h
yd
ro
zo
ne
s 
fo
rm
at
ion
N,O-dialkyl oxyamine 
formation
Cyanohydrin formation(Wohl degradation)
Scheme 1.1: Schematic illustration of chemoselective reactions of unprotected 
carbohydrates. 
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1.3.1. Reductive Amination Reaction 
 Reductive amination is the reaction of an aldehyde and a primary amine resulting 
in the formation of an imine. An imine is then reduced with reducing agents such as 
NaBH3CN to yield a secondary amine (Scheme 1.2). Reductive amination is widely used to 
label glycans for microarray applications because it is highly selective to aldehydes and 
tolerates other functional groups. Furthermore, it is a stoichiometric reaction which is 
useful for the quantitation of glycans based on the UV-absorbance or fluorescence 
intensity.20 Nevertheless, obtaining an unnatural ring-opened form as a product can be a 
drawback of this reaction because it can disturb the recognition of GBPs.33 There are 
proteins that only bind to ring-closed glycoconjugates such as anti-sialyl Lewisx (SLex) 
antibody 1 and 2, and intravenous immunoglobulin (IVIg).52 However, most GBPs 
demonstrate the ability to bind ring-opened glycoconjugates on an array.52 It is known 
that GBPs contain binding pockets that can access a few numbers of monosaccharide 
residues.27 Having a ring-opened form at the terminal monosaccharide may not disrupt 
their interactions. Cummings and coworkers52 have shown that ring-opened 
glycoconjugates on the array can have better interaction with several GBPs because the 
sterically restricted ring-closed form is reduced.  
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1.3.2. Formation of Oximes and Hydrazones  
Oximes and hydrazones are products from the conjugation of carbohydrates with 
a-nucleophiles (hydroxylamine and hydrazine). The reaction is similar to the reductive 
amination reaction as it occurs at the carbonyl carbon of an aldehyde, and the reaction is 
usually catalyzed by acid (Scheme 1.3). The attack of an a-heteroatom on the carbonyl 
carbon results in the formation of a tetrahedral intermediate. After protonation of the 
hydroxyl group, the reaction undergoes dehydration resulting in oxime or hydrazone as 
the product (Scheme 1.3).51,53 The obtained product can be in both ring-opened (also both 
E and Z) and ring-closed (also both a and b) forms (Scheme 1.4). These isomers are 
interconvertible. Therefore, the concentration of species are determined from their 
thermodynamic stability.51 
O
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N
R
+H -H2O
Reducing agent
Scheme 1.2: Proposed mechanism of reductive amination reaction. 
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The hydrolytic stability is dependent on the inductive effect of the heteroatom.54 
The hydrolysis of oxime and hydrazone can be obtained from the protonation of the imine 
nitrogen. In this case, oximes are more stable than hydrazones because the 
electronegativity of oxygen is higher than nitrogen, which prevents protonation of the 
imine nitrogen.51,53,54 The reversibility and the difference in hydrolytic stability of oximes 
and hydrazones are beneficial for various types of applications. Oximes are suitable for 
those applications that require a more stable linkage such as bioconjugation reactions, 
while hydrazones are better in applications that need labile linkage such as the controlled 
release of biologically active compounds.53,55  
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Scheme 1.3: Proposed mechanism for the formation of oxime and hydrazone. 
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1.3.3. Formation of N,O-Dialkyl Oxyamines 
 The substrates of N,O-dialkyl oxyamines are different from the oxyamines that 
form oximes in which they are dialkyl substituted on both nitrogen and oxygen on the 
molecules. The reaction is similar to the formation of the oximes that takes place on an 
aldehyde in its ring-opened form (Scheme 1.5). The advantage of N,O-dialkyl oxyamines 
compared to the oximes is that the conjugated products are in the thermodynamically 
most stable ring-closed forms, either a- or b-form depending on the nature of the 
carbohydrate substrates.51 As demonstrated by Langenhan et al.56, neoglycoconjugated 
product from glucose presented in an only b-pyranose form while three isomers: b-
pyranose, a-pyranose, and a-furanose were obtained as the products from mannose.  
Nevertheless, the equilibrium constant (Keq) of this oxyamine glycoconjugation is low. It 
is usually required a high concentration of reagents (0.1 – 1 M) to increase the yield of 
the conjugated products.51  
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Scheme 1.4: Ring-chain tautomer of the conjugated oxime. 
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 The ring-closed form obtained as a product is a benefit for the study of glycan 
because it mimics native O- and N-glycosides. In the past decade, a variety of different 
N,O-dialkyl oxyamine linkers had been developed especially for the glycan microarray 
applications (Figure 1.10). In 2014, Boons and coworkers57 developed a multifunctional 
linker 1-1 that contained a dialkyl oxyamine for the construction of the neoglycosides with 
reducing sugars and a hydrophobic chromophore for the UV detection and purification of 
the conjugated products via reverse-phase column. The advantage of this linker is that 
the terminal Fmoc (fluorenylmethyloxycarbonate) group on the linker can be removed 
yielding a free amine which can be used for the construction of the microarray. In 2017, 
the same group had modified their oxyamine linker to have hydrophobic chromophore 
and free amine on the same linker without the need of deprotection (1-2).58 Another 
bifunctional dialkyl oxyamine linker (1-3) was reported by Timmer and coworkers59 in 
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Scheme 1.5: Proposed mechanism for the formation of dialkyl-oxyamine. 
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2015. Linker 1-3 is capable of the formation neoglycosides with carbohydrates and the 
conjugation with chemical probes from the terminal azide group. The primary amine can 
also be obtained from this linker by reducing at the azide. Although linker 1-3 
demonstrated to be highly stable toward hydrolysis, it is lack of a hydrophobic 
chromophore which might not be useful for the separation and purification purposes. The 
aminoxy-based fluorescent linker 1-4 was developed by Wilson et al.60 in 2016. This 
bifunctional linker contained dialkyl oxyamine for the neoglycoconjugation and the azide 
group for the conjugation with chemical probes or for the immobilization on the solid 
support after reduction of an azide to a primary amine. Unlike linker 1-3, linker 1-4 
contains a fluorescent naphthalene group that aids in the separation and detection 
through reverse-phase chromatographic technique.  
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1.3.4. Wohl Degradation 
Wohl degradation is the conventional method to shorten aldose sugars which was 
first reported by Wohl in 1893.61 The reaction is involved in the formation of an oxime by 
hydroxylamine followed by the acetylation using acetic anhydride and sodium acetate to 
form an acetylated cyanohydrin. Then, the terminal cyanide group can be removed by the 
treatment with ammonia and silver hydroxide (Scheme 1.6). However, the original Wohl 
degradation method was modified by treating the cyanohydrin with sodium methoxide 
in methanol that led to the elimination of cyanide and deacetylation, also known as 
Zemplén degradation.62 The product obtained from the Wohl degradation is an aldose 
sugar that has one carbon shorter than the starting material. 
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Scheme 1.6: Reaction pathway of Wohl degradation. 
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As shown in Scheme 1.6, the cyanohydrin (nitrile containing hydroxyl group at the 
a-carbon) is an intermediate from the Wohl degradation process, which can be useful in 
other applications. Several methods reported the transformation of aldehydes to nitriles, 
however, they focused on the transformation of aliphatic and aromatic aldehydes. 
Bandgar and Makone reported the transformation of aldehydes to nitriles using N-
bromosuccinimide (NBS) and aqueous ammonia (Scheme 1.7).63 They demonstrated that 
the reaction was suitable for a variety of substrates from aromatic aldehydes to D-glucose 
and 2-deoxy-D-ribose.  
 
Several research groups have shown that carbohydrate cyanohydrins could be 
used as the intermediates to form biologically active compounds. The formation of 
tetrazole-containing carbohydrate has been reported by forming cyanohydrin as an 
intermediate followed by the formation of a cyclic tetrazole (Scheme 1.8).64 It is known 
that tetrazole has biologically active properties such as antifungals65 and glycosidase 
inhibitor,66 however, the authors did not report the specific biological properties of the 
compound.64 Another example of the application of carbohydrate cyanohydrins was 
reported by Fernandes and coworkers67 in 2015. They synthesized ruthenium(II) and 
R H
O NBS
NH3, H2O
0 °C
R
N
Scheme 1.7: Transformation of aldehydes to nitrile using NBS. 
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iron(II) complexes containing carbohydrate cyanohydrins as the ligands (Scheme 1.9) and 
demonstrated that these complexes had the cytotoxic activity and could be used as the 
colorectal anticancer agents.67 
 
 
 
Scheme 1.8: Formation of tetrazole from carbohydrate cyanohydrin. 
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1.3.5. Kiliani-Fischer Cyanohydrin Synthesis 
Kiliani-Fischer synthesis is the reaction to elongate aldose sugars by adding one 
more carbon. The reaction involves the addition of the cyanide to the aldehyde forming 
cyanohydrin as an intermediate, which is subsequently hydrolyzed to form aldonic acid 
lactone. The treatment of the lactone with reducing agents such as NaBH3 or with catalytic 
hydrogenation yields a new carbohydrate compound with one extra carbon (Scheme 
1.10).68 However, the products obtained from this reaction are in the mixture of 
diastereomers.  
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1.4. Thesis Overview 
 The structural complexity of glycan impedes the study and understanding of the 
roles of glycans in biological processes. The ultimate goal of this research is to develop 
chemical tools for a better understanding of the structures and functions of glycans. There 
are two chemical approaches presented herein including the development of a chemical 
auxiliary and the introduction of new synthetic methods, as shown in Figure 1.11. 
  
The design and synthesis of a new chemical auxiliary are presented in Chapter 2 
with the purpose of using the auxiliary in broad applications in glycomics research. A new 
N,O-dialkyl oxyamine auxiliary containing tetrazine moiety was synthesized in 3 steps with 
a 28% overall yield. The auxiliary is demonstrated to be useful in a variety of applications 
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Figure 1.11: The overview of the thesis. 
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including purification and fractionation of complex glycans, compatibility with 
glycosyltransferases in chemoenzymatic reaction, and ability to directly conjugate to 
chemical probes via an inverse-electron-demand Diels-Alder reaction.  
 A new synthetic method for the transformation of aldehydes to nitriles is 
presented in Chapter 3. This new synthetic approach is demonstrated to be compatible 
with a variety of reducing sugars including monosaccharides, disaccharides, and silyl-
protected saccharides. Furthermore, the reaction is also suitable for the formation of 
nitriles from aliphatic and aromatic aldehydes. This synthetic approach could be useful 
for the further transformation of the nitriles to other functional groups such as amines 
and heterocycles. Chapter 3 also presents a new efficient method to shorten reducing 
sugars by using weakly basic resins. This practical approach is applicable for the formation 
of carbohydrates through the shortening process.  
 Poly(ADP-ribose) (PAR) is a complex biopolymer that involved in many biological 
processes such as transcription and DNA damaged repair. The knowledge in the functions 
of PAR is limited due to the difficulty to obtain the defined length of PAR polymers at the 
workable scale. There are two approaches to obtain the defined length of PAR presents 
in Chapter 4. The first approach is using the chemical auxiliary to facilitate the 
fractionation and purification of PAR polymers. The second approach is the use of a novel 
b-NAD+ analogue containing a photoremovable protecting group as a substrate in the 
chemoenzymatic synthesis of ADP-ribose oligomers. 
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CHAPTER 2 
DEVELOPMENT OF A MULTIFUNCTIONAL NEOGLYCOSIDE AUXILIARY FOR 
APPLICATIONS IN GLYCOMIC RESEARCH 
 
2.1. Introduction 
 Glycans, and more frequently the glycoconjugates of proteins and lipids, are 
implicated in virtually all important biological processes.5 These conjugated glycans can 
be recognized by glycan-binding proteins (GBPs). The interactions between glycans and 
GBPs play crucial roles in biological recognition processes such as cell signaling, protein 
folding, cell adhesion, host-pathogen interactions, etc.5,69 The structural complexities and 
diverse biological functions of glycans necessitates reliable and efficient techniques to 
conduct glycomic studies. The utilization of mass spectrometry allows the rapid 
determination of the connectivity of complex carbohydrates.70,71 However, mass 
spectrometric strategy requires separation techniques either by capillary electrophoresis 
or liquid chromatography for effectively analyzing glycan structures, especially their 
isomeric species.72,73 The study of glycan-protein interactions is often interrogated using 
microarray technologies in which glycans are modified for the attachment on a slide-type 
surface and visualized by fluorescently tagged proteins.27,34 Most of these analysis 
approaches usually require the derivatization of glycans with hydrophobic moiety for the 
separation, detection, and attachment purposes. 
 Chemoselective ligation reactions at the anomeric center of carbohydrates have 
been extensively developed during the past decade.51 The attachment of an auxiliary to a 
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reducing sugar facilitates examination of biological interactions through the introduction 
of fluorescent tags, immobilization on a surface microarray, conjugation to biomolecules, 
as well as increasing retention time for chromatographic separation.20,74 A neoglycoside 
auxiliary (secondary oxyamine) is preferred because it preserves a ring-closed 
conformation product simplifying recognition by GBPs. Several elegant auxiliaries have 
been reported exhibiting compatibility with chemoenzymatic extension and/or highly 
efficient conjugation to surfaces for the production of glycan microarrays.57,59,60,75–78 
However, in order to visualize the biological processes of these glycoconjugates, they 
required further chemical modifications for conjugation to chemical probes. The purpose 
of this work is to develop a multifunctional auxiliary that can serve in a variety of glycomic 
applications and also enable direct bioorthogonal conjugation without further 
modification. 
 Inverse-electron-demand Diels-Alder (IEDDA) reactions between tetrazines and 
strained dienophiles such as trans-cyclooctene (TCO), cyclooctyne, and norbornene, have 
gained attention recently due to fast and highly chemoselective cycloadditions.79–81 The 
rate constants of the IEDDA reaction between tetrazine and TCO can be as high as 106      
M-1s-1.49,82,83 This exceptional kinetic reaction has been widely used to label small 
molecules for visualization under physiological condition.84,85 Previous studies 
demonstrated the use of glycans containing TCO for the cellular imaging via an IEDDA 
reaction with the tetrazine.85–87 Therefore, the auxiliary containing tetrazine moiety could 
be an alternative tool for labeling and studying the biological functions of glycans. 
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 Herein, the synthesis of a multifunctional neoglycoside auxiliary and the 
applications of this auxiliary are reported. The hydrophobic UV active moiety on the 
auxiliary facilitates the isolation and purification of complex carbohydrate mixtures via a 
reverse-phase chromatographic technique. The auxiliary displayed compatibility with a 
common glycosyltransferase during chemoenzymatic synthesis. The stability of the 
neoglycoside conjugate was defined over a suitable pH range and the near-quantitative 
removal was achieved when desired. Moreover, the tetrazine moiety on the auxiliary 
enabled direct conjugation to chemical probes without further modification. 
 
2.2. Experimental 
2.2.1. General Information 
1H and 13C NMR spectra were recorded at 400 MHz and 101 MHz, respectively. For 
13C NMR spectra of samples in the D2O solvent, a small amount of methanol was added 
as the internal standard. Assignments were based on COSY, NOESY, and TOCSY 
experiments and comparison with published data.88,89 HPLC analysis and preparation 
were performed on Gilson® Analytical to Semi-Preparative HPLC system using Kinetex® 5 
µm EVO C18 100 Å 4.6x150 mm and Kinetex® 5u Biphenyl 100 Å 4.6x150 mm for analytical 
columns and Kinetex® 5u EVO C18 100 Å 21.1x150 mm for a preparative column. Mass 
spectrometry analysis was performed by the School of Chemical Sciences Mass 
Spectrometry Laboratory at the University of Illinois. LCMS was operated in an 
electrospray ionization technique (ESI) using Agilent 1100 series HPLC coupled with diode 
array detector (model G1315A) and mass selective detector (model G2445A). Thin-layer 
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chromatography (TLC) analysis was performed on silica gel 60 with fluorescent indicator 
F254 (EMD Millipore) and visualized with UV light (254 nm) where applicable. Silica gel 
column chromatography was performed on SiliaFlash® F60 (Silicycle, 40-64 µm). UV-vis 
absorption spectra were recorded from the SpectraMax i3x multi-mode detection 
platform (Molecular Devices). 
All reagents were used directly without further purification. CMP-N-acetyl-
neuraminic acid was purchased from Carbosynth. a-2,3-Sialyltransferase from 
Pasteurella multocida was purchased from Sigma. Cy5-TCO was purchased from Click 
Chemistry Tools. A mixture of xylooligosaccharides was a gift from Tethyl research LLC.  
Carbohydrate symbols: D-glucose (Glc, ), D-galactose (Gal, ), N-acetyl 
neuraminic acid (Neu5Ac, ), D-xylose (Xyl,     ). 
 
2.2.2. Synthetic Procedures 
Synthesis of (4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)methanol (2-2)  
 
 
 
 
 
The synthesis procedure of Yang and coworkers (2012) was followed with 
modification.90 Specifically, 4-(hydroxymethyl)-benzonitrile (2-1) 0.2 g (1.5 mmol, 0.1 eq) 
and Zn(OTf)2 0.272 g (0.75 mmol, 5 mol%) were added to a 20 mL vial under N2. Next, 0.78 
mL of dried acetonitrile and 2.6 mL of hydrazine anhydrous were added to the reaction 
HO
N
1) MeCN, NH2NH2, 
Zn(OTf)2 
60 °C, 48 h
2) NaNO2, 1 M HCl
43%
HO
N
N N
N
2-2
2-1
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vial. The reaction was heated to 60 °C for 48 h. The reaction was cooled to room 
temperature and the solution of sodium nitrite (2.07 g, 30 mmol, 2 eq) in 5 mL water was 
added to the reaction, followed by the addition of 1 M HCl. During the addition, the 
solution turned red and produced gas. Addition of 1 M HCl was continued until no gas 
formed. Then, the solution was transferred to a separatory funnel and extracted with 
EtOAc 3 times. The organic layer was dried with Na2SO4 and concentrated using a rotary 
evaporator. The crude product was purified by silica column chromatography 
(EtOAc:Hexanes = 40:60). Yield = 0.130 g (43%).  
1H NMR (400 MHz, CDCl3) d (ppm): 8.51 (d, J = 8.5 Hz, 2H), 7.52 (d, J = 8.3, 2H), 4.77 (s, 
2H), 3.03 (s, 3H) 
13C NMR (400 MHz, CDCl3) d (ppm): 167.45, 164.15, 145.81, 131.19, 128.35, 127.61, 64.98, 
21.40. 
HR-MS (ESI) m/z calcd. for C10H11N4O (M + H)+ 203.0927, found 203.0926. 
 
Synthesis of N-Boc-N’-methylhydroxylamine (2-4) 
 
 
 
To a 50 mL round-bottom flask was added Boc anhydride (Boc2) (4.4251 g, 20 
mmol, 1 eq), 10 mL dried methylene chloride, and N-methyl-hydroxylamine (2-3) (2.1248 
g, 25.4 mmol, 1.25 eq). Next, triethylamine (2.85 mL, 39 mmol, 1.9 eq) was added 
dropwise to the solution. The reaction was stirred at room temperature overnight. The 
HO
N
H
Boc2
Et3N
CH2Cl2
92%
HO
N
Boc
2-42-3
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reaction was then washed with water and saturated sodium chloride. The organic layer 
was dried with Na2SO4 and concentrated using a rotary evaporator. Yield = 2.64 g (92%). 
1H NMR (400 MHz, CDCl3) d (ppm): 3.13 (s, 3H), 1.43 (s, 9H). 
13C NMR (101 MHz, CDCl3) d (ppm): 157.79, 81.97, 37.96, 28.42. 
HR-MS (ESI) m/z calcd. for C6H13NO3Na (M + Na)+ 170.0788, found 170.0795. 
 
Synthesis of (4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-t-butoxycarbamate-N’-
methylhydroxylamine (2-5) 
 
 
 
 
 To a 20 mL vial under N2 was added compound 2-2 (0.1415 g, 0.65 mmol, 1 eq), 
triphenylphosphine (0.205 g, 0.78 mmol, 1.2 eq), and 5 ml of dried methylene chloride. 
The solution of N-Boc-N’-methylhydroxylamine (2-4) (0.115 g, 0.78 mmol, 1.2 eq) in 1 mL 
methylene chloride was subsequently added to the reaction. The reaction was cooled to 
0 °C, followed by addition of diisopropyl azodicarboxylate (DIAD) (0.15 ml, 0.78 mmol, 1.2 
eq) dropwise. The reaction was allowed to warm to room temperature and stirred 
overnight. The reaction was concentrated and then purified by silica column 
chromatography (EtOAc:Hexanes = 30:70). Yield = 0.1441 g (67%). 
1H NMR (400 MHz, CDCl3) d (ppm): 8.58 (d, J = 8.1 Hz, 2H), 7.62 (d, J = 8.2 Hz, 2H), 4.93 (s, 
2H), 3.09 (s, 3H), 3.08 (s, 3H), 1.49 (s, 9H). 
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13C NMR (400 MHz, CDCl3) d (ppm): 167.54, 164.10, 157.28, 140.64, 132.00, 130.14, 
128.19, 81.78, 76.11, 37.30, 28.52, 21.41. 
HR-MS (ESI) m/z calcd. for C16H21N5O3Na (M + Na)+ 354.1537, found 354.1547. 
 
Synthesis of (4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamine (2-6)  
 
To a 20 mL vial under N2 was added compound 2-5 (0.1109 g, 0.335 mmol, 1 eq) 
and 3 mL of dried methylene chloride. The solution was cooled to 0 °C. Trifluoroacetic 
acid (TFA) (0.5 mL, 3.5 mmol, 10 eq) was added dropwise. The reaction was kept at 0 °C 
for 30 min then allowed to warm to room temperature and stirred for 3 h. The reaction 
was quenched with water and pH was adjusted to basic with 2 M NaOH. The solution was 
extracted with methylene chloride 3 times. The organic layer was dried over Na2SO4 and 
concentrated using a rotary evaporator. Yield = 0.0758 g (98%).  
1H NMR (400 MHz, CDCl3) d (ppm): 8.53 (d, J = 8.3 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 5.01 (s, 
2H), 3.04 (s, 3H), 2.87 (s, 3H). 
13C NMR (101 MHz, CDCl3) d (ppm): 167.44, 164.18, 143.31, 131.33, 129.00, 128.21, 75.27, 
39.61, 21.39. 
HR-MS (ESI) m/z calcd. for C11H14N5O (M + H)+ 232.1193, found 232.1192. 
O
N
N N
N
N
Boc
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TFA, CH2Cl2
0 °C to r.t., 3 h
98%
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N N
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2.2.3. General Procedure for the Preparation of Neoglycoconjugates 
 The general procedure for neoglycoconjugation of auxiliary 2-6 and reducing 
sugars is described. To a 7 mL vial, reducing sugar (5 eq) was dissolved in a sodium 
phosphate buffer (0.25 M, pH 4.7). Compound 2-6 (1 eq) was dissolved in DMF (10% v/v) 
then added to the reaction mixture (final concentration 0.1 M). The reaction mixture was 
stirred at 40 °C for 24-48 h. Then, the solution was concentrated by rotary evaporator and 
purified by HPLC preparative C18 column (for compound 2-7, 2-8, 2-9, 2-10, 2-11, and 2-
13, gradient of 80% water/ 20% acetonitrile to 50% water/ 50% acetonitrile in 10 minutes, 
for compound 2-12 gradient of 85% water/ 15% acetonitrile to 84% water/ 16% 
acetonitrile in 20 minutes). The collected fractions were concentrated to obtain the 
desired product.  
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxyl-amino-b-D-
galactopyranosyl-(1®4)-b-D-glucopyranoside (2-7). 
 
 Prepared according to the general procedure using D-lactose (0.133 g, 0.37 mmol) 
as reducing sugar to obtain compound 2-7 as a pink powder. Yield = 0.027 g (64%). 
 
훃 4
훃 4
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O
N
N
N
N
2-7
D-Lactose
N O
H
N N
NN
0.25 M Sodium phosphate 
pH 4.7, DMF
40 °C
2-6
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1H NMR (400 MHz, D2O) d (ppm):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 MHz, D2O) d (ppm): 167.86, 164.43, 141.38, 131.81, 130.71, 128.64, 103.56, 
93.72, 78.74, 76.83, 76.28, 76.01, 75.24, 73.16, 71.61, 70.33, 69.22, 61.72, 60.77, 39.44, 
20.74. 
HR-MS (ESI) m/z calcd. for C23H34N5O11 (M + H)+ 556.2249, found 556.2255. 
 
 
 
 
 1H NMR (ppm) 
Glc – H1 4.17 (d, J = 8.3 Hz) 
Glc – H2 3.63 – 3.59 
Glc – H3 3.63 – 3.59 
Glc – H4 3.52 – 3.48 
Glc – H5 3.80 – 3.77 
Glc – H6a 3.93 
Glc – H6b 3.80 – 3.73 
Gal – H1 4.41 (d, J = 7.8 Hz) 
Gal – H2 3.52 – 3.48 
Gal – H3 3.63 – 3.59 
Gal – H4 3.88 
Gal – H5 3.63 – 3.59 
Gal – H6a 3.72 – 3.66 
Gal – H6b 3.72 – 3.66 
CH aromatic 8.28 (d, J = 8.2 Hz, 2H) 
CH aromatic 7.60 (d, J = 8.2 Hz, 2H) 
CH2-O-N 4.86 (d, J = 2.7 Hz s, 2H) 
CH3-tetrazine 3.00 (s, 3H) 
CH3-N 2.78 (s, 3H) 
 40 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
glucopyranosyl-(1®4)-b-D-glucopyranoside (2-8) 
  
Prepared according to the general procedure using D-maltose (0.155 g, 0.430 
mmol) as reducing sugar to obtain compound 2-8 as a pink powder. Yield = 0.025 g (51%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Glc 1 – H1 4.17 (d, J = 9.1 Hz) 
Glc 1 – H2 3.65 – 3.55  
Glc 1 – H3  3.78 – 3.76 
Glc 1 – H4 3.76 – 3.70 
Glc 1 – H5 3.52 – 3.48 
Glc 1 – H6a 3.68 – 3.52  
Glc 1 – H6b 3.68 – 3.52 
Glc 2 – H1 5.38 (d, J = 3.9 Hz) 
Glc 2 – H2 3.58 – 3.55 
Glc 2 – H3  3.80 – 3.75 
Glc 2 – H4 3.39 
Glc 2 – H5 3.70 – 3.66 
Glc 2 – H6a 3.91 – 3.88 
Glc 2 – H6b 3.78 – 3.74 
CH aromatic 8.24 (d, J = 8.3 Hz, 2H) 
CH aromatic 7.58 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.86 (d, J = 2.7 Hz, 2H) 
CH3-tetrazine 3.01 (s, 3H) 
CH3-N 2.79 (s, 3H) 
N O
H
N N
NN
0.25 M Sodium phosphate 
pH 4.7, DMF
40 °C
2-6
훂  4
N
O
N
N
N
N
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훂  4
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13C (101 MHz, D2O) d (ppm): 167.81, 164.28, 141.44, 131.64, 130.60, 128.54, 100.27, 
93.73, 78.13, 77.29, 76.57, 75.20, 73.50, 73.28, 72.34, 70.49, 69.93, 61.43, 61.08, 39.42, 
20.73. 
HR-MS (ESI) m/z calcd. for C23H34N5O11 (M + H)+ 556.2249, found 556.2268. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
glucopyranoside (2-9) 
 
Prepared according to the general procedure using D-glucose (0.084 g, 0.467 
mmol) as reducing sugar to obtain compound 2-9 as a pink powder. Yield = 0.0613 g (66%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Glc 1 4.16 (d, J = 8.8 Hz) 
Glc 2 3.58 (t, J = 8.9 Hz) 
Glc 3  3.50 (t, J = 8.5 Hz) 
Glc 4 3.36  
Glc 5 3.36  
Glc 6a 3.88 (d, J = 12.5 Hz) 
Glc 6b 3.71 (dd, J = 12.3 Hz, J = 4.7 Hz) 
CH aromatic 8.17 (d, J = 8.1 Hz, 2H) 
CH aromatic 7.53 (d, J = 8.1 Hz, 2H) 
CH2-O-N 4.84 (s, 2H) 
CH3-tetrazine 2.98 (s, 3H) 
CH3-N 2.79 (s, 3H) 
N O
H
N N
NN
0.25 M Sodium phosphate 
pH 4.7, DMF
40 °C
2-6
O
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O
Me
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HO
HO
N
N
N
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HO
HO
HO OH
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13C (101 MHz, D2O) d (ppm): 167.76, 164.16, 141.51, 131.49, 130.51, 128.44, 93.88, 
77.97, 77.73, 75.14, 70.65, 70.05, 61.45, 39.41, 20.73. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1736. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-2-acetamido-2-
deoxy-D-glucopyranoside (2-10) 
  
Prepared according to the general procedure using N-acetyl-D-glucosamine (0.112 
g, 0.506 mmol) as reducing sugar to obtain compound 2-10 as a pink powder. Yield = 
0.0205 g (46%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
GlcNAc 1 4.24 (d, J = 9.7 Hz) 
GlcNAc 2 4.00 (t, J = 9.8 Hz) 
GlcNAc 3  3.51 (t, J = 9.8 Hz) 
GlcNAc 4 3.46-3.34 (m) 
GlcNAc 5 3.46-3.34 (m) 
GlcNAc 6a 3.89 (dd, J = 12.4, J = 1.9 Hz) 
GlcNAc 6b 3.74 (dd, J = 12.4 Hz, J = 4.9 Hz) 
NH-acetyl 2.03 (s, 3H) 
CH aromatic 8.23 (d, J = 8.4 Hz, 2H) 
CH aromatic 7.56 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.70 (d, J = 6.1 Hz, 2H) 
CH3-tetrazine 3.00 (s, 3H) 
CH3-N 2.75 (s, 3H) 
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13C (101 Hz, D2O) d (ppm): 174.65, 167.79, 164.27, 141.51, 131.57, 130.71, 128.45, 92.40, 
77.90, 76.02, 74.42, 70.20, 61.39, 53.01, 39.13, 23.00, 20.73. 
HR-MS (ESI) m/z calcd. for C19H27N6O6 (M + H)+ 435.1987, found 435.2012. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
galactofuranoside (2-11a) 
 
Prepared according to the general procedure using D-galactose (0.074 g, 0.411 
mmol) as reducing sugar. Compound 2-11a was obtained as a pink powder. Yield = 0.0032 
g (10%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Gal 1 4.49 (d, J = 6.2 Hz) 
Gal 2 4.27 (dd, J = 6.2 Hz, J = 0.5 Hz) 
Gal 3  4.14 (dd, J = 8.6 Hz, J = 7.4 Hz) 
Gal 4 3.85 (dd, J = 8.7 Hz, J = 2.7 Hz) 
Gal 5 3.76 (m) 
Gal 6a 3.64 (d, J = 2.8 Hz) 
Gal 6b 3.65 (s) 
CH aromatic 8.38 (d, J = 8.3 Hz, 2H) 
CH aromatic 7.68 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.91 (d, J = 2.3 Hz, 2H) 
CH3-tetrazine 3.05 (s, 3H) 
CH3-N 2.75 (s, 3H) 
N O
H
N N
NN
0.25 M Sodium phosphate 
pH 4.7, DMF
40 °C
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13C (101 MHz, D2O) d (ppm): 167.93, 164.57, 141.44, 131.97, 130.67, 128.73, 98.45, 
81.64, 77.16, 75.72, 75.36, 70.75, 63.42, 40.05, 20.72. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1725. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
galactopyranoside (2-11b) 
 
Prepared according to the general procedure using D-galactose (0.074 g, 0.411 
mmol) as reducing sugar. Compound 2-11b was obtained as a pink powder. Yield = 0.0183 
g (57%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Gal 1 4.16 (d, J = 9.1 Hz) 
Gal 2 3.77 (t, J = 9.2 Hz) 
Gal 3  3.65 (dd, J = 9.4 Hz, J = 3.4 Hz) 
Gal 4 3.92 (d, J = 3.2 Hz) 
Gal 5 3.66-3.64 
Gal 6a 3.81-3.77 
Gal 6b 3.73.3.69 
CH aromatic 8.27 (d, J = 8.2 Hz, 2H) 
CH aromatic 7.61 (d, J = 8.2 Hz, 2H) 
CH2-O-N 4.88 (s, 2H) 
CH3-tetrazine 3.02 (s, 3H) 
CH3-N 2.79 (s, 3H) 
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13C (101 MHz, D2O) d (ppm): 167.83, 164.35, 141.68, 131.62, 130.56, 128.54, 94.46, 77.26, 
74.98, 74.64, 69.59, 68.20, 61.84, 38.72, 20.72. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1734. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
mannopyranoside (2-12a), (4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-
methylhydroxylamino-b-D-mannopyranoside (2-12b), and (4-(6-methyl-1,2,4,5-
tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-mannofuranoside (2-12c)  
 
Prepared according to the general procedure using D-mannose (0.099 g, 0.55 
mmol) as reducing sugar. The ratio of the anomeric configurations of the products could 
not be certainly determined due to the difficulty to separate individual isomers. 
Therefore, the collected fractions contained all products were combined and determined 
the ratio of the anomeric configurations by 1H NMR. The yield was reported as the overall 
yield. Yield = 0.02878 g (66%). All three products were obtained as a pink powder.  
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For the NMR analysis of each isomer, the collected fractions from HPLC 
preparative chromatogram that contained mixtures of isomer were rejected and the 
fractions that contained only one isomer were concentrated and analyzed by NMR.  
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
mannopyranoside (2-12a) 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 MHz, D2O) d (ppm): 167.91, 164.55, 141.53, 131.89, 130.60, 128.70, 94.00, 79.02, 
75.27, 74.61, 70.18, 67.52, 61.72, 40.94, 20.70. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1725. 
 
 
 
 1H NMR (ppm) 
Man 1 4.16 (d, J = 0.6 Hz) 
Man 2 4.10 (d, J = 2.0 Hz) 
Man 3  3.61 – 3.60 
Man 4  3.75 (dd, J = 12.3 Hz, J = 6.1 Hz) 
Man 5 3.41 – 3.37  
Man 6a 3.91 (dd, J = 12.3 Hz, J = 2.2 Hz) 
Man 6b 3.61 – 3.60  
CH aromatic 8.34 (d, J = 8.4 Hz, 2H) 
CH aromatic 7.64 (d, J = 8.4 Hz, 2H) 
CH2-O-N 4.93 (d, J = 6.0 Hz, 2H) 
CH3-tetrazine 3.03 (s, 3H) 
CH3-N 2.79 (s, 3H) 
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(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
mannopyranoside (12b) 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 MHz, D2O) d (ppm): 167.95, 164.62, 141.53, 132.05, 131.12, 128.77, 94.80, 75.96, 
74.70, 71.51, 69.13, 67.58, 61.74, 41.03, 20.76. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1715. 
 
 
 
 
 
 
 1H NMR (ppm) 
Man 1 4.17 (d, J = 3.3 Hz) 
Man 2 4.18 – 4.16 
Man 3  3.66 – 3.64 
Man 4 3.69 – 3.66 
Man 5 3.65 – 3.63 
Man 6a 3.80 – 3.77 
Man 6b  3.74 – 3.70 
CH aromatic 8.38 (d, J = 8.4 Hz, 2H) 
CH aromatic 7.67 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.87 (d, J = 2.9 Hz, 2H) 
CH3-tetrazine 3.04 (s, 3H) 
CH3-N 2.67 (s, 3H) 
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 (4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
mannofuranoside (2-12c) 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 MHz, D2O) d (ppm): 167.97, 164.69, 141.35, 132.13, 130.70, 128.82, 98.83, 80.77, 
75.40, 73.27, 72.11, 69.64, 63.74, 40.33, 20.76. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1725. 
 
 
 
 
 
 1H NMR (ppm) 
Man 1 4.54 (d, J = 7.3 Hz) 
Man 2 4.38 (dd, J = 6.9 Hz, J = 4.5 Hz) 
Man 3  4.25 (dd, J = 4.4 Hz, J = 2.2 Hz) 
Man 4   3.58 (dd, J = 12.2 Hz, J = 5.7 Hz) 
Man 5 3.88 (m) 
Man 6a 3.94 (dd, J = 9.2 Hz, J = 2.3 Hz) 
Man 6b 3.74 (dd, J = 11.7 Hz, J = 3.0 Hz) 
CH aromatic 8.39 (d, J = 7.6 Hz, 2H) 
CH aromatic 7.66 (d, J = 7.7 Hz, 2H) 
CH2-O-N 4.89 (d, J = 5.1 Hz, 2H) 
CH3-tetrazine 3.03 (s, 3H) 
CH3-N 2.72 (s, 3H) 
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(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-xylopyranoside 
(2-13a) 
 
Prepared according to the general procedure using D-xylose (0.063 g, 0.42 mmol) 
as reducing sugar to obtain compound 2-13a as a pink powder. Yield = 0.0206 g (67%). 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 Hz, D2O) d (ppm): 167.91, 164.59, 141.61, 131.87, 130.58, 128.68, 94.81, 77.77, 
75.14, 70.55, 69.82, 67.49, 39.39, 20.72 
HR-MS (ESI) m/z calcd. for C16H22N5O5 (M + H)+ 364.1616, found 364.1616. 
 
 1H NMR (ppm) 
Xyl 1 4.09 (d, J = 9.1 Hz) 
Xyl 2 3.62-3.48  
Xyl 3  3.42 (t, J = 8.9 Hz) 
Xyl 4 3.25 (t, J = 11 Hz) 
Xyl 5a 3.94 (dd, J = 11.3 Hz, J = 5.4 Hz) 
Xyl 5b 3.62-3.48  
CH aromatic 8.36 (d, J = 8.0 Hz, 2H) 
CH aromatic 7.64 (d, J = 8.1 Hz, 2H) 
CH2-O-N 4.88 (d, J = 3.0 Hz, 2H) 
CH3-tetrazine 3.04 (s, 3H) 
CH3-N 2.74 (s, 3H) 
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2.2.4. Hydrolytic Stability Study 
 
The hydrolysis method of neoglycosides developed by Nitz and coworkers (2009) 
was followed with several modifications.91 Briefly, glycoconjugate 2-7 was prepared at 2.2 
mM in 20 mM of sodium phosphate buffer pH 5.0, 7.0, and 9.0, then incubated at 40 °C. 
The reaction was monitored at a given time by taking 200 µL of samples and diluting with 
400 µL of 200 mM sodium phosphate buffer pH 7.0 and subsequently analyzed by HPLC 
reverse-phase column with a gradient of 80% water/ 20% acetonitrile to 50% water/ 50% 
acetonitrile in 10 minutes. The peak areas of the remaining glycoconjugate at given times 
were converted to percent remaining and plotted as a linear decay of ln[%remaining 
glycoconjugate] vs time. The pseudo-first-order rate constants of each pH were 
determined by the equation: ln[A] = ln[A]0 – kt, where [A] = concentration of 
glycoconjugate at a given time, [A]0 = initial concentration of glycoconjugate, t = time, and 
k = rate constant. 
The degradation products from the reaction of glycoconjugate 2-7 under sodium 
phosphate pH 9 could be identified by LCMS using the ESI technique.  
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2.2.5. Hydrolysis of Conjugated Product 
 
 
To a 20 mL vial was added glycoconjugate 2-6 0.0166 g (0.0289 mmol) and 6 mL 
of 0.25% of TFA in water. The reaction was stirred at room temperature for 3 h. Then, 
DOWEX 1X8 (-OH form) 0.9 g was added to the solution and stirred for 10 minutes. 
DOWEX resins were then removed from the solution by filtration. The auxiliary was 
removed by extracting with methylene chloride 3 times. The aqueous layer was 
concentrated using a rotary evaporator to obtain unconjugated D-lactose (yield = 96%). 
 
2.2.6. Synthesis of N-Acetyl-Neuraminic Acid-a-(2®3)-Lactopyranoside 
 
To a 7 mL vial, glycoconjugate 2-6 (1 mM, 1 eq) and CMP-N-acetyl-neuraminic acid 
(1 mM, 1 eq) were added to 3 mL of Tris.HCl buffer (0.1 M, pH 8.0). Next, 50 µL of a-2,3-
sialyltransferase (1 mg/mL) was added to the reaction mixture then incubated at 37 °C. 
The reaction was monitored by HPLC (gradient of 99% water/ 1% acetonitrile to 60% 
훃 4
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N
N
N
N
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water/ 40% acetonitrile in 20 minutes). The reaction was left overnight (18 h) to reach to 
the completion. Upon completion, the reaction was concentrated by rotary evaporator 
then purified by HPLC preparative column (gradient of 99% water/ 1% acetonitrile to 60% 
water/ 40% acetonitrile in 20 minutes). The collected fractions were concentrated to 
obtain the desired product (2-17) as pink powder. Yield = 0.0024 g (91%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Glc 1 4.17 (d, J = 8.3 Hz) 
Glc 2 3.62 – 3.60 
Glc 3  3.62 – 3.60 
Glc 4 3.54 – 3.50 
Glc 5 3.57 – 3.55 
Glc 6a 3.94 
Glc 6b 3.86 – 3.82 
Gal – H1 4.49 (d, J = 7.9 Hz) 
Gal – H2 3.54 – 3.50 
Gal – H3  N/A 
Gal – H4 N/A 
Gal – H5 N/A 
Gal – H6a 3.74 – 3.66 
Gal – H6b 3.74 – 3.66 
Neu5Ac – H3a 2.71 (dd, J = 12.6 Hz, J = 4.7 Hz) 
Neu5Ac – H3b 1.76 (t, J = 12.3 Hz) 
Neu5Ac – H4 3.62 – 3.60 
Neu5Ac – H5 3.87 – 3.78 
Neu5Ac – H6 3.91 
Neu5Ac – H7 4.07 
Neu5Ac – H8 N/A 
Neu5Ac – H9 N/A 
Neu5Ac – NH-acetyl 1.99 (s, 3H) 
CH aromatic 8.40 (d, J = 8.2 Hz, 2H) 
CH aromatic 7.67 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.89 (d, J = 3.9 Hz, 2H) 
CH3-tetrazine 3.04 (s, 3H) 
CH3-N 2.78 (s, 3H) 
N/A = not assigned 
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13C (101 Hz, D2O) d (ppm): 175.64, 174.57, 167.95, 164.71, 141.30, 132.11, 130.82, 
128.81, 103.25, 100.43, 93.75, 78.59, 76.84, 76.25, 76.12, 75.84, 75.29, 73.52, 72.42, 
70.39, 70.03, 69.04, 68.73, 68.13, 63.20, 61.74, 60.75, 52.32, 40.28, 39.46, 22.68, 20.73. 
HR-MS (ESI) m/z calcd. for C34H51N6O19 (M + H)+ 847.3204, found 847.3245. 
 
2.2.7. Conjugation of Neoglycoside Auxiliary to Mixture of Xylooligosaccharides 
 
 
 
 
 
 
 
 
 
 To a 7 mL vial was added a mixture of xylooligosaccharides 0.373 g (~0.9 mmol, 5 
eq) and 1.5 mL of 0.25 M sodium phosphate buffer pH 4.7. Compound 2-6 (0.0415 g, 0.18 
mmol, 1 eq) was dissolved in 0.5 mL of DMF, then added to the xylooligosaccharides 
solution. The reaction was stirred at 40 °C for 48 h. The solution was concentrated and 
then purified by reverse-phase preparative HPLC (gradient of 90% water/ 10% acetonitrile 
to 80% water/ 20% acetonitrile in 30 minutes). The fractions containing products were 
concentrated separately using a rotary evaporator. The collected fractions were analyzed 
by 1H NMR showing the pure product of n = 2 to n =4 as pink powder. Yield n = 2 (2-18, 
0.0096 g, 11%), n = 3 (2-19, 0.0118 g, 11%), n = 4 (2-20, 0.0062 g, 3%). The collected 
fractions for longer glycans (n = 5 – 7) were analyzed by LCMS. 
 
O
HOHO
OH OH
n
O N N
NN
N H 2-6
O
HOHO
OH
N
O
N
N
N
N
n
0.25 M Sodium phosphate 
pH 4.7, DMF, 40 °C, 48 h
2-18 (n = 2, 11%)
2-19 (n = 3, 11%)
2-20 (n = 4, 3%)
Xylooligosaccharides (XOs)
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n = 2 (2-18)  
 
 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 Hz, D2O) d (ppm): 167.90, 164.55, 141.59, 131.83, 130.59, 128.67, 102.47, 
94.67, 77.06, 76.24, 75.84, 75.17, 73.41, 70.51, 69.82, 65.85, 65.33, 39.41, 20.73. 
HR-MS (ESI) m/z calcd. for C21H30N5O9 (M + H)+ 496.2038, found 496.2025. 
 
 1H NMR (ppm) 
Xyl 1 – H1 4.09 (d, J = 8.5 Hz) 
Xyl 1 – H2 3.55 
Xyl 1 – H3  3.38 
Xyl 1 – H4 3.23 
Xyl 1 – H5a 3.92 
Xyl 1 – H5b 3.58 
Xyl 2 – H1 4.42 
Xyl 2 – H2 3.21 
Xyl 2 – H3  3.53 
Xyl 2 – H4 3.29 
Xyl 2 – H5a 4.06 
Xyl 2 – H5b 3.69 
CH aromatic 8.30 (d, J = 8.3 Hz, 2H) 
CH aromatic 7.61 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.86 (d, J = 1.7 Hz, 2H) 
CH3-tetrazine 3.02 (s, 3H) 
CH3-N 2.74 (s, 3H) 
N
O
N
N
N
N
β  4
2-18
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n = 3 (2-19)  
 
 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C (101 Hz, D2O) d (ppm): 167.87, 164.47, 141.61, 131.75, 130.55, 128.62, 102.47, 102.28, 
94.67, 77.00, 76.98, 76.22, 75.82, 75.15, 74.29, 73.39, 73.32, 70.51, 69.81, 65.84, 65.30, 
63.60, 39.40, 20.73. 
HR-MS (ESI) m/z calcd. for C26H38N5O13 (M + H)+ 628.2461, found 628.2482. 
 1H NMR (ppm) 
Xyl 1 – H1 4.09 (d, J = 8.5 Hz) 
Xyl 1 – H2  3.57 
Xyl 1 – H3  3.38 
Xyl 1 – H4 3.27 
Xyl 1 – H5a 3.92 
Xyl 1 – H5b 3.60 
Xyl 2 – H1 4.42 
Xyl 2 – H2 3.21 
Xyl 2 – H3  3.50 
 Xyl 2 – H4 3.29-3.35 
Xyl 2 – H5a 4.06 
Xyl 2 – H5b 3.77-3.66 
Xyl 3 – H1 4.43 
Xyl 3 – H2 3.23 
Xyl 3 – H3 3.53 
Xyl 3 – H4 3.29-3.35 
Xyl 3 – H5a 4.06 
Xyl 3 – H5b 3.77-3.66 
CH aromatic 8.27 (d, J = 8.1 Hz, 2H) 
CH aromatic 7.59 (d, J = 8.2 Hz, 2H) 
CH2-O-N 4.85 (d, J = 1.5 Hz, 2H) 
CH3-tetrazine 3.01 (s, 3H) 
CH3-N 2.73 (s, 3H) 
N
O
N
N
N
N
β  4 β  4
2-19
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n = 4 (2-20)  
 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Xyl 1 – H1 4.10 (d, J = 8.1 Hz) 
Xyl 1 – H2  3.57 
Xyl 1 – H3  3.39 
Xyl 1 – H4 3.3.27-3.37 
Xyl 1 – H5a 3.94 
Xyl 1 – H5b 3.61 
Xyl 2 – H1 4.42-4.46 
Xyl 2 – H2 3.20-3.25 
Xyl 2 – H3  3.49-3.56 
Xyl 2 – H4 3.3.27-3.37 
Xyl 2 – H5a 4.05-4.09 
Xyl 2 – H5b 3.68-3.78 
Xyl 3 – H1 4.42-4.46 
Xyl 3 – H2 3.20-3.25 
Xyl 3 – H3 3.49-3.56 
Xyl 3 – H4 3.27-3.37 
Xyl 3 – H5a 4.05-4.09 
Xyl 3 – H5b 3.68-3.78 
Xyl 4 – H1 4.42-4.46 
Xyl 4 – H2 3.20-3.25 
Xyl 4 – H3 3.49-3.56 
Xyl 4 – H4 3.27-3.37 
Xyl 4 – H5a 4.05-4.09 
Xyl 4 – H5b 3.68-3.78 
CH aromatic 8.37 (d, J = 8.2 Hz, 2H) 
CH aromatic 7.65 (d, J = 8.2 Hz, 2H) 
CH2-O-N 4.88 (d, J = 2.6 Hz, 2H) 
CH3-tetrazine 3.04 (s, 3H) 
CH3-N 2.74 (s, 3H) 
N
O
N
N
N
N
β  4 β  4 β  4
2-20
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13C (101 Hz, D2O) d (ppm): 167.92, 164.62, 141.56, 131.92, 130.62, 128.71, 102.48, 102.29, 
102.29, 94.67, 77.01, 76.99, 76.95, 76.23, 75.83, 75.19, 74.28, 74.28, 73.40, 73.33, 73.33, 
70.51, 69.82, 65.85, 65.31, 63.60, 63.60, 39.41, 20.73. 
HR-MS (ESI) m/z calcd. for C31H46N5O17 (M + H)+ 760.2883, found 760.2870. 
 
 
 
 
n = 5 (2-24) 
   
      m/z calcd. (M+H)+ 892.3, found 892.0. 
 
 
 
 
 
 
 
n = 6 (2-25) 
   
      m/z calcd. (M+H)+ 1024.4, found 1024.1. 
 
 
 
 
 
 
 
n = 7 (2-26) 
   
      m/z calcd. (M+H)+ 1156.4, found 1156.2. 
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2.2.8. Inverse Electron-Demand Diels-Alder (IEDDA) Cycloaddition  
 
Glycoconjugate 2-7 (55 µM, 1.08 eq) and Cy5-TCO (2-21) (51 µM, 1 eq) were 
dissolved in Tris.HCl buffer (50 mM, pH 7.4) to a final volume of 510 µL. The reaction 
mixture was incubated at room temperature. The reaction was monitored by HPLC 
biphenyl column (gradient of 80% water/ 20% methanol to 30% water/ 70% methanol in 
13
O
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30 minutes) using UV detector at 647 nm and 254 nm to monitored Cy5-TCO and 2-7, 
respectively. The HPLC chromatograms are shown in Figure 2.5. Then, the solution was 
concentrated and desalted using Sephadex G-10 eluting with water. The compound 2-23 
was collected and analyzed by mass spectrometry. Interestingly, the aromatic pyrazine 
product from the oxidation of 1,4-dihydropyrazine 2-23 could also be observed from the 
mass spectrometric results. Presumably, the 1,4-dihydropyrazine 2-23 was oxidized by air 
during the desalting step.92,93 
HR-MS (ESI) m/z calcd. for C69H92N7O23S3 (M-H-2H)- 1482.5412, found 1482.5398, 
and m/z calcd. for C69H91N7O23S3 (M-2H-2H)2- 740.7668, found 740.7646. 
 
2.3. Results and Discussion 
2.3.1. Design and Synthesis of Auxiliary  
The multifunctional auxiliary was designed to fit in broad applications in glycomic 
research. The secondary oxyamine is preferred because it preserved a ring-closed 
conformation of the conjugated product.  The hydrophobic UV active moiety on the 
auxiliary facilitates the isolation and purification of complex carbohydrate mixtures via a 
reverse-phase chromatographic technique. This auxiliary displayed stability during the 
chemoenzymatic synthesis. Moreover, the tetrazine moiety on the auxiliary enabled 
direct conjugation to chemical probes without further modification. 
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 The synthesis route of auxiliary 2-6 is shown in Scheme 2.1. Commercially 
available 4-(hydroxymethyl)-benzonitrile (2-1) reacted with acetonitrile, hydrazine, and 
the presence of zinc triflate in a one-pot manner to form hydroxybenzyl tetrazine (2-2) in 
moderate yield.90 Extended reaction time to 48 h was necessary to improve the reported 
27% yield to 43% yield.90 Compound 2-2 was subsequently reacted with N-Boc-N’-
methylhydroxylamine 2-4 via Mitsunobu condition and purified by silica column to obtain 
compound 2-5. Finally, the Boc protecting group could be removed with TFA in 
dichloromethane and extracted with basic aqueous to give product 2-6 in 98% yield. 
 The UV-vis absorption spectrum of auxiliary 2-6 revealed that there are two 
characteristic maxima absorption wavelengths (Figure 2.1). At the UV region, there is the 
strong absorption at 270 nm (e270 nm = 22,127 Lmol-1cm-1). There is a weaker absorption 
maximum at the visible region at 540 nm (e540 nm = 439 Lmol-1cm-1) which can be seen at 
HO
N
1) MeCN, NH2NH2,
Zn(OTf)2
60 °C, 48 h
43%
HO
N
N N
N
PPh3, DIAD, CH2Cl2
0 °C to r.t., 18 h
67%
HO
N
Boc
Me
2-4
O
N
N N
N
TFA, CH2Cl2
98%
N
Boc
Me
O
N
N N
N
N
H
Me
2-2 2-5
2-6
2-1
2) NaNO2, 1 M HCl
0 °C to r.t., 3 h
Scheme 2.1: Synthesis of auxiliary 2-6. 
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high concentration. This UV-vis absorption spectrum demonstrated that auxiliary 2-6 
provides the ability to monitor the reaction at either UV or visible regions to avoid 
interference from other compounds in the reaction. 
 
 
 
 
 
 
 
 
 
 
 
  
Partition coefficient (logP) is a ratio that determines the distribution of the 
compound between octanol and water as shown in Eq 1 where coct = concentration of a 
compound in octanol and cwat = concentration of a compound in water.94 In drug 
discovery, logP value is one of the important parameters to be considered. It can be used 
to predict the ability of the compound to permeate through the membrane at the target 
site.94–96 A compound with high logP value can permeate through the membrane easily. 
The logP value of the auxiliary 2-6 was predicted on the ChemDraw program (Chemdraw 
0
0.5
1
1.5
2
2.5
200 400 600
Ab
s
Wavelength (nm)
2-6 (0.1 mM)
2-6 (1 mM)
Figure 2.1: UV-vis absorption spectra of 2-6 at 1 mM and 0.1 mM. 
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Prime 17.1) to be 0.96 indicating that compound 2-6 has a lipophilic property that can 
provide the ability to interact with a non-polar stationary for conjugated glycans. The 
predicted logP value reveals that the auxiliary 2-6 can potentially be useful for 
pharmaceutical applications, such as increasing the ability of highly polar biologically 
active compounds to permeate through the cell membrane. 
 
2.3.2. Evaluation of Auxiliary with Reducing Sugars 
 With the neoglycoside auxiliary 2-6 in hand, the glycoconjugate library was 
created by reaction with different reducing sugars (Table 2.1). It is known that the rate 
and efficiency of the oxyamine ligation is heavily dependent on the concentration of the 
saccharide and oxyamine, as well as the solvent and acid catalyst.97 The most efficient and 
general conditions utilized a sodium phosphate buffer (pH = 4.7), although, other buffers 
(NH4OAc and NaOAc) were found to be viable. It should be noted here that approximately 
10% of DMF improves the rate of ligation by improving the solubility of the auxiliary in 
the reaction medium. The effect from the optimal stoichiometry of the saccharide and 
auxiliary was evaluated. Two complementary reactions (Table 2.1, entries 1 and 2) 
demonstrate that the utilization of a five-fold molar excess of either the sugar or the 
auxiliary results in an acceptable yield of the conjugate. All subsequent entries in Table 
2.1 utilized an excess of reducing sugars due to the substrates being readily available and 
inexpensive. The conjugation of seven reducing sugars was carried out under the 
                                      !"#$ = log	 *+oct+wat,                                            Eq 1 
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established conditions and purified by reverse-phase chromatography on C18 
functionalized silica gel. Hexoses, pentoses, disaccharides, and N-acetyl containing 
glycans were examined and provided the expected products with yields ranging between 
46% and 68%. 
 
 
 
Table 2.1. Conjugation of auxiliary 2-6 with reducing sugars. 
 
Entry Reducing sugar Equivalent Time 
(d) 
Product Yielda 
(%) Reducing sugar 2-6 
1 D-Lactose (Lac) 5 1 1 2-7 64 
2 D-Lactose (Lac) 1 5 1 2-7 51 
3 D-Maltose (Mal) 5 1 2 2-8 51 
4 D-Glucose (Glc) 5 1 2 2-9 66 
5 N-Acetyl-D-glucosamine 
(GlcNAc) 
5 1 3 2-10 46 
6 D-Galactose (Gal) 5 1 2 2-11 67 
7 D-Mannose (Man) 5 1 2 2-12 66 
8 D-Xylose (Xyl) 5 1 2 2-13 68 
a Isolated yield of all isomers 
O
HO
OH
Reducing sugars
N O
H
N N
NN
0.25 M Sodium phosphate 
pH 4.7, DMF
40 °C
O
HO
N O
N N
NN
2-6 2-7 to 2-13
 64 
The conjugated products were characterized by NMR and mass spectrometry. The 
stereochemistry at the anomeric carbon was determined by JH1-H2 coupling constant and 
compared with published results56,88 (Table 2.2). As expected, glucose-based conjugated 
products (Lac, Mal, Glc, and GlcNAc) were exclusively formed in the b-pyranose 
configuration. The xylose product was determined to also predominately be the b-
pyranoside along with only trace amounts of a-pyranoside. The conjugation of galactose 
gave only b configured products but was observed in both the pyranose and furanose 
forms in a ratio of 85:15.  
The exclusive formation of b-pyranoside can be rationalized by the favorable 6-
exo-trig ring-closing on the Re face88 to avoid a 1,3-axial interaction.60,88,89 The reaction of 
mannose with the neoglycoside auxillary resulted in the most complex mixture due to the 
presence of axial alcohol on C2.  Three different isomers including a-pyranoside, b-
pyranoside, and a-furanoside were observed and were difficult to distinguish. In contrast 
to glucose and galactose, the 6-exo-trig ring-closing of mannoside occurs preferentially 
on the Si face and due to favourability of the opposing dipole-dipole interactions at C1 
and C2 leading to the a-pyranoside as a major product.60,88,89 
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Table2.2 Configuration ratio of conjugated products. 
Entry Compound Configuration ratio 
b-Pyranose a-Pyranose   b-Furanose  a-Furanose  
1 2-7 100 0 0 0 
2 2-8 100 0 0 0 
3 2-9 100 0 0 0 
4 2-10 100 0 0 0 
5 2-11 85 
(2-11b) 
0 15 
(2-11a) 
0 
6 2-12 40 
(2-12b) 
45 
(2-12a) 
0 15 
(2-12c) 
7 2-13 97 
(2-13a) 
3 
(2-13b) 
0 0 
O
NHO
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N N
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2.3.3. Stability Study 
The hydrolytic stability of glycoconjugate 2-7 was studied under aqueous sodium 
phosphate buffer at pH values of 5, 7, and 9 at 40 °C. The reactions were monitored by 
HPLC with UV detection at 254 nm. The peak area of the remaining glycoconjugate 2-7 at 
the given times was recorded and converted to the remaining concentration (Figure 2.2). 
The hydrolysis rate constants were calculated from the pseudo-first-order condition (See 
appendix A). As expected, the hydrolysis rate of glycoconjugate 2-7 is rapid at pH 5 with 
the half-life at 44 h. At pH 7, glycoconjugate 2-7 was very stable with half-lift estimated 
to be 990 h providing a useful tool for the in vitro and in vivo investigation of glycan 
functions. Under basic condition at pH 9, the half-life was determined to be 158 h. 
Interestingly, the neoglycoside hydrolysis product was not observed. Instead, it was found 
that at pH 9 hydrolysis of the tetrazine moiety occurs with hydrazide (2-14), oxadiazole 
(2-15), and benzonitrile (2-16) derivatives observed as the degradation products98 
(Scheme 2.2).  
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The degradation mechanisms could be rationalized based on the previous study 
that investigated the degradation of tetrazine under basic alkali.98 As shown in Scheme 
2.3a, the degradation product 2-14 was produced from the attacking of hydroxide at the 
C-6 position on the tetrazine ring followed by proton transfer resulting in the formation 
of tetrahedron intermediate (2-28). The cheletropic exclusion was then taken placed 
which led to the opening of the tetrazine ring and releasing of nitrogen gas to form 2-29. 
The proton transfer (tautomerism) on the compound 2-29 led to the formation of 
degraded product hydrazide 2-14. The nucleophilic elimination at the C-3 position of 2-14 
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Figure 2.2: Hydrolytic stability of glycoconjugated 2-7. 
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caused further degradation to yield degraded product benzonitrile 2-16 (Scheme 2.3b). 
The proton transfer on 2-14 led to the formation of 2-30 followed by the nucleophilic 
addition at C-3 position resulting in the formation of 2,3-dihydrooxadiazole 2-31 (Scheme 
2.3c). However, this compound was not stable and could be oxidized under air resulting 
in the formation of aromatic oxadiazole 2-15.98  
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Scheme 2.2: Degradation of glycoconjugate 2-7 in sodium phosphate pH 9. 
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2.3.4. Removal of Auxiliary from a Conjugated Product 
The advantage of oxyamine auxiliaries is that they can be easily removed from the 
conjugated carbohydrate with the presence of acid. A previous study demonstrated that 
the treatment of oxyamine-linked glycoconjugate with 0.25% v/v TFA would not affect to 
the acid-labile fucoside and sialoside.57 Thus, the glycoconjugate 2-7 was treated with 
0.25% of TFA in water and incubated at room temperature for 3 h. Then, the reaction was 
neutralized by DOWEX 1X8 (OH- form) resins which were easily removed by filtration 
(Scheme 2.4). The auxiliary was conveniently removed by extraction with 
dichloromethane and the unconjugated carbohydrate could be recovered from the 
aqueous layer. After evaporation, unconjugated lactose was obtained in 96% yield 
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2.3.5. Applications 
With the intention of using the multifunctional auxiliary in applications beyond 
glycomics research, the compatibility and stability of 2-6 were evaluated in the 
chemoenzymatic synthesis of complex oligosaccharides (Scheme 2.5). The glycoconjugate 
2-7 was the prudent choice to illustrate chemoenzymatic extension due to lactose being 
a common motif in human milk oligosaccharides.78,99 The glycoconjugate 2-7 and CMP-N-
acetyl-neuraminic acid were treated with a-(2,3)-sialyltransferase resulted in the 
formation of glycoconjugate trisaccharide 2-17 with the addition of a-(2,3)-linked Neu5Ac 
moiety (Scheme 2.5). This auxiliary demonstrated that it increased the affinity of the 
trisaccharide product to the hydrophobic stationary phase during reverse-phase 
chromatography relative to the unconjugated and could be monitored by the UV 
detector. After completion, the product was conveniently purified on a preparative HPLC 
column to the obtain product in excellent yield. 
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Scheme 2.5: Chemoenzymatic extension of glycoconjugate 2-7. 
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The structural complexity and high polarity of oligosaccharides in nature impede 
glycomic investigations due to the difficulty in purification and isolation. To demonstrate 
the utility of auxiliary 2-6, the fractionation of a complex oligosaccharide mixture was 
attempted. A mixture of xylooligosaccharides (XOs) was chosen as it contained xylose 
oligomers of several chain lengths. The conjugation condition was carried out as 
previously described above (Figure 2.3a). After conjugation at the reducing end of xylose 
oligomers, the formation of conjugated xylosides could be analyzed by HPLC. After 48 h 
of reaction time, the conjugated products were purified by preparative reverse-phase 
chromatography. The HPLC chromatogram showed the ability to fractionate conjugated 
XOs up to 7 xylose units (Figure 2.3b). The conjugated xylodioside (2-18), xylotrioside (2-
19), and xylotetroside (2-20) were collected and characterized by NMR and mass 
spectrometry and the longer conjugated glycans were identified by low-resolution ESI 
mass spectrometry. The results demonstrated that this auxiliary can aid in the 
fractionation and purification of carbohydrate mixtures.  
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Finally, the ability to visualize oligosaccharides at the cellular level is necessary for 
the study of biological functions of glycans. Towards this goal, auxiliary 2-6 containing the 
tetrazine moiety can be readily joined with the strained alkene of a chemical probe 
through the IEDDA reaction. The bioorthogonal labeling of glycoconjugate 2-7 with Cy5-
TCO was conducted by incubating the substrates in Tris buffer pH 7.4 at room 
O
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Figure 2.3: Glycoconjugation and fractionation of xylooligosaccharides: (a) 
schematic conjugation reaction and (b) HPLC preparative chromatogram. 
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temperature (Scheme 2.6). The reaction was monitored by HPLC using a biphenyl-
functionalized silica column using UV detection at 647 nm which was specific for the Cy5 
and 254 nm to indicate 2-7 (Scheme 2.4). As expected, the starting materials were rapidly 
consumed to form an initial adduct (2-23), and then slowly rearranged to form a 1,4-
dihydropyrazine 2-24.100  This isomeric rearrangement could be observed from HPLC 
chromatograms which proceeded to the completion within 18 h (Figure 2.4). The 
cycloaddition product 2-24 was then desalted by Sephadex G10 and identified by mass 
spectrometry. 
 
 
 
O
O
N
H
N
H
O
H
N
Cy5
Cy5-TCO (2-21)
훃 4
N
O
N
N
N
N
2-7
훃 4
N
O
N
N
2-22
H
H
O
N
H
O N
H
O
H
N
Cy5
훃 4
N
O
N
HN
2-23
O
N
H
O N
H
O
H
N
Cy5
Tris.HCl pH 7.4, r.t.,1 h
Scheme 2.6: IEDDA cycloaddition of glycoconjugate 2-7 and Cy5-TCO (2-21). 
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254 nm 
Figure 2.4: HPLC chromatograms of the IEDDA cycloaddition of glycoconjugate 2-7 
and Cy5-TCO. 
Standard Cy5-TCO 
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2.4. Conclusions 
A novel multifunctional neoglycoside auxiliary containing tetrazine moiety (2-6) 
was successfully synthesized with the overall yield of 28%. The auxiliary was conjugated 
with a variety of reducing sugars to create a conjugated glycan library. The yields of all 
conjugated products were in the range of 46 – 64%. All conjugated products from glucose-
based saccharides provided the only b configuration. Conjugated products from galactose 
and mannose gave a and b configurations in both pyranose and furanose forms. The 
hydrolytic stability of glycoconjugate 2-7 was studied at different pH values which 
revealed the high stability near physiological conditions. However, the glycoconjugate 2-
7 was less stable under acidic conditions due to the high rate of hydrolysis and relative 
stable under basic condition. The degradation of the tetrazine moiety was observed in 
basic solution which could be detected by mass spectrometry. The conjugated auxiliary 
could be efficiently cleaved under mildly acidic conditions and conveniently removed by 
simple liquid-liquid extraction. The auxiliary demonstrated the capability and efficiency in 
different glycomic applications. During the chemoenzymatic reaction, the auxiliary 
appeared to be suitable for the enzyme to incorporate sialic acid onto the glycoconjugate 
2-7. The hydrophobic property of the auxiliary facilitated fractionation and purification of 
complex oligosaccharides mixtures by a reverse-phase HPLC technique. Furthermore, the 
tetrazine moiety allowed the conjugated product to be bioothogonally labeled via IEDDA 
reaction. 
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CHAPTER 3 
TRANSFORMATION OF ALDEHYDES TO NITRILES IN AQUEOUS SOLUTION 
  
3.1. Introduction 
Nitrile is an important functional group in organic synthesis because it can be 
transformed into several functional groups such as amine,101,102 carboxylic acid,103,104 
ester,105,106 ketone,107 and heterocycles.108,109 Furthermore, nitriles are involved in broad 
applications, including pharmaceutical110 and materials.111,112  In the past decades, several 
methods reported the formation of nitriles from different functional groups such as 
amine, amide, and alcohol. However, these methods require harsh conditions or metal 
complex catalysts.113  The transformation of aldehydes to nitriles has become more 
attractive because the reaction conditions are mild and do not require toxic reagents. 
Formation of nitriles through dehydration of oximes is one of the most classical 
methods.114 In general, an aldehyde is reacted with hydroxylamine to form aldoxime 
followed by dehydration with acetic anhydride, thionyl chloride, or lead oxide to form a 
desirable nitrile114,115 (Scheme 3.1). This dehydration condition is considerably harsh; it 
requires an excess of dehydrating agents, high temperature, and has low functional group 
tolerance.116 
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To avoid using harsh conditions and increase the compatibility of the reaction with 
a variety of functional groups, several approaches have been reported to convert 
aldehydes to nitriles in a one-pot manner. In 2012, Nantz et al.117 reported a method to 
transform aldehydes to nitriles using O-(diphenylphosphinyl)hydroxylamine (DPPH, 3-1) 
as a nitrogen source (Scheme 3.2a) in toluene at 85 °C. In 2015, An and Yu reported an 
alternative method to transform aldehydes to nitriles using O-(4-CF3-benzoyl)-
hydroxylamine (CF3-BHA, 3-2) as a nitrogen source.118 This transformation could be done 
at room temperature using a Brønsted acid as a catalyst (Scheme 3.2b). A method to 
convert aldehydes to nitriles in aqueous medium was reported in 2016 by Moura-Letts 
and coworkers.119 In this method, hydroxylamine-O-sulfonic acid (3-3) was used as a 
nitrogen source (Scheme 3.2c). The main advantage of this method is that the product 
can be easily isolated by extraction with a suitable organic solvent.       
 
 
R H
O
Aldehyde
NH2OH
Hydroxylamine
R N
OH
Dehydrating 
agent
R N
Aldoxime
Scheme 3.1: Transformation of an aldehyde to a nitrile via dehydration of oxime. 
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Reducing sugar is a sugar containing an aldehyde group when it is in a ring-opened 
form. Although many publications reported the formation of nitriles from aldehydes, only 
a few examples studied cyanohydrin formations from reducing sugars.63 A novel method 
for the formation of cyanohydrins from reducing sugars in one step is described herein. 
O-Phenylhydroxylamine hydrochloride (3-4) was used as a nitrogen source, and the 
reaction proceeded under the aqueous condition at room temperature. This reaction is 
demonstrated to be suitable for a variety of carbohydrates including mono- and 
disaccharides, silyl-protected saccharide, as well as aliphatic and aromatic aldehydes. 
R H
O
O
P
Ph
Ph
O
H2N
Toluene, 85 °C
R N
R H
O
H+, methanol, r.t.
R N
F3C
O
O
NH2
R H
O
H2O, acetic acid, 50 °C
R N
O S
O
O
OH
H2N
Aldehyde
3-1
3-2
3-3
Aldehyde
Aldehyde
Scheme 3.2: Transformation of aldehydes to nitriles using different 
hydroxylamine sources. 
a 
b 
c 
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Furthermore, a new convenient method to shorten reducing sugars using weakly basic 
resins which can be easily removed by filtration is presented.    
 
3.2. Experimental 
3.2.1. General Information 
All chemicals and reagents were purchased and used without further purification. 
Deuterium oxide buffer solution was prepared by dissolving 0.227 g of NaH2PO4 and 0.221 
g of NaH2PO4 in 16 mL of deuterium oxide and measured the pD value of the buffer 
solution by pH meter. It is worth noting here that the pH meter was calibrated with 
aqueous (H2O) calibration buffer. Therefore, pD was calculated based on Krezel and Bal120 
(pD = pH + 0.45).  Concentrated phosphoric acid and 1 M NaOH in deuterium oxide were 
used to adjust the pD values. Lewatit MP 62 resin was purchased from Sigma and washed 
with ethanol through the vacuum filtration before used. 1H and 13C NMR spectra were 
recorded at 400 MHz, 101 MHz, respectively. For 13C NMR spectra of samples in the D2O 
solvent, a small amount of methanol was added as the internal standard. Thin-layer 
chromatography (TLC) analysis was performed on silica gel 60 with fluorescent indicator 
F254 (EMD Millipore) and visualized with UV light (254 nm) where applicable. Silica gel 
column chromatography was performed on SiliaFlash® F60 (Silicycle, 40-64 µm). Mass 
spectrometry analysis was performed by the School of Chemical Sciences Mass 
Spectrometry Laboratory at the University of Illinois. 
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3.2.2. General Procedure for the Formation of Cyanohydrins 
 
 
 
  
To a 7 mL vial was added reducing sugar (1 equiv), O-phenylhydroxylamine 
hydrochloride (3-4) (1.2 equiv), and 0.2 M sodium phosphate pD 7.25 to the final 
concentration of 0.1 M. The reaction was stirred at room temperature until the oxime 
intermediates were disappeared (monitored by 1H NMR). Then, the reaction mixture was 
transferred into a separatory funnel and washed with diethyl ether for 10 times. The 
remaining aqueous solution was evaporated to dryness. Ethanol was added to the solid 
residue to extract the product from the phosphate salt. The phosphate salt residues in 
the ethanol solution were removed by centrifugation. The solvent was evaporated to 
obtain the desired product. 
 
D-Ribonitrile (3-5)  
   
Prepared according to the general procedure using D-ribose (0.0226 g, 0.150 
mmol) as reducing sugar. Yield = 0.0208 g (94%). 
 
O
H2N
ŎHClR H
O
R
N
Reducing sugar 3-4
0.2 M Sodium phosphate
pD 7.25, r.t.
O
H2N
ŎHCl
0.2 M Sodium phosphate
pD 7.25, r.t.
3-4
HO
OH OH
OH
N
3-5
O
HO OH
HO
OH
D-RiboseD-Ribose 
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1H NMR (400 MHz, D2O) d (ppm): 4.88 (d, J = 3.5 Hz, 1H), 3.88 – 3.75 (m, 2H), 3.72 – 3.60 
(m, 2H). 
13C NMR (101 MHz, D2O) d (ppm): 119.22, 72.46, 72.14, 63.65, 63.02. 
HR-MS (ESI) m/z calcd. for C5H9NO4Na (M + Na)+ 170.0429, found 170.0431. 
 
D-Arabinonitrile (3-6) 
 
Prepared according to the general procedure using D-arabinose (0.0086 g, 0.0577 
mmol) as reducing sugar. Yield = 0.0071 g (83%). 
 
1H NMR (400 MHz, D2O) d (ppm): 4.90 (d, J = 2.3 Hz, 1H), 3.85 – 3.76 (m, 2H), 3.76 – 3.70 
(m, 1H), 3.66 (dd, J = 11.6, 5.4 Hz, 1H). 
13C NMR (101 MHz, D2O) d (ppm): 120.42, 72.02, 70.47, 63.15, 62.29. 
HR-MS (ESI) m/z calcd. for C5H9NO4Na (M + Na)+ 170.0429, found 170.0434. 
 
 
 
 
O
H2N
ŎHCl
3-4
OHO
HO
OHOH
D-Arabinose
HO
OH OH
OH
N
3-6
0.2 M Sodium phosphate
pD 7.25, r.t.
D-Arabinose 
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D-Xylonitrile (3-7) 
   
Prepared according to the general procedure using D-xylose (0.0489 g, 0.326 
mmol) as reducing sugar. Yield = 0.0471 g (98%). 
 
1H NMR (400 MHz, D2O) d (ppm): 4.71 (dd, J = 5.8, 0.9 Hz, 1H), 3.91 – 3.80 (m, 2H), 3.69 – 
3.54 (m, 2H). 
13C NMR (101 MHz, D2O) d (ppm): 119.75, 72.02, 71.21, 62.94, 62.86. 
HR-MS (ESI) m/z calcd. for C5H9NO4Na (M + Na)+ 170.0429, found 170.0434. 
 
L-Arabinonitrile (3-8) 
    
Prepared according to the general procedure using L-arabinose (0.046 g, 0.307 
mmol) as reducing sugar. Yield = 0.0455 g (100%). 
 
1H NMR (400 MHz, D2O) d (ppm): 4.89 (d, J = 2.2 Hz, 1H), 3.84 – 3.75 (m, 2H), 3.74 – 3.68 
(m, 1H), 3.65 (dd, J = 11.6, 5.5 Hz, 1H). 
O
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13C NMR (101 MHz, D2O) d (ppm): 120.44, 72.09, 70.49, 63.17, 62.27. 
HR-MS (ESI) m/z calcd. for C5H9NO4Na (M + Na)+ 170.0429, found 170.0433. 
 
2-Deoxy-D-ribonitrile (3-9) 
  
Prepared according to the general procedure using 2-deoxy-D-ribose (0.0114 g, 
0.085 mmol) as reducing sugar. Yield = 0.0107 g (96%). 
 
1H NMR (400 MHz, D2O) d (ppm): 3.99 – 3.91 (m, 1H), 3.84 – 3.71 (m, 1H), 3.70 – 3.56 (m, 
2H), 2.87 (ddd, J = 17.2, 4.1, 0.5 Hz, 1H), 2.77 (ddd, J = 17.2, 6.8, 0.5 Hz, 1H). 
13C NMR (101 MHz, D2O) d (ppm): 120.04, 73.97, 67.67, 62.89, 22.64. 
HR-MS (ESI) m/z calcd. for C5H9NO3Na (M + Na)+ 154.0480, found 154.0484. 
 
D-Gluconitrile (3-10) 
  
Prepared according to the general procedure using D-glucose (0.0082 g, 0.045 
mmol) as reducing sugar. Yield = 0.0072 g (90%). 
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1H NMR (400 MHz, D2O) d (ppm): 4.72 (d, J = 7.3 Hz, 1H), 4.06 (dd, J = 7.4, 1.6 Hz, 1H), 3.82 
(dd, J = 11.8, 2.4 Hz, 1H), 3.79 – 3.70 (m, 2H), 3.64 (dd, J = 11.5, 5.3 Hz, 1H). 
13C NMR (101 MHz, D2O) d (ppm): 119.75, 71.22, 71.14, 70.09, 63.47, 63.16. 
HR-MS (ESI) m/z calcd. for C6H11NO5Na (M + Na)+ 200.0535, found 200.0528. 
 
D-Galactonitrile (3-11) 
   
Prepared according to the general procedure using D-galactose (0.0162 g, 0.090 mmol) as 
reducing sugar. Yield = 0.0155 g (97%). 
 
1H NMR (400 MHz, D2O) d (ppm): 4.91 (d, J = 1.9 Hz, 1H), 3.96 – 3.86 (m, 2H), 3.68 – 3.62 
(m, 3H). 
13C NMR (101 MHz, D2O) d (ppm): 120.61, 71.46, 70.40, 69.16, 63.63, 62.43. 
HR-MS (ESI) m/z calcd. for C6H11NO5Na (M + Na)+ 200.0535, found 200.0540. 
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D-Allonitrile (3-12) 
   
Prepared according to the general procedure using D-allose (0.0139 g, 0.077 
mmol) as reducing sugar. Yield = 0.0086 g (63%). 
1H NMR (400 MHz, D2O) d (ppm): 4.87 (dd, J = 3.9, 1.1 Hz, 1H), 3.96 (ddd, J = 7.6, 3.9, 1.1 
Hz, 1H), 3.91 – 3.84 (m, 1H), 3.78 – 3.70 (m, 2H), 3.63 (ddd, J = 11.9, 7.3, 1.1 Hz, 1H). 
13C NMR (101 MHz, D2O) d (ppm): 119.47, 73.04, 72.70, 72.38, 63.71, 62.73. 
HR-MS (ESI) m/z calcd. for C6H11NO5Na (M + Na)+ 200.0535, found 200.0540. 
 
 
D-Mannonitrile (3-13) 
   
Prepared according to the general procedure using D-mannose (0.0335 g, 0.186 
mmol) as reducing sugar. Yield = 0.0317 g. (96%). 
 
1H NMR (400 MHz, D2O) d (ppm): 4.62 (d, J = 8.4 Hz, 1H), 4.03 (dd, J = 8.3, 1.5 Hz, 1H), 
3.81 (dd, J = 11.7, 2.6 Hz, 1H), 3.75 – 3.69 (m, 1H), 3.68 – 3.58 (m, 2H). 
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13C NMR (101 MHz, D2O) d (ppm): 120.94, 70.98, 70.82, 69.07, 63.67, 62.71. 
HR-MS (ESI) m/z calcd. for C6H11NO5Na (M + Na)+ 200.0535, found 200.0537. 
 
D-Maltonitrile (3-14) 
    
Prepared according to the general procedure using D-maltose (0.0355 g, 0.098 
mmol) as reducing sugar. Yield = 0.0186 g. (53%). 
 
1H NMR (400 MHz, D2O) d (ppm): 5.08 (d, J = 3.7 Hz, 1H), 4.91 (d, J = 5.4 Hz, 1H), 4.12 
(ddd, J = 5.3, 3.9, 1.1 Hz, 1H), 3.92 (pd, J = 5.7, 4.8, 3.0 Hz, 2H), 3.86 – 3.61 (m, 6H), 3.55 
(dd, J = 10.0, 3.9 Hz, 1H), 3.40 (t, J = 9.6 Hz, 1H). 
13C NMR (101 MHz, D2O) d (ppm): 119.75, 101.47, 101.33, 80.40, 73.30, 72.90, 72.70, 
72.26, 69.99, 63.03, 62.92, 60.96. 
HR-MS (ESI) m/z calcd. for C12H21NO10Na (M + Na)+ 362.1063, found 362.1060. 
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L-Fuconitrile (3-15) 
   
Prepared according to the general procedure using L-fucose (0.0133 g, 0.0812 
mmol) as reducing sugar. CD3OD (20% v/v) was added to the reaction to increase the 
solubility. Yield = 0.0078 g (59%). 
 
1H NMR (400 MHz, D2O) d (ppm): 4.92 (d, J = 2.0 Hz, 1H), 4.11 – 4.03 (m, 1H), 3.85 (dd, J = 
9.5, 2.1 Hz, 1H), 3.46 (dd, J = 9.5, 1.6 Hz, 1H), 1.23 (d, J = 6.5 Hz, 3H). 
13C NMR (101 MHz, D2O) d (ppm): 120.65, 72.57, 71.86, 66.11, 62.55, 19.23. 
HR-MS (ESI) m/z calcd. for C6H11NO4Na (M + Na)+ 184.0586, found 184.0591. 
 
N-Acetyl-D-glucosaminonitrile (3-16) 
    
Prepared according to the general procedure using N-acetyl-D-glucosamine 
(0.0250 g, 0.114 mmol) as reducing sugar. Yield = 0.0174 g (70%). 
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1H NMR (400 MHz, D2O) d (ppm): 4.93 (d, J = 8.2 Hz, 1H), 4.25 (dt, J = 8.2, 0.7 Hz, 1H), 3.89 
– 3.82 (m, 1H), 3.77 – 3.73 (m, 2H), 3.70 – 3.59 (m, 1H), 2.06 (s, 3H). 
13C NMR (101 MHz, D2O) d (ppm): 174.88, 117.83, 71.22, 70.44, 69.37, 63.47, 57.21, 22.36. 
HR-MS (ESI) m/z calcd. for C8H14N2O5Na (M + Na)+ 241.0800, found 241.0803. 
 
3.2.3. Synthesis of 5-O-Tert-Butyl-Diphenylsilyl-D-Ribonitrile 
  
To a 7 mL vial was added 5-O-tert-butyl-diphenylsilyl-D-ribose (0.131 g, 0.337 
mmol, 1 equiv), O-phenylhydroxylamine hydrochloride (0.059 g, 0.404 mmol, 1.2 equiv), 
2 mL of 0.2 M sodium phosphate pD 7.25 and 2 mL of methanol. The reaction was stirred 
at room temperature until the change of starting materials could not be observed 
(monitored by TLC). The reaction mixture was evaporated to dryness. The crude mixture 
was purified by silica column (Rf = 0.3, 40:60 EtOAc:Hexanes). Yield = 0.0895 g (69%). 
 
1H NMR (400 MHz, CDCl3) d (ppm): 7.76 – 7.56 (m, 4H), 7.55 – 7.34 (m, 6H), 4.77 (d, J = 
3.9 Hz, 1H), 3.93 – 3.81 (m, 3H), 3.78 (dd, J = 8.0, 4.3 Hz, 1H), 1.08 (s, 9H). 
13C NMR (101 MHz, CDCl3) d (ppm): 135.66, 132.50, 130.38, 128.15, 117.98, 72.83, 71.72, 
64.65, 64.28, 27.00, 19.36. 
HR-MS (ESI) m/z calcd. for C21H28NO4Si (M + H)+ 386.1788, found 386.1789. 
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3.2.4. General Procedure for the Formation of Nitriles  
 
 
 
 
To a 7 mL vial, aldehyde (1 equiv) and O-phenylhydroxylamine hydrochloride (3-
4) (1.2 equiv) were dissolved in 4:1 of methanol:0.5 M sodium phosphate pH 6.5 to the 
final concentration of 0.1 M. The reaction was stirred at 60 °C until the changes of starting 
materials could not be observed (monitored by TLC). Then, the reaction mixture was 
cooled to room temperature and extracted with 3 mL CH2Cl2 a total of 5 times. The 
combined organic layer was dried over Na2SO4 and concentrated by rotary evaporator. 
The crude product was purified by silica column chromatography. 
 
4-Hydroxy-3-methoxybenzonitrile (3-18) 
 
Prepared according to the general procedure using vanillin (3-28) (0.0254 g, 0.167 
mmol) as an aldehyde. The reaction time was 8 h. The crude product was purified by silica 
column chromatography (EtOAc:Hexanes 40:60). Yield = 0.0248 g (99%). 
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1H NMR (400 MHz, CDCl3) d (ppm): 7.22 (dd, J = 8.2, 1.8 Hz, 1H), 7.08 (d, J = 1.7 Hz, 1H), 
6.96 (d, J = 8.2 Hz, 1H), 3.92 (s, 3H). 
13C NMR (101 MHz, CDCl3) d (ppm): 150.01, 146.74, 127.10, 119.39, 115.33, 113.82, 
103.35, 56.39 
HR-MS (ESI) m/z calcd. for C8H8NO2 (M + H)+ 150.0555, found 150.0557 
 
Trans-Cinnamonitrile (3-19) 
  
Prepared according to the general procedure using trans-cinnamaldehyde (3-27) 
(0.025 g, 0.189 mmol) as an aldehyde. The reaction time was 72 h. The crude product was 
purified by silica column chromatography (EtOAc:Hexanes 10:90). Yield = 0.0155 g (63%). 
1H NMR (400 MHz, CDCl3) d (ppm): 7.49 – 7.36 (m, 6H), 5.88 (d, J = 16.7 Hz, 1H). 
13C NMR (101 MHz, CDCl3) d (ppm): 150.74, 133.62, 131.35, 129.28, 127.52, 118.27, 96.42 
HR-MS (ESI) m/z calcd. for C9H7N (M)+× 129.0578, found 129.0581. 
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N-Boc-4-(cyanomethyl)piperidine (3-20) 
 
 Prepared according to the general procedure using N-Boc-4-piperidine-
acetaldehyde (3-29) (0.0308 g, 0.136 mmol) as an aldehyde. The reaction time was 72 h. 
The crude product was purified by silica column chromatography (EtOAc:Hexanes 40:60). 
Yield = 0.0183 g (60%). 
 
1H NMR (101 MHz, CDCl3) d (ppm): 4.14 (s, 2H), 2.70 (t, J = 12.2 Hz, 2H), 2.30 (d, J = 6.4 Hz, 
2H), 1.93 – 1.73 (m, 3H), 1.44 (s, 9H), 1.32 – 1.17 (m, 2H). 
13C NMR (101 MHz, CDCl3) d (ppm): 154.74, 118.24, 79.82, 43.48, 33.47, 31.40, 28.55, 
24.21. 
HR-MS (ESI) m/z calcd. for C12H20N2O2Na (M + Na)+ 247.1422, found 247.1430 
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 (3S)-Citronellylnitrile (3-21) 
 
Prepared according to the general procedure using (-)-citronellal (3-30) (0.0244 g, 
0.158 mmol) as an aldehyde. The reaction time was 24 h. The crude product was purified 
by silica column chromatography (EtOAc:Hexanes 5:95). Yield = 0.0139 g (58%). 
1H NMR (400 MHz, CDCl3) d (ppm): 5.07 (tp, J = 7.1, 1.5 Hz, 1H), 2.42 – 2.16 (m, 2H), 2.10 
– 1.95 (m, 2H), 1.86 (dq, J = 13.1, 6.5 Hz, 1H), 1.68 (s, 3H), 1.61 (s, 3H), 1.46 (ddt, J = 13.3, 
8.5, 6.5 Hz, 1H), 1.40 – 1.22 (m, 1H), 1.07 (d, J = 6.7 Hz, 3H). 
13C NMR (101 MHz, CDCl3) d (ppm): 132.43, 123.62, 119.05, 35.99, 30.08, 25.84, 25.39, 
24.58, 19.53, 19.50. 
HR-MS (ESI) m/z calcd. for C10H17N (M)+× 151.1361, found 151.1368. 
 
3.2.5. General Procedure for the Elimination of Cyanohydrins 
To a 20 mL vial was added sugar cyanohydrin and ethanol to a final concentration 
of 0.01 M. Lewatit MP 62 resins (approximately 10 times by mass compared to the mass 
of cyanohydrin) were added to the mixture then the vial was connected to a gas bubbler 
with a 5% NaOH trap by way of a Tygon® tube and host adapter. The purpose of this 
apparatus was to trap cyanide gas produced during the reaction. The reaction was stirred 
(300 rpm) at 70 °C for 7 h. The resins were removed by vacuum filtration, and the solution 
was evaporated to obtain the desired product.  
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3.2.5.1. Preparation of D-Lyxose (3-22) 
 
 Prepared according to the general procedure using D-galactonitrile (3-11) (0.0058 
g, 0.033 mmol) as sugar cyanohydrin. Yield = 0.0039 g (79%). 
1H NMR spectrum of product matched existing 1H NMR of commercially available D-
lyxose. 
 
3.2.5.2. Preparation of D-Arabinose (3-23) 
 
 Prepared according to the general procedure using D-mannonitrile (3-13) (0.0065 
g, 0.0365 mmol) as sugar cyanohydrin. Yield = 0.0041 g (75%). 
1H NMR spectrum of product matched existing 1H NMR of commercially available D-
arabinose. 
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3.2.5.3. Preparation of a-D-Glucopyranosyl-(1®3)-D-Arabinopyranose 
 
 Prepared according to the general procedure using D-maltonitrile (3-14) (0.0037 
g, 0.01 mmol) as sugar cyanohydrin. Yield = 0.0018 g (58%). 
1H NMR (400 MHz, CDCl3) d (ppm): 5.41 (d, J = 3.8 Hz, 1H), 5.22 (d, J = 3.3 Hz, 0.5H), 4.65 
(d, J = 7.9 Hz, 0.5H), 4.05 – 3.58 (m, 9H), 3.47 (t, J = 9.5 Hz, 1.5H), 3.35 – 3.30 (m, 0.5H). 
HR-MS (ESI) m/z calcd. for C11H19O10 (M-H)- 311.0978, found 311.0977. 
 
3.3. Results and Discussion 
3.3.1. Optimization Study with D-Ribose 
In a preliminary study, the reaction of D-ribose and O-phenylhydroxylamine 
hydrochloride (3-4) in an aqueous solution yielded cyanohydrin. This observation led to 
an evaluation of the reaction conditions under various aqueous environments at room 
temperature (Table 3.1). All aqueous solutions in the optimization studies were prepared 
from deuterium oxide, which allowed for monitoring the reaction by 1H NMR 
spectroscopy. The NMR spectra demonstrated that the oxime was formed as an 
intermediate, then the phenyl group was subsequently eliminated, and the terminal 
nitrile (3-5) was obtained as a product (Scheme 3.3). The incompletion from entries 1 and 
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2 indicated that the presence of acid in solution prevented the reaction to proceed to the 
completion because the hydrolysis rate of the oxime is high under a low pH environment. 
Compound 3-4 was used as a hydrochloride salt, which increased the acidity of the 
solution. The cyanohydrin formation under phosphate buffer conditions at pD 5.45 and 
pD 7.45 could proceed to the completion within 7 h (entries 3 and 4). It was reasoned that 
under the buffer conditions, the hydrochloric acid produced from a starting material was 
neutralized. The pD values of the reaction mixtures were recorded, and the change of the 
pD values was not observed. Therefore, the reaction condition of 0.2 M of sodium 
phosphate buffer at pD 7.45 was used as a general procedure for further investigations. 
 
O
HO OH
HO
O
H2N
ŎHCl HO
OH OH
OH
OH N
HO
OH OH
OH
N
O
D-Ribose 3-4 3-5
Scheme 3.3: Proposed reaction mechanism. 
D-Ribose 
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Next, various types of hydroxylamine sources were evaluated for the formation of 
cyanohydrin from reducing sugar under the standard condition of 0.2 M sodium 
phosphate pD 7.45 (Table 3.2). The reactions were monitored by 1H NMR spectroscopy 
for 24 h at room temperature. As expected, the cyanohydrin product was not obtained 
from the reaction of D-ribose with O-benzylhydroxylamine hydrochloride (3-25) (entry 2); 
however, only an oxime was observed. The cyanohydrin was obtained from the reaction 
of D-ribose with hydroxylamine-O-sulfonic acid (3-3) in 90% yield after 24 h (entry 3). The 
incomplete reaction after 24 h could be rationalized from the fact that sulfuric acid was 
obtained as a byproduct, which increased the hydrolysis rate of an oxime intermediate. 
For the reaction of D-ribose with O-(diphenylphosphinyl)-hydroxylamine (3-1) and O-
Table 3.1 Optimization study with D-ribose. 
 
Entry Condition Time (h) Yielda (%) 
1 D2O 7 83 
2 1% Acetic acid in D2O 7 83 
3 0.2 M Sodium phosphate in D2O pD 5.45 7 100 
4 0.2 M Sodium phosphate in D2O pD 7.45 7 100 
a Determined by 1H NMR 
O
HO OH
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(mesitylsulfonyl)hydroxylamine (3-26) (entries 4 and 5, respectively), only a trace of 
cyanohydrin product was observed. The poor solubility of substrate 3-1 and 3-26 in water 
was believed to be a major reason. Furthermore, a previous study demonstrated that 
oxime intermediates from the reaction of 3-1 with aldehydes were stable at room 
temperature, but the nitrile products could be observed after heating the reaction at 85 
°C for several hours.117 The quantitative yield from entry 1 demonstrated that 3-4 was a 
suitable nitrogen source for the formation of cyanohydrins from a variety of 
carbohydrates. 
  
 
 
Table 3.2 Evaluation of cyanohydrin formation with hydroxylamine sources. 
 
 
Entry  Time (h) Yielda (%) 
1  24 100 
2  24 0 
3  24 90 
4  24 trace 
5  24 trace 
a Determined by 1H NMR 
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3.3.2. Transformation of Reducing Sugars to Cyanohydrins 
The transformation of 13 reducing sugars to cyanohydrins is reported in Table 3.3. 
All carbohydrate substrates were reacted with 3-4 in 0.2 M sodium phosphate at pD 7.25 
and the reactions were monitored by 1H NMR spectroscopy. Phenols produced as 
byproduct could be easily removed from the reaction mixtures by extraction with diethyl 
ether. In most cases, after evaporation of the aqueous solution to dryness, the 
cyanohydrin products were obtained by dissolving the dried mixture with ethanol. The 
exception to this purification protocol was the case of silyl-protected ribose (entry 13); 
the reaction mixture was purified by silica column. The reactions of 3-4 with pentoses 
(entries 1 to 4) was highly efficient; they proceeded to the completion within 12 h. 
Interestingly, it required longer reaction time for the substrate 2-deoxy-D-ribose (entry 5) 
to proceed to completion. The reactions of hexoses (entries 6 to 8) and disaccharides 
(entry 10) were slower and often required 48 h to reach completion. However, the 
reaction of D-mannose (entry 9) required only 24 h for the full conversion. It could be 
reasoned that the axial OH group on the C-2 position did not interfere during the 
nucleophilic attack on the carbonyl carbon. L-Fucose, GlcNAc, and silyl-protected ribose 
(entries 11, 12, and 13, respectively) required longer reaction time than typical likely due 
to the steric hindrance on the substrates. The isolated yield from the reaction of maltose 
was lower than expected because the maltonitrile was poorly soluble in ethanol. The 
reaction of L-fucose and N-GlcNAc showed lower of isolated yields than expected because 
both cyanohydrin products were partially soluble in diethyl ether, which were removed 
during the purification process. 
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Table 3.3 Transformation of reducing sugars to cyanohydrins. 
 
Entry Reducing sugar Time (h)  Yielda (%) 
1 D-Ribose 12   94 
2 D-Arabinose 12  81 
3 D-Xylose 12  98 
4 L-Arabinose 12  100 
5 2-Deoxy-D-ribose 16  96 
6 D-Glucose 48  90 
7 D-Galactose 48  97 
8 D-Allose 48  63 
9 D-Mannose 24  96 
10 D-Maltose 48  53 
11 L-Fucose 72  59 
12 N-Acetyl-D-glucosamine 
(GlcNAc)  
72  70 
13 5-O-TBDPS-D-riboseb,c 72  69 
aIsolated yield; bMeOH was added (50% v/v) to increase solubility; cTBDPS = tert-butyldiphenylsilyl 
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3.3.3. Optimization Study with Cinnamaldehyde 
The scope of the aldehyde substrates was extended to aromatic, aliphatic, and 
a,b-unsaturated aldehydes. Reaction conditions used for carbohydrate compounds 
needed to be modified to be used for these hydrophobic substrates since the organic are 
poorly soluble in water. Cinnamaldehyde (3-27) was chosen to optimize reaction 
conditions. A 4:1 ratio of methanol to aqueous sodium phosphate pH 6.5 was found to be 
the best solvent for dissolving 3-27. Since the reactions could be monitored by TLC, the 
protonated solutions were used for the reaction instead of using the deuterated 
condition. The concentration of sodium phosphate affects the yields of the products. As 
shown in Table 3.4, a 0.5 M of sodium phosphate increased the yields of the product as 
compared to a 0.2 M (entries 1 and 2). However, the yield decreased when a 1 M sodium 
phosphate (entry 3) was used because it caused the reaction mixture to become 
heterogeneous. The effect of biphasic conditions prepared from n-butanol and sodium 
phosphate buffer was also studied (Table 3.4, entries 4 and 5). The concentration of 
sodium phosphate did not affect the yield of the product. Nevertheless, these biphasic 
conditions were less efficient than monophasic conditions. Therefore, the condition in 
entry 2 was chosen as a general procedure to be used with organic compounds. 
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3.3.4. Transformation of Hydrophobic Aldehydes to Nitriles 
 To study the formation of nitriles from hydrophobic compounds, reactions using 
a 4:1 ratio of methanol to 0.5 M sodium phosphate pH 6.5 was used as a solvent, and 
conducted at 60 °C. The results in Table 3.5 suggests that this condition is efficient for the 
selective transformation of aldehydes to nitriles with a variety of substrates, especially, 
for the transformation of vanillin (3-28) which could be completed within 8 h with 
exceptional yield (entry 1). This reaction is also suitable for an acid-labile functional group, 
such as tert-butyloxycarbonyl protecting group (Boc) (3-29), as shown in entry 3. 
Table 3.4 Optimization study with cinnamaldehyde.  
 
 
 
Entry Condition Time (h) Isolated yield 
(%) 
1 4:1 of MeOH:0.2 M sodium phosphate pH 6.5 72 32 
2 4:1 of MeOH:0.5 M sodium phosphate pH 6.5 72 63 
3 4:1 of MeOH:1 M sodium phosphate pH 6.5 72 38 
4 1:1 of n-BuOH:0.5 M sodium phosphate pH 6.5 72 49 
5 1:1 of n-BuOH:1.0 M sodium phosphate pH 6.5 72 51 
O
H2N
ŎHCl
Conditions
H
O N
3-27 3-4
3-19
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Furthermore, the unsaturated aliphatic aldehyde (3-30) could also be transformed to a 
nitrile under the same condition in an acceptable yield (58%). 
 
 
Table 3.5 Transformation of aldehydes to nitriles. 
 
 
 
Entry  Time (h) Isolated Yield 
(%) 
 
1 
 
 
 
8 99 
 
2 
 
 
72 63 
 
3 
 
 
 
72 60 
 
4 
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3.3.5. Application  
 Wohl degradation was selected to demonstrate the application of the 
carbohydrate cyanohydrins. It is well known that the Wohl degradation is one of the most 
common methods for shortening aldose sugars through the formation of acetylated 
cyanohydrin and elimination of the terminal cyanide by using ammonia or silver hydroxide 
(Scheme 3.4). The goal of this study is to find an alternative and robust approach to 
shortening sugars by using the weakly basic resins, which allow for convenient 
purification through filtration.  
 
Previously, weakly basic resins (WBS) were used to remove palladium and 
platinum ions from aqueous solution.121,122 It was hypothesized that these types of resin 
would act similarly to ammonia to eliminate the terminal cyanide. Therefore, three 
cyanohydrins were chosen to study in a new degradation approach using Lewatit MP62 
resin as a base (Table 3.6). The resin is very efficient for the reaction. By using the resin, 
D-Galactonitrile (3-11) could be degraded to D-lyxose (3-22), and D-mannonitrile (3-14) 
could be degraded to D-arabinose (3-23) (entries 1 and 2, respectively). The same reaction 
condition was also applied for removing terminal cyanide from a disaccharide 
cyanohydrin. Entry 3 shows that cyanide was eliminated from a D-maltonitrile (3-14) to 
1) NH2OH
2) Ac2O, NaOAc N
OAc
OAc
OAc
OAc
AcO H
O
OH
OH
OH
HO
OH
OH
OH
OH
HO H
O
Aldose sugar
NH3
Scheme 3.4: Conventional Wohl degradation. 
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form D-glucopyranose-(1®3)-D-arabinopyranose (3-24), which is a new type of reducing 
sugar. This practical approach provides an alternative way to produce rare reducing 
sugars from the commercially available ones. 
 
 
 
 
 
 
 
Table 3.6 Degradation of cyanohydrins.  
 
 
 
Entry  Time (h) Product (Yield) 
1  7  
2  7  
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3.4 Conclusions 
 A new method for transforming aldehydes to nitriles using commercially available 
O-phenylhydroxylamine hydrochloride as a nitrogen source is described. The method 
works exceptionally well under aqueous solution with the presence of sodium phosphate 
buffer. Several reducing sugars were transformed to cyanohydrins in high yields. The 
lower yields obtained from D-maltose was due to the solubility issue.  This method was 
modified to be compatible with hydrophobic compounds by using a mixture of an organic 
solvent and sodium phosphate buffer. Several functionalized aliphatic and aromatic 
aldehydes were transformed to nitriles in acceptable yields. The reaction conditions were 
also suitable for a compound containing an acid-labile functional group.  
A new method for shortening reducing sugars by using weakly basic resins was 
demonstrated. The cyanohydrin compounds (3-11, 3-13, 3-14) were used as reactants for 
the demonstration. The reducing sugars obtained from the degradation of D-
galactonitrile, D-mannonitrile, and D-maltonitrile were D-lyxose (3-22), D-arabinose (3-23), 
and D-glucose-a-(1®3)-D-arabinose (3-24), respectively.  
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CHAPTER 4  
SYNTHESIS OF PHOTOCAGED b-NAD+ ANALOGUE AND CHEMOENZYMATIC SYNTHESIS 
OF POLY(ADP-RIBOSE) 
 
4.1. Introduction  
  Poly(ADP-ribose) (poly(adenosine diphosphate ribose)) or PAR is a natural 
polymer that was discovered more than 50 years ago as a product from the enzymatic 
reaction of b-NAD+ with poly(ADP-ribose) polymerase (PARP) (Scheme 4.1).123,124 To date, 
there are at least 18 enzymes in the PARP family based on the similarity at the catalytic 
domain as shown in Figure 4.1.125 However, there are only 4 enzymes that have been 
known to process the poly(ADP-ribosyl)ation (PARylation) including PARP1, PARP2, 
tankyrase1 (TANK1), and tankyrase2 (TANK2).126,127 PARylation is involved in many 
biological processes such as DNA-damage repair, transcription, mitosis, and 
apoptosis.125,128,129 During DNA strand breaks (either single- or double-strand breaks), 
PARP1 is activated, and it starts catalyzing PAR formation onto itself (automodification) 
or associated proteins such as histones (heteromodification).130–132 
ON
HO OH
H2N
O
O
P
O
P
O
OO
O O
O
HO OH
N
N
N
N
NH2
훃-NAD+
Protein
PARP
Scheme 4.1: Incorporation of PAR on target protein by PARP enzyme.  
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PAR polymers involve in many biological processes through the noncovalent 
interactions with a variety of associated proteins.133,134 For example, PAR that is formed 
during the activation of PARP1 at the DNA-damage site can act as a scaffold to recruit 
PAR-binding proteins involving in DNA repairs, such as XRCC1, ALC1, APLF, and CHFR.135 
Furthermore, the interaction between PAR and associated proteins depends on the chain 
length of PAR. For example, during the DNA-damaged repair, long PAR polymers (>40 
sequence comparisons and domain searches, some 30 bacterial
strains distributed over six different phyla have been identified
that have acquired genes potentially encoding ARTs.7,52 In
archaea the classical ART signature has not been identified by
sequence comparisons or domain searches.52 However, an ADP-
ribosylating enzyme has been discovered in the archaeon
Sulfolobus solfataricus capable of catalyzing ADPr polymer-
ization.54 In addition, ADP-ribosylating proteins have also been
identified in viruses.52,55 The presence of only a single
component of the ADPr metabolism suggests that these proteins
are relevant for host−pathogen interactions. Indeed, some
pathogens have been described to rely on their ADP-ribosylating
proteins for pathogenesis, pathogen propagation, and replica-
tion, as well as modulation of the host immune response.8,56−61
Of note is that the bacterial ARTs and thus most likely also the
corresponding hydrolases are considered predecessors of the
eukaryotic genes and proteins.7
Best characterized among the noneukaryotic ARTs are the
bacterial ADP-ribosyltransferase toxins found in many different
species, including human, plant, and insect pathogens. These
toxins are highly substrate specific and transfer one ADPr unit
typically onto a single host target, thereby contributing to
bacterial pathogenesis.8,62 For example, diphtheria toxin and
closely related toxins affect protein biosynthesis by specifically
modifying eEF2 at position 715, a modified histidine or
diphthamide residue that is critical for protein synthesis.63,64
As pointed out above, the primary diversification of the ART
enzyme family occurred during the development of different
bacterial conflict systems and the various eukaryotic ARTs were
subsequently acquired by horizontal gene transfer.7,65 These
conflict systems include toxin−antitoxin (TA) systems.66,67 TA
Figure 4.Human ADP-ribosyltransferases of the diphtheria toxin like (ARTD) and of the cholera toxin like (ARTC) families. Schematic comparison of
the domain architecture of the human ADP-ribosyltransferase proteins. MARylation and PARylation refer to the catalytic activity as mono-ADP-
ribosyltransferases and enzymes that can synthesize poly-ADPr chains, respectively. Please note that human ARTC2 is a pseudogene. The following
domains are indicated: AMD, automodification domain; ARC, ankyrin repeat cluster, can mediate protein−protein interactions; ART, ADP-
ribosyltransferase domain; ART w/E, ADP-ribosyltransferase domain with a catalytically relevant glutamate; BRCT, BRCA1 carboxy-terminal domain,
found in many DNA damage repair and cell cycle checkpoint proteins; GPI, glycosylphosphatidylinositol anchor, a PTM at the C-terminus of some
proteins in the endoplasmic reticulum, typically requiring the removal of a C-terminal peptide to expose the modification site; GRD, glycine-rich
domain; HPS, histidine−proline−serine region; Macro, the macrodomain is closely associated with ADPr metabolism, and some possess ADP-ribose-
1′-phosphatase, some possess ADP-ribosylhydrolase activity, and some interact with MARylated or PARylated substrates, while the macrodomain can
serve as ADPr or O-acetyl-ADP-ribose binding module; MVP-ID, major vault particle interaction domain; NES, nuclear export sequence; PRD, PARP
regulatory domain, an autoinhibitory domain for ARTD1 and suggested to be involved in branching activity; PRD-like, similarity to PRD but
functionally poorly characterized; RRM, RNA-binding/recognition motif; SAM, sterile αmotif, can mediate homo- or heterodimerization; SAP, SAF/
acinus/PIAS-DNA-binding domain; SP, signal peptide, required for targeting the synthesis of a protein to the endoplasmic reticulum; TMD,
transmembrane domain; TR, 10 amino acid tandem repeats with the consensus sequence [GS]-E-K-N-[QW]-K-L-E-D-H; UIM, ubiquitin interaction
motif; VIT, vault protein inter-α-trypsin domain, suggested to mediate protein−protein interactions; vWA, vonWillebrand type A domain, suggested to
mediate protein−protein interactions; WGR, domain named after a conserved central motif (W-G-R), found in some polyA polymerases; WWE, a
protein−protein interaction domain named after three conserved residues (W-W-E), some interact with iso-ADP-ribose; ZF, zinc finger domain; ZF/
TPH, Ti-PARP (ARTD14) homologous zinc finger domain.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.7b00122
Chem. Rev. 2018, 118, 1092−1136
1097
Figure 4.1: Schematic comparison of t e domain of poly(ADP-ribose) polymerases. 
PARylation and MARylation refer to the poly(ADP-ribosyl)ation and mono(APD-
ribosyl)ation, respectively. Reprinted with permission from ref 125. Copyright 
(2018) American Chemical Society. 
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units) are preferred for associated DNA repair proteins XPA, DEK, and ChK1 but short PAR 
polymers are preferred for DNA repair proteins p53 and WRN.136 
 PAR composes of ADP-ribose between 2 to 200 units connecting at the 2’-OH of 
adenosine via an a-glycosidic linkage. In every 20 to 50 repeating units, the branching of 
the polymer can be observed at the 2’’-OH of the ribose136 (Figure 4.2). PAR structure can 
be considered as a combination of polynucleotide and polysaccharide. PAR contains 
ribose (reducing sugar) at the terminal end and can branch at the hydroxyl group via a 
glycosidic linkage, which makes its properties similar to the carbohydrates (glycans).    
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Figure 4.2: Structure of poly(ADP-ribose). 
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The structural complexity and heterogeneity of PARs impede scientists to study 
their biological functions related to their structures. One of the reasons is the lack of tools 
to access PAR in homogeneous forms. This work is intended to use the chemical tools to 
obtain PAR in homogeneous forms by two approaches. The first approach uses chemical 
auxiliary to facilitate fractionation and purification of the PAR polymers. Another 
approach uses a new b-NAD+ analogue substrate for the chemoenzymatic synthesis of 
PAR in a controlled manner. 
Recently, Mitchison and coworkers reported the in vitro enzymatic synthesis of 
PAR obtaining the polymers in hundreds of milligram scales with a variety of polymer 
sizes. They also demonstrated the fractionation of PAR through an anion exchange 
chromatogram to obtain the defined length polymers.137 However, this method is still not 
feasible to obtain a specifically defined length of PAR polymer at a workable yield. This 
Chapter focused on applying the auxiliary 2-6 from Chapter 2 to PAR envisioning that 
auxiliary 2-6 can facilitate fractionation and purification to obtain the defined length of 
PAR polymers.  
 Although PAR polymers with specifically defined lengths can be obtained via 
chemical synthesis, there are many labile functional groups and specific stereochemistry 
in PAR polymer that challenge synthetic chemists. Filippov and coworkers138 reported the 
synthesis of PAR oligomers through the solid-phase synthetic approach. Although this 
method demonstrated a robust approach to obtain a specifically defined length of PAR, it 
required multiple synthetic steps for preparing starting materials that were used as 
building blocks.      
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 Recently, Marx and coworkers139 reported modified b-NAD+ analogues that could 
be used as substrates for wild-type PARP1 for labeling target proteins. The report shows 
that by changing hydroxyl group at 2’ position of b-NAD+ to hydrogen (compound 4-1 and 
4-2, Figure 4.3), PARP1 still recognized these compounds as substrates and they were 
used as chain-terminators during PARylation. Inspired by this modification, it is envisioned 
that the formation of PAR can also be controlled selectively through the chemoenzymatic 
synthesis by modifying the substrate at the 2’ position. With this approach, it could be 
able to terminate a PAR formation by adding a protecting group at 2’-OH (compound 4-
20). After selective deprotection, a 2’-OH will be available for further elongation. 
 
 
 
4.2. Experimental 
4.2.1. General Information 
All chemicals and reagents were purchased and used without further purification. 
All the reactions were performed in flame dried glassware under a nitrogen atmosphere 
unless stated. Dimethylformamide (DMF), pyridine, methylene chloride, and methanol 
were dried over 4 Å molecular sieves. Thin-layer chromatography (TLC) analysis was 
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Figure 4.3: Structure of b-NAD+ analogue substrates for PARP1 as chain terminators. 
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performed on silica gel 60 with fluorescent indicator F254 (EMD Millipore) and visualized 
with UV light (254 nm) where applicable. Silica gel column chromatography was 
performed on SiliaFlash® F60 (Silicycle, 40-64 µm). 1H, 13C, and 31P NMR spectra were 
recorded at 400 MHz, 101 MHz, and 162 MHz, respectively. HPLC analysis and preparation 
were performed on Gilson® Analytical to Semi-Preparative HPLC system using Kinetex® 5 
µm EVO C18 100 Å 4.6x150 mm and SiliaChrom C18 5 µm 100 Å 4.6x150 mm for analytical 
columns and Kinetex® 5u EVO C18 100 Å 21.1x150 mm for a preparative column. Mass 
spectrometry analysis was performed by the School of Chemical Sciences Mass 
Spectrometry Laboratory at the University of Illinois. 
 Human PARP1 enzyme (high specific activity) was purchased from Trevigen. ADP-
ribose and deoxyribonucleic acid from calf thymus were purchased from Sigma. 
Adenosine 5’-monophosphate was purchased from Acros. Beta-nicotinamide adenine 
dinucleotide was purchased from Alfa Aesar. Nicotinamide mononucleotide (NMN) was 
purchased from Accela Chembio. 
List of solvents used on HPLC: 
Solvent A = water 
  Solvent B = acetonitrile 
  Solvent C = 8 mM Et3NHOAc in water 
  Solvent D = 8 mM Et3NHOAc in acetonitrile 
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4.2.2. Synthetic Procedures 
Synthesis of compound 4-3a and 4-3b 
  
 
The synthetic procedure was modified from Szczepankiewicz et al.140 To a 7 mL 
vial was added Na2CO3 (0.032 g, 0.3 mmol, 2 equiv) and 0.8 mL of glacial acetic acid. After 
Na2CO3 dissolved, b-NAD+ (0.1 g, 0.15 mmol, 1 equiv) was added to the solution. The 
reaction mixture was heated at 90 °C for 2 h. The reaction was removed from the heat 
then 2 mL of cold denatured alcohol (90:5:5 of ethanol:methanol:2-propanol) was added 
dropwise resulting in the formation of precipitates. The precipitates were filtered via 
vacuum filtration and washed with 6 mL of cold denatured alcohol. The solid was dried 
under high vacuum to obtain the product as light brown solid. Yield = 0.0663 g (73%). 
 
1H NMR spectrum of product matched 1H NMR of reference 140. 
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Synthesis of compound 4-4 
 
 To a 7 mL vial was added compound 4-3a and 4-3b (0.025 g, 0.0415 mmol, 1 equiv) 
and 0.42 mL of 1 M NaOH. The reaction mixture was stirred at room temperature for 50 
min. The mixture was neutralized with glacial acetic acid (pH of the solution was checked 
by pH paper). Then, 2 mL of cold denatured alcohol (90:5:5 of ethanol:methanol:2-
propanol) was added dropwise resulting in the formation of precipitates. The precipitates 
were filtered through cotton-packed glass pipet. The precipitates that remained in the 
glass pipet were removed by dissolving with water. After removing water by a rotary 
evaporator, a brown solid was obtained as the product. It should be noted here that 
hydrolysis at the pyrophosphate was also observed, but we chose to do conjugation in 
the next step without further purification. Yield = 0.0192 g (85%). 
The 1H NMR was determined based on 1H NMR of purchased ADPr.  
1H NMR (400 MHz, CDCl3) d (ppm): 8.59 (s, 1H), 8.49 (s, 1H), 6.12 (d, J = 6.0, 1H), 5.29 (d, 
J = 3.9 Hz, 0.4H), 5.18 (d, J = 2.4 Hz, 0.6H), 4.50 (m, 2H), 4.42 – 4.31 (m, 1H), 4.31 – 3.90 
(m, 7H). 
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Synthesis of compound 4-5 
 
 To a 7 mL vial, compound 4-4 (0.068 g, 0.11 mmol, 1 equiv) was dissolved in 0.8 
mL sodium phosphate buffer (0.25 M, pH 4.7). Another 7 mL vial, compound 2-6 (0.076 g, 
0.33 mmol, 3 equiv) was dissolved in 0.2 mL DMSO then added to the 4-4 solution. The 
reaction mixture was stirred at 40 °C for 72 h. The conjugated product was purified by 
HPLC preparative C18 column (gradient of 99% solvent A/ 1% solvent B to 60% solvent A/ 
40% solvent B in 10 minutes). Yield = 0.0137 g (16%). 
1H NMR (400 MHz, D2O) d (ppm): 8.29 (s, 1H), 8.20 (d, J = 8.3 Hz, 2H), 7.95 (s, 1H), 7.50 (d, 
J = 7.9 Hz, 2H), 5.91 (d, J = 5.6 Hz, 1H), 4.85 – 4.83 (m, 2H), 4.65 – 4.52 (m, 2H), 4.44 (t, J = 
4.6 Hz, 1H), 4.32 (s, 1H), 4.28 – 4.18 (m, 4H), 4.19 – 4.04 (m, 3H), 3.07 (s, 3H), 2.67 (s, 3H). 
31P NMR (162 MHz, D2O) d (ppm): -10.10 (d, J = 10.1 Hz). 
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Synthesis of compound 4-8 
 
  
 
 
 
 The synthetic procedure of Chaulk and MacMillan was followed with 
modification.141 To a 40 mL vial was added adenosine (4-6) (0.5 g, 1.87 mmol, 1 equiv) 
and dry DMF 17 mL under N2. The solution was heated to 100 °C until adenosine 
dissolved. The solution was cooled in the iced-water bath. To a 7 mL vial, sodium hydride 
(0.112 g, 2.8 mmol, 1.5 equiv) was washed with hexanes 3 times then suspended in 2 mL 
of dry DMF under N2. The suspension was transferred to adenosine solution and the 
reaction mixture was stirred in the iced-water bath for 45 min. To a 7 mL vial was added 
2-Nitrobenzylbromide (4-7) (0.6 g, 2.8 mmol, 1.5 equiv) and dry DMF 2 mL, then 
transferred to the reaction mixture. The reaction was stirred at room temperature for 5 
h. The reaction was added dropwise to ice-cold water and left stirring at room 
temperature for overnight. Light yellow precipitates were collected by vacuum filtration 
and dried under high vacuum. The product was used for the next reaction with further 
purification. Yield = 0.519 g (69%). 
 The product could be further purified by washing the precipitates with acetonitrile 
through vacuum filtration.   
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1H NMR (400 MHz, DMSO-d6) d (ppm): 8.35 (s, 1H), 8.10 (s, 1H), 7.97 (d, J = 8.1 Hz, 1H), 
7.59 (q, J = 8.3, 7.8 Hz, 2H), 7.49 (t, J = 7.5 Hz, 1H), 7.36 (s, 2H), 6.11 (d, J = 6.1 Hz, 1H), 
5.47 – 5.39 (m, 2H), 5.04 (d, J = 14.4 Hz, 1H), 4.87 (d, J = 14.8 Hz, 1H), 4.60 (t, J = 5.5 Hz, 
1H), 4.42 (q, J = 5.1 Hz, 1H), 4.05 (q, J = 3.6 Hz, 1H), 3.70 (dt, J = 12.8, 4.6 Hz, 1H), 3.58 
(ddd, J = 11.6, 7.1, 3.7 Hz, 1H). 
13C NMR (101 MHz, DMSO-d6) d (ppm): 156.16, 152.40, 148.96, 147.04, 139.64, 133.96, 
133.61, 133.57, 128.51, 124.37, 119.35, 86.47, 86.09, 81.13, 68.93, 67.80, 61.43. 
HR-MS (ESI) m/z calcd. for C17H19N6O6 (M + H)+ 403.1366, found 403.1360. 
 
Synthesis of compound 4-9 
 
 
The synthesis procedure of Chaulk and MacMillan was followed with 
modification.141 To a 20 mL vial, precipitates of 4-8 (0.358 g, 0.889 mmol, 1 equiv) was 
evaporated from dry acetonitrile 2 times then added 8.0 mL of dry pyridine and 
trimethylsilyl chloride (0.56 mL, 4.45 mmol, 5 equiv). The reaction was stirred at room 
temperature for 45 min. Benzoyl chloride (0.52 mL, 4.45 mmol, 5 equiv) was added to the 
reaction mixture and stirred at room temperature for 3.5 h. To the reaction was added 
2.5 mL of water then cooled in the iced-water bath for 5 min. Cold NH4OH (29%, 12 mL) 
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was added to the reaction and stirred in the iced-water bath for 50 min. The reaction 
mixture was concentrated by a rotary evaporator. During evaporation, a small amount of 
silica gel was added to the concentrating mixture. The product was purified by silica 
column chromatography (MeOH:CH2Cl2 = 5:95). Yield = 0.269 g (60%). 
 
1H NMR (400 MHz, CDCl3) d (ppm): 9.31 (s, 1H), 8.71 (s, 1H), 8.05 (s, 1H), 8.04 (d, J = 9.4 
Hz, 2H), 7.83 (dd, J = 7.9, 1.5 Hz, 1H), 7.66 – 7.58 (m, 1H), 7.53 (dd, J = 8.3, 6.8 Hz, 2H), 
7.39 (td, J = 7.4, 1.5 Hz, 1H), 7.36 – 7.28 (m, 2H), 5.95 (d, J = 7.4 Hz, 1H), 5.04 (d, J = 12.9 
Hz, 1H), 4.94 (dd, J = 7.4, 4.5 Hz, 1H), 4.68 (d, J = 13.0 Hz, 1H), 4.66 (d, J = 4.4 Hz, 1H), 4.35 
(s, 1H), 3.96 (d, J = 13.0 Hz, 1H), 3.77 (d, J = 12.6 Hz, 1H). 
13C NMR (101 MHz, CDCl3) d (ppm): 164.78, 152.26, 150.39, 147.94, 143.33, 133.53, 
133.42, 133.14, 131.84, 129.80, 129.40, 129.10, 129.00, 128.10, 124.98, 124.45, 89.19, 
88.15, 81.13, 70.76, 70.13, 63.20. 
HR-MS (ESI) m/z calcd. for C24H23N6O7 (M + H)+ 507.1628, found 507.1624. 
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Synthesis of compound 4-10 
 
The synthesis procedure of Hergenrother et al. was followed with modification.142 
To a 20 mL vial was added compound 4-9 (0.267 g, 0.528 mmol, 1 equiv), imidazole (0.180 
g, 2.64 mmol, 5 equiv), dry DMF 3 mL. Tert-butyldimethylsilyl chloride (0.398 g, 2.64 
mmol, 5 equiv) was dissolved in 2 mL of dry DMF then added to the reaction mixture 
dropwise. The reaction was stirred at room temperature for 18 h. The reaction was 
concentrated and purified by silica column chromatography (50:50 EtOAc:Hexanes). Yield 
= 0.279 g (72%). 
 
1H NMR (400 MHz, CDCl3) d (ppm): 9.04 (s, 1H), 8.80 (s, 1H), 8.35 (s, 1H), 8.07 – 7.98 (m, 
3H), 7.72 (d, J = 7.8 Hz, 1H), 7.61 (t, J = 7.4 Hz, 1H), 7.58 – 7.49 (m, 3H), 7.40 (t, J = 7.2 Hz, 
1H), 6.33 (d, J = 4.4 Hz, 1H), 5.18 – 5.01 (m, 2H), 4.59 (dt, J = 14.2, 4.4 Hz, 2H), 4.22 (q, J = 
3.2 Hz, 1H), 4.02 (dd, J = 11.6, 3.6 Hz, 1H), 3.81 (dd, J = 11.4, 2.9 Hz, 1H), 0.93 (s, 9H), 0.91 
(s, 9H), 0.12 (s, 3H), 0.11 (s, 6H), 0.09 (s, 3H). 
13C NMR (101 MHz, CDCl3) d (ppm): 164.79, 153.02, 152.93, 151.70, 149.67, 141.90, 
134.34, 133.95, 133.02, 129.15, 129.05, 128.83, 128.39, 128.08, 124.91, 123.60, 87.16, 
85.87, 82.57, 70.34, 69.29, 62.25, 26.24, 25.90, 18.68, 18.26, -4.47, -5.15.  
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HR-MS (ESI) m/z calcd. for C36H51N6O7Si2 (M + H)+ 735.3358, found 735.3364. 
 
Synthesis of compound 4-11 
 
 
The synthesis procedure of Hergenrother et al. was followed with modification.142 
To a 20 mL vial was added compound 4-10 (0.285 g, 0.373 mmol, 1 equiv) and THF 5.2 
mL, stirred in iced-water bath. Trichloroacetic acid (2.8 g, 17.16 mmol, 46 equiv) was 
dissolved in 1.3 mL of water, then added to the 4-10 solution dropwise. The reaction was 
stirred in iced-water bath for 4.5 h. The reaction was quenched by adding saturated 
NaHCO3 solution. The reaction was extracted with CH2Cl2 3 times and dried with Na2SO4. 
The solvent was removed by rotary evaporator to obtain product as a light-yellow foam. 
Yield = 0.219 g (95%). 
1H NMR (400 MHz, CDCl3) d (ppm): 8.98 (d, J = 14.7 Hz, 1H), 8.74 (s, 1H), 8.10 (s, 1H), 8.07 
– 8.03 (m, 2H), 7.93 – 7.87 (m, 1H), 7.69 – 7.60 (m, 1H), 7.59 – 7.52 (m, 2H), 7.43 – 7.38 
(m, 2H), 7.35 – 7.29 (m, 1H), 6.03 (d, J = 7.9 Hz, 1H), 4.97 (d, J = 14.1 Hz, 1H), 4.90 (dd, J = 
7.8, 4.4 Hz, 1H), 4.70 (d, J = 14.1 Hz, 1H), 4.67 (d, J = 4.9 Hz, 1H), 4.26 (s, 1H), 3.97 (dd, J = 
13.1, 1.7 Hz, 1H), 3.82 – 3.70 (m, 1H), 0.92 (s, 9H), 0.14 (s, 3H), 0.10 (s, 3H). 
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13C NMR (101 MHz, CDCl3) d (ppm): 164.52, 152.23, 152.16, 150.52, 150.40, 143.48, 
133.54, 133.39, 133.29, 133.19, 129.16, 128.78, 128.62, 128.04, 124.81, 124.70, 90.10, 
89.66, 80.63, 71.70, 69.13, 63.11, 25.80, 18.22, -4.50, -4.70. 
HR-MS (ESI) m/z calcd. for C30H37N6O7Si (M + H)+ 621.2493, found 621.2490. 
 
Synthesis of compound 4-13 
 
 
A modified procedure of Filippov et al.138 was proceeded. To a 7 mL vial was added 
compound 4-11 (0.027 g, 0.0434 mmol, 1 equiv) and DMF 0.2 mL. Another 7 mL vial was 
added 1-methylimidazolium chloride (0.0154 g, 0.1302 mmol, 3 equiv), 1-
methylimidazole (0.0071 g, 0.0868 mmol, 2 equiv), and DMF 0.3 mL. The mixture was 
transferred to the 4-11 solution dropwise. Then, di-tert-butyl-N,N’-
diisopropylphosphoramidite (4-12) (0.021 mL, 0.0615 mmol, 1.5 equiv) was added to the 
mixture dropwise. The reaction mixture was stirred at room temperature for 40 min. Tert-
butyl-peroxide in decane (5-6 M) (0.24 mL, 0.238 mmol, 5.5 equiv) was added to the 
reaction mixture and the reaction was stirred at room temperature for 1 h.  The reaction 
was quenched with 1 mL of saturated NaHCO3 solution. The reaction was extracted with 
EtOAc (5 mL, 3 times). The organic was washed with water (5 mL,1 time) then dried over 
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Na2SO4. The solution was concentrated and purified by silica column chromatography 
(5:95 MeOH:CH2Cl2). Yield 0.0247 g (70%). 
 
1H NMR (400 MHz, CDCl3) d (ppm): 9.28 (s, 1H), 8.78 (s, 1H), 8.35 (s, 1H), 8.07 – 7.96 (m, 
3H), 7.69 (dt, J = 7.9, 1.3 Hz, 1H), 7.64 – 7.57 (m, 1H), 7.52 (tdd, J = 8.1, 6.5, 1.1 Hz, 3H), 
7.38 (ddd, J = 8.2, 7.4, 1.6 Hz, 1H), 6.30 (d, J = 4.9 Hz, 1H), 5.10 (d, J = 14.7 Hz, 1H), 5.02 
(d, J = 14.8 Hz, 1H), 4.69 (t, J = 4.8 Hz, 1H), 4.61 (t, J = 4.2 Hz, 1H), 4.39 – 4.26 (m, 2H), 4.13 
(dt, J = 12.6, 4.8 Hz, 1H), 1.49 (s, 18H), 0.89 (s, 9H), 0.14 (s, 3H), 0.08 (s, 3H). 
31P NMR (162 MHz, CDCl3) d (ppm): -8.79. 
HR-MS (ESI) m/z calcd. for C38H54N6O10SiP (M + H)+ 813.3408, found 813.3417. 
 
 Synthesis of compound 4-14 
 
 
To a 7 mL vial was added compound 4-13 (0.269 g, 0.331 mmol, 1 equiv) and 
CH2Cl2 3 mL, stirred in the iced-water bath. Trifluoroacetic acid (TFA) (0.26 mL, 3.31 mmol, 
10 equiv) was added to the 4-3 solution dropwise. The reaction was stirred in the iced-
water bath for 2 h. The reaction was then warmed to room temperature and stirred for 
another 5 h. The solvent was removed by rotary evaporator and purified by HPLC 
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preparative C18 column (gradient of 80% solvent A/ 20% solvent B to 50% solvent A/ 50% 
solvent B in 10 minutes). Yield = 0.083 g (43%). 
 
1H NMR (400 MHz, CD3OD) d (ppm): 8.83 (s, 1H), 8.72 (s, 1H), 8.14 – 8.08 (m, 2H), 7.96 – 
7.89 (m, 1H), 7.80 – 7.72 (m, 1H), 7.71 – 7.65 (m, 1H), 7.64 – 7.54 (m, 3H), 7.45 (t, J = 7.6 
Hz, 1H), 6.40 (d, J = 4.4 Hz, 1H), 5.23 (d, J = 14.5 Hz, 1H), 5.08 (d, J = 14.4 Hz, 1H), 4.66 (t, 
J = 4.8 Hz, 1H), 4.59 (t, J = 4.4 Hz, 1H), 4.35 (q, J = 4.5, 3.7 Hz, 1H), 4.33 – 4.28 (m, 1H), 4.27 
– 4.18 (m, 1H). 
13C NMR (101 MHz, CD3OD) d (ppm): 168.51, 153.09, 153.02, 152.76, 150.15, 149.14, 
143.71, 134.73, 134.57, 134.43, 134.14, 130.55, 129.77, 129.52, 125.54, 122.66, 88.61, 
88.49, 85.62, 83.66, 70.28, 65.88. 
31P NMR (162 MHz, CD3OD) d (ppm): 1.26. 
HR-MS (ESI) m/z calcd. for C24H24N6O10P (M + H)+ 587.1292, found 587.1288. 
 
Synthesis of compound 4-15 
 
To a 7 mL vial was added compound 4-14 (0.016 g, 0.027 mmol, 1 equiv) and 
MeOH 1 mL, stirred in the iced-water bath. The solution of 7 M NH3 in MeOH was added 
to the 4-14 solution dropwise. The reaction was stirred in the iced-water bath for 2 h. The 
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reaction was then warmed to room temperature and stirred for another 42 h. The solvent 
was removed by a rotary evaporator and purified by HPLC preparative C18 column 
(gradient of 99% solvent A/ 1% solvent B to 90% solvent A/ 10% solvent B in 10 minutes). 
Yield = 0.011 g (84%). 
 
1H NMR (400 MHz, CD3OD ) d (ppm): 8.51 (s, 1H), 8.16 (s, 1H), 7.90 (dd, J = 8.2, 1.3 Hz, 
1H), 7.72 – 7.64 (m, 1H), 7.52 (td, J = 7.6, 1.4 Hz, 1H), 7.40 (ddd, J = 8.1, 7.4, 1.5 Hz, 1H), 
6.25 (d, J = 6.1 Hz, 1H), 5.15 (d, J = 14.5 Hz, 1H), 4.96 (d, J = 14.6 Hz, 1H), 4.66 (dd, J = 6.1, 
4.9 Hz, 1H), 4.60 (dd, J = 4.9, 3.0 Hz, 1H), 4.32 – 4.26 (m, 1H), 4.13 (m, 2H). 
13C NMR (101 MHz, CD3OD) d (ppm): 157.21, 153.84, 150.71, 148.82, 141.04, 135.29, 
134.43, 130.22, 129.40, 125.44, 120.07, 87.29, 86.68, 84.39, 71.21, 70.17, 65.70. 
31P NMR (162 MHz, CD3OD) d (ppm): 2.27. 
HR-MS (ESI) m/z calcd. for C17H20N6O9P (M + H)+ 483.1029, found 483.1021. 
 
Synthesis of compound 4-17 
 
 
 The synthesis was performed under a normal atmosphere. To a 20 mL vial was 
added 1.56 mL of acetic anhydride and 1.54 mL of pyridine, stirred in the iced-water bath. 
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Nicotinamide mononucleotide (NMN) (4-16) (0.05 g, 0.149 mmol, 1 equic) was dissolved 
in 0.4 mL of water, then added to the acetic anhydride/pyridine solution dropwise. The 
reaction was stirred in the iced-water bath for 1 h, then warmed to room temperature 
and stirred for another 5 h. The solvent was removed by a rotary evaporator. The residue 
was evaporated repeatedly with 2 mL of water 3 times, then left on high-vacuum 
overnight. To the residue was added 2 mL of 1:1 water:pyridine and stirred at room 
temperature for 3 h. The solvent was removed by rotary evaporator. The residue was 
evaporated repeatedly with 1 mL of 1:1 water:pyridine for 5 times, then left it on high-
vacuum overnight. The product was used for the next step without further purification. 
Yield = 0.0554 g (89%). 
 
1H NMR (400 MHz, D2O) d (ppm): 9.50 (p, J = 0.7 Hz, 1H), 9.32 (d, J = 6.3 Hz, 1H), 8.99 (dt, 
J = 8.2, 1.7 Hz, 1H), 8.32 – 8.26 (m, 1H), 6.58 (d, J = 5.1 Hz, 1H), 5.64 – 5.59 (m, 1H), 5.56 
(dd, J = 5.4, 3.7 Hz, 1H), 4.35 (ddd, J = 11.9, 4.4, 2.1 Hz, 1H), 4.17 (ddd, J = 11.9, 4.7, 1.9 
Hz, 1H), 2.17 (s, 3H), 2.15 (s, 3H). 
13C NMR (400 MHz, D2O) d (ppm): 172.67, 172.48, 146.80, 143.23, 140.69, 134.28, 128.84, 
97.87, 84.98, 76.73, 70.91, 63.56, 19.88. 
31P NMR (162 MHz, D2O) d (ppm): 1.14. 
HR-MS (ESI) m/z calcd. for C15H20N2O10P (M + H)+ 419.0856, found 419.0851. 
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Synthesis of compound 4-19 
 
 To a 7 mL vial was added compound 4-17 (0.0202 g, 0.0483 mmol, 2.8 equiv), 1,1’-
carbonyldiimidazole (CDI) (0.078 g, 0.483 mmol, 28 equiv) and DMF 1 mL. The mixture 
stirred at room temperature for 4 h. To the reaction was added 5 mL of dry MeOH and 
stirred at room temperature for 30 min. The solvent was removed by a rotary evaporator 
to afford 4-18. The compound 4-18 was left on high-vacuum overnight.  
A 0.3 mL of DMF was added to compound 4-18. In another vial, compound 4-15 
was added 0.35 mL of 0.5 M MgCl2 in DMF then transferred to 4-18 solution dropwise. 
The reaction was stirred at room temperature for 24 h. The solvent was removed by 
rotary evaporator and purified by HPLC preparative C18 column (gradient of 99% solvent 
A/ 1% solvent B to 20% solvent A/ 10% solvent B in 10 minutes). Yield = 0.0068 g (43%). 
 
1H NMR (400 MHz, D2O) d (ppm): 9.30 (s, 1H), 9.18 – 9.11 (m, 1H), 8.86 – 8.77 (m, 1H), 
8.22 – 8.14 (m, 1H), 8.13 (s, 1H), 8.01 (s, 1H), 7.61 – 7.57 (m, 1H), 7.38 – 7.31 (m, 2H), 7.24 
(ddd, J = 8.8, 6.7, 2.3 Hz, 1H), 6.36 (d, J = 4.3 Hz, 1H), 5.82 (d, J = 7.2 Hz, 1H), 5.52 – 5.43 
(m, 2H), 5.22 (d, J = 13.9 Hz, 1H), 4.72 – 4.63 (m, 3H), 4.61 (dd, J = 5.5, 2.0 Hz, 1H), 4.43 
(m, 1H), 4.34 (m, 1H), 4.21 (m, 3H), 2.15 (s, 3H), 2.12 (s, 3H). 
31P NMR (162 MHz, D2O) d (ppm): -10.30 (d, J = 18.9 Hz), -10.63 (d, J = 20.1 Hz). 
HR-MS (ESI) m/z calcd. for C32H37N8O18P2 (M+H)+ 883.1701, found 883.1682. 
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Synthesis of compound 4-20 
 
To a 7 mL vial was added compound 4-19 (0.0017 g, 1.88 µmol, 1 equiv) and dry 
MeOH 0.36 mL, stirred in iced-water bath. Then, 0.14 mL of cold 7 M NH3 in MeOH was 
added to the 4-19 solution dropwise (final concentration of NH3 was 2 M). The reaction 
was stirred in the iced-water bath for 5 h. The solvent was removed by a rotary 
evaporator. The residue was evaporated repeatedly with 1 mL of water 3 times to afford 
product 4-20. Yield = 0.0013 g (85%). 
1H NMR (400 MHz, D2O) d (ppm): 9.25 (d, J = 1.6 Hz, 1H), 9.09 – 9.05 (m, 1H), 8.75 (dt, J = 
8.2, 1.3 Hz, 1H), 8.15 – 8.12 (m, 1H), 8.11 (s, 1H), 7.98 (s, 1H), 7.57 (dd, J = 7.7, 1.1 Hz, 1H), 
7.34 – 7.31 (m, 2H), 7.21 (ddd, J = 8.9, 6.6, 2.4 Hz, 1H), 6.01 (d, J = 5.5 Hz, 1H), 5.81 (d, J = 
7.5 Hz, 1H), 5.21 (d, J = 13.7 Hz, 1H), 4.70 – 4.64 (m, 2H), 4.59 (m, 2H), 4.49 (t, J = 2.4 Hz, 
1H), 4.42 (t, J = 5.3 Hz, 1H), 4.39 (dd, J = 5.0, 2.8 Hz, 1H), 4.37 – 4.30 (m, 2H), 4.24 – 4.11 
(m, 3H). 
31P NMR (162 MHz, D2O) d (ppm): -10.35 (d, J = 22.0 Hz), -10.62 (d, J = 21.4 Hz). 
HR-MS (ESI) m/z calcd. for C28H33N8O16P2 (M+H)+ 799.1490, found 799.1476. 
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4.2.3. Chemoenzymatic Study 
4.2.3.1. Reaction of PARP1 with Natural b-NAD+ 
 The reaction condition of Lin et al.143 was followed with modification. To a 2 mL 
vial was added natural b-NAD+ (100 µM), activated DNA (0.25 µg/µL), and PARP1 (0.15 
µM) in 100 µL reaction buffer (containing 100 mM Tris.HCl, 10 mM MgCl2, 1 mM DTT, pH 
8.0). The mixture was incubated in a water-bath at 37 °C. The reaction was monitored 
with the UV detection at 254 nm at the given times by taking 10 µL of sample and diluting 
with 90 µL of water and subsequently analyzed by HPLC reverse-phase column with 
gradient of 99% solvent C/ 1% solvent D to 95% solvent C/ 5% solvent D in 10 min.  
 
4.2.3.2. Reaction of PARP1 with b-NAD+ Analogue 
 To a 2 mL vial was added b-NAD+ analogue 4-20 (100 µM), ADPr (100µM), 
activated DNA (0.25 µg/µL), and PARP1 (0.15 µM) in 100 µL reaction buffer (containing 
100 mM Tris.HCl, 10 mM MgCl2, 1 mM DTT, pH 8.0). The mixture was incubated in a water-
bath at 37 °C. The reaction was monitored with the UV detection at 254 nm at the given 
times by taking 10 µL of sample and diluting with 90 µL of water and subsequently 
analyzed by HPLC reverse-phase column with gradient of 99% solvent C/ 1% solvent D to 
90% solvent C/ 10% Solvent D in 15 min, then gradient of 90% solvent C/ 10% solvent D 
to 50% solvent C/ 50% Solvent D in 30 sec, then hold 50% solvent C/ 50% solvent D for 10 
min. 
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4.3 Results and Discussion 
4.3.1. Synthesis of ADP-Ribose from b-NAD+ 
 The first approach in this chapter is the use of auxiliary 2-6 to facilitate 
fractionation and purification of PAR. The efficiency of the conjugation method between 
auxiliary 2-6 and ADP-ribose (ADPr), which is a monomer of PAR, and the stability of the 
conjugated product were determined prior to the study with PAR polymers. Although 
ADPr is commercially available, it is highly expensive ($219/100 mg, Sigma-Aldrich). 
Therefore, ADPr was synthesized from b-NAD+ ($78.50/1 g, Sigma-Aldrich) through the 
two step sequences (Scheme 4.2). The first step was the synthesis of 2’- and 3’-O-acetyl-
ADP-ribose (4-3a and 4-3b) from b-NAD+ which reported by Szczepankiewicz et al.140 The 
initial step of this transformation was the substitution of acetate at the C-1 position (4-
3c). However, this acetate ester underwent ester migration to the hydroxyl group at C-2 
and C-3 positions, which were more thermodynamically stable (Scheme 4.3), resulting in 
the formation of compound 4-3a and 4-3b as products.140 The reaction of 4-3a and 4-3b 
in diluted NaOH in 50 min gave product 4-4 in 85% yield. However, it should be noted 
here that by mixing 4-3a and 4-3b with NaOH for a long period (more than 1.5 h) could 
result in the undesired adenosine monophosphate (AMP) as a product. 
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4.3.2. Neoglycoconjugation of ADP-Ribose with Auxiliary  
 With the auxiliary 2-6 and ADPr 4-4 in hand, the glycoconjugation between 2-6 
and 4-4 was conducted following the procedure explained in Chapter 2 but a three-fold 
molar excess of auxiliary 2-6 was used instead (Scheme 4.4). Also, due to the solubility 
issue of ADPr in DMF, DMSO was used as a cosolvent. The reaction was monitored by 
HPLC reverse-phase column. It is known that ADPr is highly polar and generally unable to 
retain in the reverse-phase column when using water:acetonitrile as a mobile phase. 
Surprisingly, the hydrophobicity from 2-6 allows the conjugated product 4-5 to retain in 
the C18 column when using water:acetonitrile as a mobile phase, and the product 4-5 can 
be purified by HPLC preparative C18 column. Unfortunately, the stability issue of the 
conjugated product and the low yield discouraged for further investigations. It was shown 
that the conjugated product could be hydrolyzed during the removal of solvent from the 
rotary evaporator. The removal of the solvent after the purification by HPLC could be 
achieved via a freeze-dry technique. Furthermore, there was only 16% yield obtained 
from the conjugation reaction, which is not feasible for the conjugation with PAR 
polymers that are more complex than ADPr. Therefore, the reaction condition requires 
further optimization, such as increasing the concentration of the substrates and increase 
the solubility of the substrate by changing the solvents that used in the reaction. 
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4.3.3. Design of the Photocaged b-NAD+ Analogue and Strategy Toward Synthesis of 
ADP-Ribose Oligomers in a Controlled Manner 
 The photocaged b-NAD+ analogue was designed based on the knowledge that 
PARP1 elongates the PAR polymer at the 2’-OH position. It is believed that by modifying 
this position with protecting group, it can prevent the undesired elongation. There are 2 
requirements for a suitable protecting group. First, after putting the protecting group on 
the b-NAD+, the PARP1 enzyme should still recognize it as a substrate. Second, the 
protecting group should be removed under the mild condition, and the removal process 
should not disturb other functional groups on the polymer. The photoremovable 2-
nitrobenzyl group is chosen in this aspect because it can be selectively removed by the 
UV light144 (Scheme 4.5).   
  
A previous study reported that PARP1 could catalyze the formation of the PAR 
chain onto a functionalized-ADPr.145 In this aspect, it is envisioned that with the presence 
of ADPr (free ADPr) in the solution containing PARP1 and b-NAD+, PARP1 can catalyze the 
formation of PAR from b-NAD+ onto a free ADPr. With the similar events but using a b-
NAD+ analogue (4-20) as a substrate, the PARP1 enzyme would catalyze the formation of 
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Scheme 4.5: Deprotection of photoremovable 2-nitrobenzyl with UV light. 
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a dimer of ADPr analogue (Scheme 4.6a). After selective removal of the protecting group 
by UV light, the 2’-OH of an ADPr dimer will be available for the addition of the next 
monomer analogue. By repeating this process for several rounds, the desired length of 
the ADPr oligomers will be obtained (Scheme 4.6b). 
 
 
 
 
+ 
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ADPr dimer 
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ADPr dimer 
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1) PARP1,             
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Scheme 4.6: Proposed a new approach for chemoenzymatic synthesis of PAR: 
(a) synthesis of ADP-ribose dimer and (b) synthetic sequence for the synthesis 
of ADPr oligomers. 
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4.3.4. Synthesis of Photocaged b-NAD+ Analogue 
 The b-NAD+ analogue is designed to contain a photoremovable 2-nitrobenzyl 
group at the 2’-OH (4-20). In general, the introduction of the benzyl group from benzyl 
halide onto the hydroxyl group can be done by using a strong base. However, those 
reaction conditions would not be practical in this aspect because b-NAD+ contains a 
variety of labile functional groups. According to the retrosynthetic analysis (Scheme 4.7), 
the formation of pyrophosphate between nicotinamide mononucleotide (NMN, 4-16) and 
the photocaged AMP (4-15) can be achieved through the imidazolide activating process. 
The photocaged AMP can be obtained from the introduction of a phosphate group at the 
5’-OH of the adenosine 4-8.  
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The synthetic route of the photocaged AMP is shown in Scheme 4.8. The synthesis 
of 2-nitrobenzyl adenosines (4-8 and 4-9) was achieved following a published procedure.3 
The treatment of adenosine (4-6) with sodium hydride in DMF followed by the addition 
of 2-nitrobenzyl bromide (4-7) led to the selective alkylation at the 2’-OH to form 4-8. 
After the precipitation, compound 4-8 can be used for the next step without further 
purification. There was an attempt to introduce a phosphate group onto a 5’-OH of the 4-
8 by using phosphoryl chloride. However, the multiple phosphorylated products were 
observed, and they were difficult to determine which hydroxyl group was 
phosphorylated. Therefore, the amine and the 3’-OH were protected (Compound 4-11) 
before the introduction of the phosphate. The primary amine on the adenine was 
protected with the benzoyl group in pyridine to obtain 4-9 in 60% yield. Subsequently, the 
two hydroxyl groups were silylated with TBSCl in DMF to afford 4-10. Then, a silyl 
protecting group at the 5’-OH was selectively deprotected using trichloroacetic acid in 
THF/H2O142,146 to afford 4-11 in 95% yield Di-tert-butyl phosphoramidite (4-12) and the 
combination of 1-methylimidazole and 1-methylimidazolium chloride were chosen for the 
phosphorylation of 4-11 to afford 4-13 because this condition reduced the amount of H-
phosphonate byproduct.138,147 The deprotection of di-tert-butyl on the phosphate and the 
TBS group on the 3’-OH could be done simultaneously using TFA in CH2Cl2. After 
purification with reverse-phase HPLC, compound 4-14 was obtained in an acceptable 
yield. Finally, the benzoyl protecting group was removed by methanolic ammonia to 
afford photocaged AMP 4-15. 
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Nicotinamide mononucleotide (NMN) (4-16) is commercially available and was 
used without further purification. The attempt to use an unprotected NMN for a 
pyrophosphate formation was not practical because multiple pyrophosphate products 
were observed.  One of the reasons is that NMN is poorly soluble in an organic solvent, 
even in DMF. Furthermore, the hydroxyl groups on the NMN could also act as a 
nucleophile to react at the activated phosphate during the activation process. Therefore, 
2’- and 3’-OH on NMN were protected with acetate group prior to the activation step by 
using acetic anhydride in pyridine/water to afford 4-17 (Scheme 4.9).  
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The pyrophosphate synthesis of compound 4-17 and 4-15 was achieved through 
the activation of the phosphate group on 4-17 with CDI in dry DMF (Scheme 4.10). Ten 
equivalents of CDI were used to form the monophosphate imidazolide 4-18. The excess 
CDI was quenched with dry methanol. Next, compound 4-15 was dissolved in a DMF 
solution containing 0.5 M MgCl2 then transferred to the solution of 4-18 dropwise to 
afford the protected b-NAD+ analogue 4-19. There was an attempt to remove the acetate 
protecting group by Et3N in MeOH containing EDTA upon purification. However, the 
product was difficult to purify by reverse-phase HPLC because its polarity is similar to 
byproducts. Therefore, compound 4-19 was purified before the deprotection of the 
acetate group. The acetate deprotection was done in 2 M NH3 in MeOH at 0 °C. It was 
shown that by using a high concentration of ammonia (7 M NH3 in MeOH), the 
nicotinamide group was cleaved to form an undesired photocaged ADP-ribose. Finally, 
photocaged b-NAD+ 4-20 was obtained through the multiple evaporations with water to 
remove excess ammonia and ammonium acetate. 
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4.3.5. Chemoenzymatic Synthesis of ADP-Ribose Dimer Using Photocaged b-NAD+ 
Analogue 
Since the concentrations of substrate (b-NAD+) and the amount of enzyme could 
affect the activity of the enzyme. The reaction conditions were investigated to find the 
suitable condition for the PARylation of PARP1. Natural b-NAD+ was used in this study and 
the reaction was monitored by HPLC with the UV detection at 254 nm. It was found that 
the reaction contained 100 µM of natural b-NAD+ and 0.15 µM of PARP1 was suitable for 
the PARylation, as indicated by the HPLC chromatograms that b-NAD+ was consumed by 
the enzyme within 30 min (Figure 4.4). However, the formation of AMP could also be 
observed from the reaction mixture after 24 h.  
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With the b-NAD+ analogue 4-20 in hand, the formation of the ADPr dimer 
analogue (as shown in Scheme 4.6a) was attempted in vitro with PARP1 using the similar 
condition as describes for a natural b-NAD+. If the ADPr dimer analogue is formed, the 
HPLC chromatogram should show the decrease of 4-20 and ADPr peaks and the increase 
of a new peak between two starting material peaks. However, the HPLC chromatograms 
(Figure 4.5) showed that b-NAD+ analogue 4-20 was not consumed by the enzyme after 
24 h indicating that the desired ADPr dimer analogue was not formed. The decrease of 
ADPr peak did not indicate the formation of the expected dimer; however, ADPr was 
hydrolyzed to AMP after 24 h, as confirmed with the standard AMP. 
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Figure 4.4: HPLC chromatogram from the reaction of PARP 1 with natural b-NAD+. 
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To determine whether compound 4-20 was a suitable substrate for PARP1, the 
study of PARylation of PARP1 using both natural b-NAD+ and b-NAD+ analogue 4-20 as 
substrates was conducted. The HPLC chromatograms (Figure 4.6) demonstrated that only 
natural b-NAD+ was consumed by the enzyme as indicated by the decrease of b-NAD+ 
peak and the increase of NMN peak, which was compared with the NMN standard. 
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Figure 4.5: HPLC chromatogram from the reaction of PARP 1 with 
ADPr and b-NAD+ analogue 4-20. 
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Unfortunately, the decrease in b-NAD+ analogue 4-20 could not be observed. This 
information was therefore led to the conclusion that b-NAD+ analogue 4-20 was not a 
suitable substrate for the PARP1 enzyme.  
 
 
For further investigation, ADPr and natural b-NAD+ were used to evaluate the 
desired approach whether PARP1 could be able to catalyze the elongation of PAR from b-
NAD+ onto ADPr in solution. The HPLC chromatograms (Figure 4.7) showed that the peak 
of b-NAD+ only decreased slightly indicating that the activity of PARP1 was decreased 
compared to the experiment that used only natural b-NAD+ (Figure 4.4), which was 
Figure 4.6: HPLC chromatogram from the reaction of PARP 1 with 
natural b-NAD+ and b-NAD+ analogue 4-20. 
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consumed by the enzyme within 30 min. The ADPr peak decreased after 24 h with the 
increase of AMP peak. It was reasoned that the low concentration of the enzyme affected 
the rate of the reaction while the presence of ADPr in the solution decreased the 
enzymatic activity. The increase of AMP peak with the decrease of ADPr peak indicated 
that the reaction condition was not suitable for ADPr for a long period. Therefore, the 
reaction conditions need to be further evaluated, such as increasing the amount of 
enzyme and decreasing the concentration of ADPr to maintain the enzymatic activity. 
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Figure 4.7: HPLC chromatogram from the reaction of PARP1 
with natural b-NAD+ and ADPr. 
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4.4 Conclusions and Future Directions 
 The neoglycoside auxiliary 2-6 was successfully conjugated with ADPr under 
sodium phosphate buffer pH 4.7. The conjugated product was obtained in 16% yield. 
Although this conjugation reaction provided enough efficiency to reasonably obtain the 
conjugated product, it might not be sufficient for the conjugation with PAR. The structures 
of PAR are more complicated than ADPr and will result in the lower efficiency of the 
conjugation. As mentioned in Chapter 1, section 1.3.3 that the equilibrium constant of 
neoglycoconjugation is low, and the reaction is usually required high concentration of the 
substrates. The reaction condition for the conjugation of auxiliary 2-6 with ADPr is needed 
to be further optimized by increasing the concentration of the substrates. Furthermore, 
the solubility of both substrates can be enhanced by changing the solvents used in the 
reaction. 
A photocaged b-NAD+ analogue (4-20) was successfully synthesized from the 
pyrophosphate formation between the photocaged AMP (4-15) and the acetylated NMN 
(4-17). The photoremovable 2-nitrobenzyl was installed at the 2’-OH of adenosine before 
the addition of a phosphate at the 5’-OH to obtain the photocaged AMP. The two hydroxyl 
groups (2’’- and 3’’-OH) on NMN needed to be protected with acetyl group before the 
activation of the phosphate to avoid the formation of byproducts during the 
pyrophosphate coupling with 4-15.  
 Chemoenzymatic synthesis of ADP-ribose dimer using b-NAD+ analogue 4-20 and 
ADP-ribose as substrates was not successful due to the inability of PARP1 to recognize 
compound 4-20 as a substrate. The protecting group on the b-NAD+ analogue is needed 
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to be modified to be recognized by the enzyme, such as using a smaller protecting group. 
The results from the chemoenzymatic reaction of natural b-NAD+ and ADP-ribose 
suggested that the reaction conditions need to be further evaluated by increasing the 
amount of enzyme and decreasing the concentration of ADPr. However, the reason that 
precluded from a full investigation of the chemoenzymatic reaction is a lack of ability to 
access a high amount of the enzyme. 
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APPENDIX A: PSEUDO FIRST-ORDER HYDROLYSIS GRAPHS OF COMPOUND 2-7 
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Figure A.1. Pseudo first-order hydrolysis graph of compound 2-7 at pH 5. 
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Figure A.2. Pseudo first-order hydrolysis graph of compound 2-7 at pH 7. 
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Figure A.3. Pseudo first-order hydrolysis graph of compound 2-7 at pH 9. 
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APPENDIX B: NMR SPECTRA FOR CHAPTER 2 
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Figure B.1. 1H NMR spectrum of compound 2-2. 
Figure B.2. 13C NMR spectrum of compound 2-2. 
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Figure B.3. 1H NMR spectrum of compound 2-4. 
Figure B.4. 13C NMR spectrum of compound 2-4. 
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Figure B.5. 1H NMR spectrum of compound 2-5. 
 
Figure B.6. 1H NMR spectrum of compound 2-5. 
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Figure B.7. 1H NMR spectrum of compound 2-6. 
Figure B.8. 13C NMR spectrum of compound 2-6. 
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Figure B.9. 1H NMR spectrum of compound 2-7. 
Figure B.10. 1H NMR spectrum of compound 2-7. 
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13C (101 MHz, D2O) d (ppm): 167.86, 164.43, 141.38, 131.81, 130.71, 128.64, 103.56, 
93.72, 78.74, 76.83, 76.28, 76.01, 75.24, 73.16, 71.61, 70.33, 69.22, 61.72, 60.77, 39.44, 
20.74. 
HR-MS (ESI) m/z calcd. for C23H34N5O11 (M + H)+ 556.2249, found 556.2255. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
glucopyranosyl-(1®4)-b-D-glucopyranoside (2-8) 
  
Prepared according to the general procedure A using D-maltose (0.155 g, 0.430 
mmol) as a reducing sugar to obtain compound 2-8 as a pink powder. Yield = 0.025 g 
(51%). 
1H NMR (400 MHz, D2O) d (ppm): 
 1H NMR (ppm) 
Glc 1 – H1 4.17 (d, J = 9.1 Hz) 
Glc 1 – H2 3.65 – 3.55  
Glc 1 – H3  3.78 – 3.76 
Glc 1 – H4 3.76 – 3.70 
Glc 1 – H5 3.52 – 3.48 
Glc 1 – H6a 3.68 – 3.52  
훂  4
N
O
N
N
N
N
2-8
Figure B.11. 1H NMR spectrum of compound 2-8. 
Figure B.12. 13C NMR spectrum of compound 2-8. 
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 28 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
glucopyranoside (2-9) 
 
Prepared according to the general procedure A using D-glucose (0.084 g, 0.467 
mmol) as a reducing sugar to obtain compound 2-9 as a pink powder. Yield = 0.0613 g 
(66%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 1H NMR (ppm) 
Glc 1 4.16 (d, J = 8.8 Hz) 
Glc 2 3.58 (t, J = 8.9 Hz) 
Glc 3  3.50 (t, J = 8.5 Hz) 
Glc 4 3.36  
Glc 5 3.36  
Glc 6a 3.88 (d, J = 12.5 Hz) 
Glc 6b 3.71 (dd, J = 12.3 Hz, J = 4.7 Hz) 
CH aromatic 8.17 (d, J = 8.1 Hz, 2H) 
CH aromatic 7.53 (d, J = 8.1 Hz, 2H) 
CH2-O-N 4.84 (s, 2H) 
O
N
O
Me
OH
HO
HO OH
N
N
N
N
2-9
Figure B.13. 1H NMR spectrum of compound 2-9. 
Figure B.14. 13C NMR spectrum of compound 2-9. 
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13C (101 MHz, D2O) d (ppm): 167.76, 164.16, 141.51, 131.49, 130.51, 128.44, 93.88, 
77.97, 77.73, 75.14, 70.65, 70.05, 61.45, 39.41, 20.73. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1736. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-2-acetamido-2-
deoxy-D-glucopyranoside (2-10) 
  
Prepared according to the general procedure A using N-acetyl-D-glucosamine 
(0.112 g, 0.506 mmol) as a reducing sugar to obtain compound 2-10 as a pink powder. 
Yield = 0.0205 g (46%). 
1H NMR (400 MHz, D2O) d (ppm): 
CH3-tetrazine 2.98 (s, 3H) 
CH3-N 2.79 (s, 3H) 
 1H NMR (ppm) 
GlcNAc 1 4.24 (d, J = 9.7 Hz) 
GlcNAc 2 4.00 (t, J = 9.8 Hz) 
GlcNAc 3  3.51 (t, J = 9.8 Hz) 
GlcNAc 4 3.46-3.34 (m) 
O
N
O
Me
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HO HN
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2-10
Figure B.15. 1H NMR spectrum of compound 2-10. 
Figure B.16. 13C NMR spectrum of compound 2-10. 
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 30 
 
 
 
 
 
 
 
 
 
13C (101 Hz, D2O) d (ppm): 174.65, 167.79, 164.27, 141.51, 131.57, 130.71, 128.45, 92.40, 
77.90, 76.02, 74.42, 70.20, 61.39, 53.01, 39.13, 23.00, 20.73. 
HR-MS (ESI) m/z calcd. for C19H27N6O6 (M + H)+ 435.1987, found 435.2012. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
galactofuranoside (2-11a) 
 
Prepared according to the general procedure A using D-galactose (0.074 g, 0.411 
mmol) as a reducing sugar. Compound 2-11a was obtained as a pink powder. Yield = 
0.0032 g (10%). 
GlcNAc 5 3.46-3.34 (m) 
GlcNAc 6a 3.89 (dd, J = 12.4, J = 1.9 Hz) 
GlcNAc 6b 3.74 (dd, J = 12.4 Hz, J = 4.9 Hz) 
NH-acetyl 2.03 (s, 3H) 
CH aromatic 8.23 (d, J = 8.4 Hz, 2H) 
CH aromatic 7.56 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.70 (d, J = 6.1 Hz, 2H) 
CH3-tetrazine 3.00 (s, 3H) 
CH3-N 2.75 (s, 3H) 
O N O
N
N
N
N
OH
HO
OH
HO
2-11a
Figure B.17. 1H NMR spectrum of compound 2-11a. 
 
Figure B.18. 13C NMR spectrum of compound 2-11a. 
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 32 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
galactopyranoside (2-11b) 
 
Prepared according to the general procedure A using D-galactose (0.074 g, 0.411 
mmol) as a reducing sugar. Compound 2-11b was obtained as a pink powder. Yield = 
0.0183 g (57%). 
1H NMR (400 MHz, D2O) d (ppm): 
 
 1H NMR (ppm) 
Gal 1 4.16 (d, J = 9.1 Hz) 
Gal 2 3.77 (t, J = 9.2 Hz) 
Gal 3  3.65 (dd, J = 9.4 Hz, J = 3.4 Hz) 
Gal 4 3.92 (d, J = 3.2 Hz) 
Gal 5 3.66-3.64 
Gal 6a 3.81-3.77 
Gal 6b 3.73.3.69 
CH aromatic 8.27 (d, J = 8.2 Hz, 2H) 
CH aromatic 7.61 (d, J = 8.2 Hz, 2H) 
CH2-O-N 4.88 (s, 2H) 
O
N
O
Me
HO OH
N
N
N
N
2-11b
HO OH
Figure B.19. 1H NMR spectrum of compound 2-11b. 
Figure B.20. 13C NMR spectrum of compound 2-11b. 
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(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
mannopyranoside (2-12a) 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Man 1 4.16 (d, J = 0.6 Hz) 
Man 2 4.10 (d, J = 2.0 Hz) 
Man 3  3.61 – 3.60 
Man 4  3.75 (dd, J = 12.3 Hz, J = 6.1 Hz) 
Man 5 3.41 – 3.37  
Man 6a 3.91 (dd, J = 12.3 Hz, J = 2.2 Hz) 
Man 6b 3.61 – 3.60  
CH aromatic 8.34 (d, J = 8.4 Hz, 2H) 
CH aromatic 7.64 (d, J = 8.4 Hz, 2H) 
CH2-O-N 4.93 (d, J = 6.0 Hz, 2H) 
CH3-tetrazine 3.03 (s, 3H) 
CH3-N 2.79 (s, 3H) 
O
OH
HO
HO
2-12a
OH
N
O
N
N
N
N
Figure B.21. 1H NMR spectrum of compound 2-12a. 
Figure B.22. 13C NMR spectrum of compound 2-12a. 
 171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 35 
13C (101 MHz, D2O) d (ppm): 167.91, 164.55, 141.53, 131.89, 130.60, 128.70, 94.00, 79.02, 
75.27, 74.61, 70.18, 67.52, 61.72, 40.94, 20.70. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1725. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-
mannopyranoside (12b) 
 
1H NMR (400 MHz, D2O) d (ppm): 
 1H NMR (ppm) 
Man 1 4.17 (d, J = 3.3 Hz) 
Man 2 4.18 – 4.16 
Man 3  3.66 – 3.64 
Man 4 3.69 – 3.66 
Man 5 3.65 – 3.63 
Man 6a 3.80 – 3.77 
Man 6b  3.74 – 3.70 
CH aromatic 8.38 (d, J = 8.4 Hz, 2H) 
CH aromatic 7.67 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.87 (d, J = 2.9 Hz, 2H) 
O
N
O
Me
OH
HO
HO
N
N
N
N
2-12b
OH
Figure B.23. 1H NMR spectrum of compound 2-12b. 
Figure B.24. 13C NMR spectrum of compound 2-12b. 
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13C (101 MHz, D2O) d (ppm): 167.95, 164.62, 141.53, 132.05, 131.12, 128.77, 94.80, 75.96, 
74.70, 71.51, 69.13, 67.58, 61.74, 41.03, 20.76. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1715. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-a-D-
mannofuranoside (2-12c) 
 
1H NMR (400 MHz, D2O) d (ppm): 
CH3-tetrazine 3.04 (s, 3H) 
CH3-N 2.67 (s, 3H) 
 1H NMR (ppm) 
Man 1 4.54 (d, J = 7.3 Hz) 
Man 2 4.38 (dd, J = 6.9 Hz, J = 4.5 Hz) 
Man 3  4.25 (dd, J = 4.4 Hz, J = 2.2 Hz) 
Man 4   3.58 (dd, J = 12.2 Hz, J = 5.7 Hz) 
Man 5 3.88 (m) 
Man 6a 3.94 (dd, J = 9.2 Hz, J = 2.3 Hz) 
Man 6b 3.74 (dd, J = 11.7 Hz, J = 3.0 Hz) 
HO OHO
H
HOHO
N O
N
N
N
N
2-12c
Figure B.25. 1H NMR spectrum of compound 2-12c. 
Figure B.26. 13C NMR spectrum of compound 2-12c. 
 173 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 37 
 
 
 
 
 
 
13C (101 MHz, D2O) d (ppm): 167.97, 164.69, 141.35, 132.13, 130.70, 128.82, 98.83, 80.77, 
75.40, 73.27, 72.11, 69.64, 63.74, 40.33, 20.76. 
HR-MS (ESI) m/z calcd. for C17H24N5O6 (M + H)+ 394.1721, found 394.1725. 
 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-N-methylhydroxylamino-b-D-xylopyranoside 
(2-13a) 
 
Prepared according to the general procedure A using D-xylose (0.063 g, 0.42 
mmol) as a reducing sugar to obtain compound 2-13a as a pink powder. Yield = 0.0206 g 
(67%). 
 
 
 
CH aromatic 8.39 (d, J = 7.6 Hz, 2H) 
CH aromatic 7.66 (d, J = 7.7 Hz, 2H) 
CH2-O-N 4.89 (d, J = 5.1 Hz, 2H) 
CH3-tetrazine 3.03 (s, 3H) 
CH3-N 2.72 (s, 3H) 
O
N
O
Me
HO OH
N
N
N
N
2-13a
HO
Figure B.27. 1H NMR spectrum of compound 2-13a. 
Figure B.28. 13C NMR spectrum of compound 2-13a. 
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2.2.7. Hydrolysis of Conjugated Auxiliary 
 
 
To a 20 mL vial was added glycoconjugate 2-6 0.0166 g (0.0289 mmol) and 6 mL 
of 0.25% of TFA in water. The reaction was stirred at room temperature for 3 h. Then, 
DOWEX 1X8 (-OH form) 0.9 g was added to the solution and stirred for 10 minutes. 
DOWEX resins were then filtered out of the solution. The auxiliary was removed by 
extracting with CH2Cl2 3 times. The aqueous layer was concentrated using rotary 
evaporator to obtain unconjugated D-lactose (yield = 96%). 
 
2.2.4. Synthesis of N-Acertyl-neuraminic acid-a-(2®3)-Lactopyranoside (2-17) 
 
To a 7 mL vial, glycoconjugated 2-6 (1 mM, 1 eq) and CMP-N-acetyl-neuraminic 
acid (1 mM, 1 eq) were added to 3 mL of Tris.HCl buffer (0.1 M, pH 8.0). Next, 50 µL of a-
2,3-sialyltransferase (1 mg/mL) was added to the reaction mixture then incubated at 37 
oC. The reaction was monitor by HPLC (gradient of 99% water/ 1% acetonitrile to 60% 
water/ 40% acetonitrile in 20 minutes). The reaction was left overnight to reach to 
completion. Upon completion, the reaction was concentrated by rotary evaporator then 
훃 4
N
O
N
N
N
N
2-7
1) 0.25% TFA in water
2) DOWEX 1X8 (OH-)
훃 4
O
N
N N
N
N
H
Me
96%
2-6
D-Lactose
훃  4
N
O
훂  3
NN
N N
2-17
Figure B.29. 1H NMR spectrum of compound 2-17. 
Figure B.30. 13C NMR spectrum of compound 2-17. 
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n = 2 (2-18)  
 
 
 
1H NMR (400 MHz, D2O) d (ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1H NMR (ppm) 
Xyl 1 – H1 4.09 (d, J = 8.5 Hz) 
Xyl 1 – H2 3.55 
Xyl 1 – H3  3.38 
Xyl 1 – H4 3.23 
Xyl 1 – H5a 3.92 
Xyl 1 – H5b 3.58 
Xyl 2 – H1 4.42 
Xyl 2 – H2 3.21 
Xyl 2 – H3  3.53 
Xyl 2 – H4 3.29 
Xyl 2 – H5a 4.06 
Xyl 2 – H5b 3.69 
CH aromatic 8.30 (d, J = 8.3 Hz, 2H) 
CH aromatic 7.61 (d, J = 8.3 Hz, 2H) 
CH2-O-N 4.86 (d, J = 1.7 Hz, 2H) 
CH3-tetrazine 3.02 (s, 3H) 
CH3-N 2.74 (s, 3H) 
N
O
N
N
N
N
β  4
2-18
Figure B.31. 1H NMR spectrum of compound 2-18. 
Figure B.32. 13C NMR spectrum of compound 2-18. 
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13C (101 Hz, D2O) d (ppm): 167.90, 164.55, 141.59, 131.83, 130.59, 128.67, 102.47, 
94.67, 77.06, 76.24, 75.84, 75.17, 73.41, 70.51, 69.82, 65.85, 65.33, 39.41, 20.73. 
HR-MS (ESI) m/z calcd. for C21H30N5O9 (M + H)+ 496.2038, found 496.2025. 
n = 3 (2-19)  
 
 
 
 1H NMR (ppm) 
Xyl 1 – H1 4.09 (d, J = 8.5 Hz) 
Xyl 1 – H2  3.57 
Xyl 1 – H3  3.38 
Xyl 1 – H4 3.27 
Xyl 1 – H5a 3.92 
Xyl 1 – H5b 3.60 
Xyl 2 – H1 4.42 
Xyl 2 – H2 3.21 
Xyl 2 – H3  3.50 
 Xyl 2 – H4 3.29-3.35 
Xyl 2 – H5a 4.06 
Xyl 2 – H5b 3.77-3.66 
Xyl 3 – H1 4.43 
Xyl 3 – H2 3.23 
N
O
N
N
N
N
β  4 β  4
2-19
Figure B.33. 1H NMR spectrum of compound 2-19. 
Figure B.34. 1H NMR spectrum of compound 2-19. 
 177 
 
 
 
 
 47 
n = 4 (2-20)  
 
 
 1H NMR (ppm) 
Xyl 1 – H1 4.10 (d, J = 8.1 Hz) 
Xyl 1 – H2  3.57 
Xyl 1 – H3  3.39 
Xyl 1 – H4 3.3.27-3.37 
Xyl 1 – H5a 3.94 
Xyl 1 – H5b 3.61 
Xyl 2 – H1 4.42-4.46 
Xyl 2 – H2 3.20-3.25 
Xyl 2 – H3  3.49-3.56 
Xyl 2 – H4 3.3.27-3.37 
Xyl 2 – H5a 4.05-4.09 
Xyl 2 – H5b 3.68-3.78 
Xyl 3 – H1 4.42-4.46 
Xyl 3 – H2 3.20-3.25 
Xyl 3 – H3 3.49-3.56 
Xyl 3 – H4 3.27-3.37 
Xyl 3 – H5a 4.05-4.09 
Xyl 3 – H5b 3.68-3.78 
N
O
N
N
N
N
β  4 β  4 β  4
2-20
Figure B.35. 1H NMR spectrum of compound 2-20. 
Figure B.36. 13C NMR spectrum of compound 2-20. 
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Figure C.1. 1H NMR spectrum of compound 3-5. 
Figure C.2. 13C NMR spectrum of compound 3-5. 
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Figure C.3. 1H NMR spectrum of compound 3-6. 
Figure C.4. 13C NMR spectrum of compound 3-6. 
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Figure C.5. 1H NMR spectrum of compound 3-7. 
Figure C.6. 1H NMR spectrum of compound 3-7. 
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Figure C.7. 1H NMR spectrum of compound 3-8. 
Figure C.8. 13C NMR spectrum of compound 3-8. 
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Figure C.9. 1H NMR spectrum of compound 3-9. 
 
Figure C.10. 13C NMR spectrum of compound 3-9. 
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Figure C.11. 1H NMR spectrum of compound 3-10. 
 
Figure C.12. 13C NMR spectrum of compound 3-10. 
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Figure C.13. 1H NMR spectrum of compound 3-11. 
 
Figure C.14. 13C NMR spectrum of compound 3-11. 
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Figure C.15. 1H NMR spectrum of compound 3-12. 
Figure C.16. 13C NMR spectrum of compound 3-12. 
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Figure C.17. 1H NMR spectrum of compound 3-13. 
 
Figure C.18. 13C NMR spectrum of compound 3-13. 
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Figure C.19. 1H NMR spectrum of compound 3-14. 
Figure C.20. 13C NMR spectrum of compound 3-14. 
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Figure C.21. 1H NMR spectrum of compound 3-15. 
Figure C.22. 13C NMR spectrum of compound 3-15. 
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Figure C.23. 1H NMR spectrum of compound 3-16. 
Figure C.24. 13C NMR spectrum of compound 3-16. 
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Figure C.25. 1H NMR spectrum of compound 3-17. 
Figure C.26. 13C NMR spectrum of compound 3-17. 
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Figure C.27. 1H NMR spectrum of compound 3-18. 
Figure C.28. 13C NMR spectrum of compound 3-18. 
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Figure C.29. 1H NMR spectrum of compound 3-19. 
Figure C.30. 13C NMR spectrum of compound 3-19. 
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Figure C.31. 1H NMR spectrum of compound 3-20. 
Figure C.32. 13C NMR spectrum of compound 3-20. 
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Figure C.33. 1H NMR spectrum of compound 3-21. 
Figure C.34. 13C NMR spectrum of compound 3-21. 
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Figure C.35. 1H NMR spectrum of compound 3-22. 
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Figure C.36. 1H NMR spectrum of compound 3-23. 
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Figure C.37. 1H NMR spectrum of compound 3-24. 
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Figure D.1. 1H NMR spectrum of compound 4-3a and 4-3b. 
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Figure D.2. 1H NMR spectrum of compound 4-4. 
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Figure D.4. 31P NMR spectrum of compound 4-5. 
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Figure D.5. 1H NMR spectrum of compound 4-8. 
Figure D.6. 13C NMR spectrum of compound 4-8. 
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Figure D.7. 1H NMR spectrum of compound 4-9. 
Figure D.8. 13C NMR spectrum of compound 4-9. 
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Figure D.9. 1H NMR spectrum of compound 4-10. 
Figure D.10. 13C NMR spectrum of compound 4-10. 
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Figure D.11. 1H NMR spectrum of compound 4-11. 
Figure D.12. 13C NMR spectrum of compound 4-11. 
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Figure D.13. 1H NMR spectrum of compound 4-13. 
Figure D.14. 31P NMR spectrum of compound 4-13. 
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Figure D.15. 1H NMR spectrum of compound 4-14. 
Figure D.16. 13C NMR spectrum of compound 4-14. 
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Figure D.17. 31P NMR spectrum of compound 4-14. 
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Figure D.18. 1H NMR spectrum of compound 4-15. 
Figure D.19. 13C NMR spectrum of compound 4-15. 
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Figure D.20. 31P NMR spectrum of compound 4-15. 
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Figure D.21. 1H NMR spectrum of compound 4-17. 
Figure D.22. 13C NMR spectrum of compound 4-17. 
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Figure D.23. 31P NMR spectrum of compound 4-17. 
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Figure D.24. 1H NMR spectrum of compound 4-19. 
Figure D.25. 31P NMR spectrum of compound 4-19. 
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Figure D.26. 1H NMR spectrum of compound 4-20. 
Figure D.27. 31P NMR spectrum of compound 4-20. 
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